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 ชื่อวิทยานิพนธ การสังเคราะหและยนืยันโครงสรางของสารประกอบเชิงซอนของโลหะ
รูทีเนียม โดยมีลิแกนด 5-methyl-2-(phenylazo)pyridine 






ไดสังเคราะหลิแกนด เอโซอิมีนตัวใหม  คือ  5-methyl-2-(phenylazo)pyridine 
(5mazpy)  เมื่อนําลิแกนดใหม  5mazpy มาทําปฏิกิริยากับ RuCl3.3H2O ในตัวทําละลายเอทานอล  
เกิดเปนสามไอโซเมอรของสารประกอบ [Ru(5mazpy)2Cl2]  ไดแก   cis-trans-cis (ctc)    cis-cis-cis 
(ccc) และ  trans-cis-cis (tcc)  มีการสังเคราะหสารประกอบเชิงซอน   [Ru(5mazpy)2L](PF6)2    
[Ru(5mazpy)2L′](PF6)2 และ  [Ru(L′)25mazpy](PF6)2  เมื่อ L คือ 2-(phenylazo)pyridine (azpy)   5-
methyl-2-(phenylazo)pyridine (5mazpy)  และ  L′ คือ  2,2′-bipyridine (bpy)    1,10-phenanthro- 
lene  (phen)   ไดศึกษาเคมีของสารประกอบเชิงซอนดังกลาวโดยเทคนิคการวิเคราะหหาปริมาณ
ธาตุที่เปนองคประกอบ   แมสสเปกโทรเมททรี    การวัดการดูดกลืนแสง  และ อินฟราเรดสเปกโทร 
สโกป   ศึกษานิวเคลียรแมกเนติกเรโซแนนซสเปกตราของสารประกอบเชิงซอนโดยใชเทคนิค  1H    
13C    DEPT   1H-1H COSY    และ 1H-13C HMQC  นิวเคลียรแมกเนติกเรโซแนนซสเปกโทรสโกป   
ศึกษาไฟฟาเคมีของสารประกอบโดยเทคนิคไซคลิกโวลแทมเมทรี  ยืนยันโครงสรางของลิแกนด 
5mazpy และ สารประกอบเชิงซอน  ctc, ccc, tcc-[Ru(5mazpy)2Cl2] และ [Ru(5mazpy)2bpy](PF6)2 
โดยเทคนิคการเลี้ยวเบนของรังสีเอ็กซบนผลึกเดี่ยว  ผลจากการศึกษาดวยเทคนิคอินฟราเรดสเปก
โทรสโกป แถบการยืดของ N=N ในสารประกอบเชิงซอนปรากฏที่ความถี่ที่ต่ํากวาในลิแกนดอิสระ 
ซ่ึงสนับสนุนอันตรกิริยาการเกิดพันธะไพระหวางโลหะรูทีเนียมและลิแกนด (5mazpy)  นอกจากนี้
มีการสังเคราะหสารประกอบเชิงซอน [Ru(5mazpy)2L](NO3)2  [Ru(5mazpy)2L′]Cl2 และ  [Ru(L′)2 
5mazpy]Cl2  เพื่อศึกษาคุณสมบัติการจับกันระหวางดีเอ็นเอกับสารประกอบเชิงซอนโดยเทคนิคการ
ไทเทรตวัดการดูดกลืนแสง  (absorption titration) การแยงจับ (competitive binding) การวัดความ
หนืด (viscosity measurements) และ ไซคลิกโวลแทมเมทรี (cyclic voltammetry) ติดตามการตัด
สายพลาสมิดดีเอ็นเอ (pBIND)โดยเทคนิค agarose gel electrophoresis ผลจากการศึกษาแสดงให
เห็นวาสารประกอบเชิงซอนจับกับดีเอ็นเอ แบบการแทรกสอด (intercalation) และตัดสายพลาสมิด 
 
 ดีเอ็นเอ นอกจากนี้มีการทดสอบการออกฤทธิ์ทางชีวภาพของสารประกอบเชิงซอนของโลหะ
รูทีเนียมตอเซลลมะเร็งปอด (A549 และ Anti-NCl-H187) มะเร็งลําไส (WIDR)  มะเร็งรังไข 
(IGROV) มะเร็งเตานม (MCF-7 และ BC) มะเร็งอัณทะ (PC3) มะเร็งผิวหนัง (SK-MEL-28) มะเร็ง
เม็ดเลือด (CEM) และ มะเร็งเยื่อบุที่ปาก (KB) พบวา สารประกอบเชิงซอน ctc-[Ru(5mazpy)2Cl2] 
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The new azoimine functionalized ligand, 5-methyl-2-(phenylazo)- 
pyridine (5mazpy) was synthesized. It reacted with RuCl3.3H2O in ethanolic solution 
to give three isomers of [Ru(5mazpy)2Cl2]. These isomers are cis-trans-cis (ctc), cis-
cis-cis (ccc), trans-cis-cis (tcc).  In addition, the [Ru(5mazpy)2L](PF6)2, [Ru 
(5mazpy)2L′](PF6)2 and [Ru(L′)25mazpy](PF6)2 complexes (L = 2-(phenylazo)pyri- 
dine (azpy), 5-methyl-2-(phenylazo)pyridine (5mazpy); L′ = 2,2′-bipyridine (bpy), 
1,10-phenanthrolene (phen)) were also synthesized. They were characterized by 
elemental analysis, mass spectrometry, UV-visible absorption spectroscopy, and 
infrared spectroscopy. The NMR spectra have been resolved using 1H, 13C, DEPT, 
1H-1H COSY, and 1H-13C HMQC NMR spectroscopy. The electrochemistry of the 
complexes was investigated by cyclic voltammetry. The structures of 5mazpy, ctc-, 
ccc-, tcc-[Ru(5mazpy)2Cl2], and [Ru(5mazpy)2bpy](PF6)2 have been confirmed by X-
ray crystallography. Results from infrared spectroscopy show that N=N stretching 
mode in the complexes appeared at a lower frequency than that in the free ligand 
supporting Ru-azo nitrogen pi bonding interaction. In addition, the complexes of 
[Ru(5mazpy)2L](NO3)2, [Ru(5mazpy)2L′]Cl2 and [Ru(L′)25mazpy]Cl2 were also 
synthesized for studing DNA interaction. The DNA-binding properties of the 
ruthenium complexes were investigated by absorption titration, competitive binding, 
viscosity measurements, and cyclic voltammetry. In addition, the cleavage reaction on 
plasmid DNA (pBIND) has been monitored by agarose gel electrophoresis. The 
experimental results suggest that the ruthenium complexes bind to DNA in an 
intercalative mode and can cleave the plasmid DNA. Besides, the biological acticity 
of ruthenium complexes have been also studied with a series of human tumor cell 
lines, lung cancer (A549  and  Anti-NCl-H187), colon cancer (WIDR), ovarian cancer 
 (IGROV), breast cancer (MCF-7 and BC), prostate cancer (PC3), melanoma cancer 
(SK-MEL-28), leukemia (CEM) and oral human epidermal carcinoma (KB). The 
results showed that ctc-[Ru(5mazpy)2Cl2] displays high activity in lung cancer (A549) 
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 The Relevance of the Research Work to Thailand 
 
 
Cancer in Thailand is becoming a significant health problem. It is the 
leading cause of death in Thailand. The platinun compounds are widely used as 
chemotherapy drug such as  cisplatin and carboplatin. It is most commonly used to 
treat testicular, bladder, lung, stomach and ovarian cancers. But they have toxic side 
effects. Therefore, the researcher try to develop the new  drugs. In this work we focus 
on the ruthenium(II) complexes which contain the new bidentate ligand, 5-methyl-2-
(phenylazo)pyridine (5mazpy). The [Ru(5mazpy)2Cl2], [Ru(5mazpy)2L](PF6)2, [Ru 
(5mazpy)2L′](PF6)2, and [Ru(L′)25mazpy](PF6)2 complexes (L = 2-(phenylazo)pyri- 
dine (azpy), 5-methyl-2-(phenylazo)pyridine (5mazpy); L′ = 2,2′-bipyridine (bpy), 
1,10-phenanthroline (phen)) were synthesized and characterized. In addition, the 
water soluble complexes, [Ru(5mazpy)2L](NO3)2, [Ru(5mazpy)2L′]Cl2, [Ru(L′)2 
5mazpy]Cl2, were also synthesized for study of DNA interaction. Furthermore, all 
complexes, [Ru(5mazpy)2Cl2], [Ru(5mazpy)2L](PF6)2, [Ru(5mazpy)2L′](PF6)2, [Ru 
(L′)25mazpy](PF6)2, [Ru(5mazpy)2L](NO3)2, [Ru(5mazpy)2L′]Cl2, and [Ru(L′)2 
5mazpy]Cl2, were investigated cytotoxicity against a series of human tumor cell lines 
(A549, CEM, IGROV, MCF-7, PC3, SK-MEL-28, WIDR, Anti-NCI-H187, BC, and 
KB). The result from this work is a basic knowledge for developing the new 
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(NO3)2, [Ru(5mazpy)2L′]Cl2, and [Ru(L′)25mazpy]Cl2 complexes 
in the absence and presence of CT DNA 
IC50 values (µM) of a series of ruthenium(II) complexes and 
cisplatin against a series of tumor cell lines (A549, CEM, 
IGROV, MCF-7, PC3, SK-MEL-28, WIDR) 
IC50 values (µg/mL) of a series of ruthenium(II) complexes and 
cisplatin against a series of tumor cell lines (Anti-NCI-H187, BC, 
KB) 
The solvents for UV-Visible spectrum and the their cut-off              
Bond lengths (Å) and angles (o) of the 5mazpy ligand    
Bond lengths (Å) and angles (o) of the ctc-[Ru(5mazpy)2Cl2] 
complex                
Bond lengths (Å) and angles (o) of the ccc-[Ru(5mazpy)2Cl2] 
complex         
Bond lengths (Å) and angles (o) of the tcc-[Ru(5mazpy)2Cl2] 
complex    
Bond lengths (Å) and angles (o) of the [Ru(5mazpy)2bpy](PF6)2 









































































The five posible of the [Ru(5mazpy)2Cl2] isomer                              
FAB mass spectrum of the 5mazpy ligand                                        
FAB mass spectrum of the ctc-[Ru(5mazpy)2Cl2] complex              
FAB mass spectrum of the ccc-[Ru(5mazpy)2Cl2] complex              
FAB mass spectrum of the tcc-[Ru(5mazpy)2Cl2] complex              
Infrared spectrum of the 5mazpy ligand                                            
Infrared spectrum of the ctc-[Ru(5mazpy)2Cl2] complex                  
Infrared spectrum of the ccc-[Ru(5mazpy)2Cl2] complex                 
Infrared spectrum of the tcc-[Ru(5mazpy)2Cl2] complex    
UV-Visible absorption spectrum of the 5mazpy ligand in CH2Cl2    
UV-Visible absorption spectrum of the ctc-[Ru(5mazpy)2Cl2]         
complex in CH2Cl2     
UV-Visible absorption spectrum of the ccc-[Ru(5mazpy)2Cl2]         





























































UV-Visible absorption spectrum of the tcc-[Ru(5mazpy)2Cl2]         
complex in CH2Cl2       
1H NMR spectrum of the 5mazpy ligand in CDCl3                           
1H-1H COSY NMR spectrum of the 5mazpy ligand in CDCl3          
13C NMR spectrum of the 5mazpy ligand in CDCl3                          
DEPT 135 NMR spectrum of the 5mazpy ligand in CDCl3              
1H-13C HMQC NMR spectrum of the 5mazpy ligand in CDCl3       
1H NMR spectrum of the ctc-[Ru(5mazpy)2Cl2] complex in 
CDCl3                
1H-1H COSY NMR spectrum of the ctc-[Ru(5mazpy)2Cl2] 
complex  in CDCl3 
13C NMR spectrum of the ctc-[Ru(5mazpy)2Cl2] complex in 
CDCl3  
DEPT 135 NMR spectrum of the ctc-[Ru(5mazpy)2Cl2] complex 
in CDCl3 
1H-13C HMQC NMR spectrum of the ctc-[Ru(5mazpy)2Cl2]            
complex in CDCl3 
1H NMR spectrum of the ccc-[Ru(5mazpy)2Cl2] complex                
in CDCl3 
1H-1H COSY NMR spectrum of the ccc-[Ru(5mazpy)2Cl2]              
complex in CDCl3 
13C NMR spectrum of the ccc-[Ru(5mazpy)2Cl2] complex               
in CDCl3      
DEPT 135 NMR spectrum of ccc-[Ru(5mazpy)2Cl2] in CDCl3   
1H-13C HMQC NMR spectrum of ccc-[Ru(5mazpy)2Cl2]                 



























































1H NMR spectrum of the tcc-[Ru(5mazpy)2Cl2] complex                 
in CDCl3 
1H-1H COSY NMR spectrum of the tcc-[Ru(5mazpy)2Cl2]              
complex in CDCl3 
13C NMR spectrum of the tcc-[Ru(5mazpy)2Cl2] complex                
in CDCl3 
DEPT 135 NMR spectrum of the tcc-[Ru(5mazpy)2Cl2] complex  
in CDCl3 
1H-13C HMQC NMR spectrum of the tcc-[Ru(5mazpy)2Cl2] 
complex in CDCl3 
Cyclic voltammogram of the 5mazpy ligand in CH2Cl2                      
(0.1 M TBAH) at scan rate 100 mVs-1 
Cyclic voltammogram of the ctc-[Ru(5mazpy)2Cl2] complex           
in CH2Cl2  (0.1 M TBAH) at scan rate 100 mVs-1 
Cyclic voltammogram of the ccc-[Ru(5mazpy)2Cl2] complex          
in CH2Cl2 (0.1 M TBAH) at scan rate 100 mVs-1 
Cyclic voltammogram of the tcc-[Ru(5mazpy)2Cl2] complex           
in CH2Cl2  (0.1 M TBAH) at scan rate 100 mVs-1                  
X-ray structure of the 5mazpy ligand    
X-ray structure of the ctc-[Ru(5mazpy)2Cl2] complex                      
X-ray structure of the ccc-[Ru(5mazpy)2Cl2] complex 
X-ray structure of the tcc-[Ru(5mazpy)2Cl2] complex 
The structure of the 5-methyl-2-(phenylazo)pyridine (5mazpy),      
2-(phenylazo)pyridine (azpy), 2,2′-bipyridine(bpy),   



























































ESI mass spectrum of the [Ru(5mazpy)3](PF6)2 complex                 
ESI mass spectrum of the [Ru(5mazpy)2azpy](PF6)2 complex          
ESI mass spectrum of the [Ru(5mazpy)2bpy](PF6)2 complex           
ESI mass spectrum of the [Ru(5mazpy)2phen](PF6)2 complex          
Infrared spectrum of the [Ru(5mazpy)3](PF6)2 complex                   
Infrared spectrum of the [Ru(5mazpy)2azpy](PF6)2 complex            
Infrared spectrum of the [Ru(5mazpy)2bpy](PF6)2 complex             
Infrared spectrum of the [Ru(5mazpy)2phen](PF6)2 complex            
Infrared spectrum of the [Ru(bpy)25mazpy](PF6)2 complex             
Infrared spectrum of the [Ru(phen)25mazpy](PF6)2 complex            
UV-Visible absorption spectrum of the [Ru(5mazpy)3](PF6)2           
complex in CH3CN  
UV-Visible absorption spectrum of the [Ru(5mazpy)2azpy](PF6)2   
complex in CH3CN  
UV-Visible absorption spectrum of the [Ru(5mazpy)2bpy](PF6)2     
complex in CH3CN  
UV-Visible absorption spectrum of the [Ru(5mazpy)2phen](PF6)2   
complex in CH3CN 
UV-Visible absorption spectrum of the [Ru(bpy)25mazpy](PF6)2     
complex in CH3CN  
UV-Visible absorption spectrum of the [Ru(phen)25mazpy](PF6)2   
complex in CH3CN  
1H NMR spectrum of the [Ru(5mazpy)3](PF6)2 complex in  
acetone-d6         
1H-1H COSY NMR spectrum of the [Ru(5mazpy)3](PF6)2 






























































13C NMR spectrum of the [Ru(5mazpy)3](PF6)2 complex                         
in acetone-d6 
DEPT 135 NMR spectrum of the [Ru(5mazpy)3](PF6)2 complex      
in acetone-d6 
1H-13C HMQC NMR spectrum of the [Ru(5mazpy)3](PF6)2             
complex  in acetone-d6 
1H NMR spectrum of the [Ru(5mazpy)2azpy](PF6)2 complex in       
acetone-d6 
1H-1H COSY NMR spectrum of the [Ru(5mazpy)2azpy](PF6)2        
complex in acetone-d6 
13C NMR spectrum of the [Ru(5mazpy)2azpy](PF6)2 complex              
in acetone-d6 
DEPT 135 NMR spectrum of the [Ru(5mazpy)2azpy](PF6)2            
complex  in acetone-d6 
1H-13C HMQC NMR spectrum of the [Ru(5mazpy)2azpy](PF6)2      
complex in acetone-d6 
1H NMR spectrum of the [Ru(5mazpy)2bpy](PF6)2 complex in        
acetone-d6 
1H-1H COSY NMR spectrum of the [Ru(5mazpy)2bpy](PF6)2          
complex in acetone-d6 
13C NMR spectrum of the [Ru(5mazpy)2bpy](PF6)2 complex                
in acetone-d6 
DEPT 135 NMR spectrum of the [Ru(5mazpy)2bpy](PF6)2              
complex in acetone-d6 
1H-13C HMQC NMR spectrum of the [Ru(5mazpy)2bpy](PF6)2       






























































1H NMR spectrum of the [Ru(5mazpy)2phen](PF6)2 complex in      
acetone-d6 
1H-1H COSY NMR spectrum of the [Ru(5mazpy)2phen](PF6)2        
complex   in acetone-d6 
13C NMR spectrum of the [Ru(5mazpy)2phen](PF6)2 complex           
in acetone-d6 
DEPT 135 NMR spectrum of the [Ru(5mazpy)2phen](PF6)2            
complex in acetone-d6  
1H-13C HMQC NMR spectrum of the [Ru(5mazpy)2phen](PF6)2     
complex in acetone-d6 
1H NMR spectrum of the [Ru(bpy)25mazpy](PF6)2 complex in        
acetone-d6 
1H-1H COSY NMR spectrum of the [Ru(bpy)25mazpy](PF6)2          
complex  in acetone-d6 
13C NMR spectrum of the [Ru(bpy)25mazpy](PF6)2 complex                
in acetone-d6 
DEPT 135 NMR spectrum of the [Ru(bpy)25mazpy](PF6)2              
complex in acetone-d6 
1H-13C HMQC NMR spectrum of the [Ru(bpy)25mazpy](PF6)2       
complex in acetone-d6 
1H NMR spectrum of the [Ru(phen)25mazpy](PF6)2 complex in      
acetone-d6 
1H-1H COSY NMR spectrum of the [Ru(phen)25mazpy](PF6)2        
complex in acetone-d6 
13C NMR spectrum of the [Ru(phen)25mazpy](PF6)2 complex          






























































DEPT 135 NMR spectrum of the [Ru(phen)25mazpy](PF6)2            
complex in acetone-d6 
1H-13C HMQC NMR spectrum of the [Ru(phen)25mazpy](PF6)2     
complex  in acetone-d6 
Cyclic voltammogram of the [Ru(5mazpy)3](PF6)2 complex in        
CH3CN (0.1 M TBAH) at scan rate 100 mVs-1 
Cyclic voltammogram of the [Ru(5mazpy)2azpy](PF6)2 complex     
in CH3CN (0.1 M TBAH) at scan rate 100 mVs-1 
Cyclic voltammogram of the [Ru(5mazpy)2bpy](PF6)2 complex      
in CH3CN (0.1 M TBAH) at scan rate 100 mVs-1 
Cyclic voltammogram of the [Ru(5mazpy)2phen](PF6)2 complex    
in CH3CN (0.1 M TBAH) at scan rate 100 mVs-1 
Cyclic voltammogram of the [Ru(bpy)25mazpy](PF6)2 complex      
in CH3CN (0.1 M TBAH) at scan rate 100 mVs-1 
Cyclic voltammogram of the [Ru(phen)25mazpy](PF6)2 complex    
in CH3CN (0.1 M TBAH) at scan rate 100 mVs-1 
X-ray structure of the [Ru(5mazpy)2bpy](PF6)2 complex                  
Infrared spectrum of the [Ru(5mazpy)3](NO3)2.5H2O complex        
Infrared spectrum of the [Ru(5mazpy)2azpy](NO3)2.4H2O 
complex               
Infrared spectrum of the [Ru(5mazpy)2bpy]Cl2.6H2O complex        
Infrared spectrum of the [Ru(5mazpy)2phen]Cl2.7H2O complex      
Infrared spectrum of the [Ru(bpy)25mazpy]Cl2.6H2O complex        
Infrared spectrum of the [Ru(phen)25mazpy]Cl2.9H2O complex      































































1H-1H COSY NMR spectrum of the [Ru(5mazpy)3](NO3)2.5H2O    
complex in CD3OD 
13C NMR spectrum of the [Ru(5mazpy)3](NO3)2.5H2O complex     
in CD3OD 
DEPT 135 NMR spectrum of the [Ru(5mazpy)3](NO3)2.5H2O         
complex in CD3OD 
1H-13C HMQC NMR spectrum of the 
[Ru(5mazpy)3](NO3)2.5H2O complex in CD3OD 
1H NMR spectrum of the [Ru(5mazpy)2azpy](NO3)2.4H2O 
complex   in CD3OD 
1H-1H COSY NMR spectrum of the 
Ru(5mazpy)2azpy](NO3)2.4H2O omplex in CD3OD
13C NMR spectrum of the [Ru(5mazpy)2azpy](NO3)2.4H2O 
complex in CD3OD 
DEPT 135 NMR spectrum of the 
[Ru(5mazpy)2azpy](NO3)2.4H2O complex in CD3OD 
1H-13C HMQC NMR spectrum of the [Ru(5mazpy)2azpy](NO3)2. 
4H2O complex in CD3OD
1H NMR spectrum of the [Ru(5mazpy)2bpy]Cl2.6H2O complex       
in CD3OD 
1H-1H COSY NMR spectrum of the [Ru(5mazpy)2bpy]Cl2.6H2O    
complex in CD3OD 
13C NMR spectrum of the [Ru(5mazpy)2bpy]Cl2.6H2O complex     
in CD3OD 






























































1H-13C HMQC NMR spectrum of the 
[Ru(5mazpy)2bpy]Cl2.6H2O complex in CD3OD 
1H NMR spectrum of the [Ru(5mazpy)2phen]Cl2.7H2O complex     
in CD3OD 
1H-1H COSY NMR spectrum of the [Ru(5mazpy)2phen]Cl2.7H2O  
complex in CD3OD 
13C NMR spectrum of the [Ru(5mazpy)2phen]Cl2.7H2O complex    
in CD3OD 
DEPT 135 NMR spectrum of the [Ru(5mazpy)2phen]Cl2.7H2O       
complex in CD3OD 
1H-13C HMQC NMR spectrum of the [Ru(5mazpy)2phen] 
Cl2.7H2O complex in CD3OD 
1H NMR spectrum of the [Ru(bpy)25mazpy]Cl2.6H2O complex       
in CD3OD 
1H-1H COSY NMR spectrum of the [Ru(bpy)25mazpy]Cl2.6H2O    
complex in CD3OD 
13C NMR spectrum of the [Ru(bpy)25mazpy]Cl2.6H2O complex     
in CD3OD 
DEPT 135 NMR spectrum of the [Ru(bpy)25mazpy]Cl2.6H2O         
complex in CD3OD 
1H-13C HMQC NMR spectrum of the 
[Ru(bpy)25mazpy]Cl2.6H2O  complex in CD3OD 
1H NMR spectrum of the [Ru(phen)25mazpy]Cl2.9H2O complex     
in CD3OD      



























































13C NMR spectrum of the [Ru(phen)25mazpy]Cl2.9H2O complex    
in CD3OD 
DEPT 135 NMR spectrum of the [Ru(phen)25mazpy]Cl2.9H2O       
complex in CD3OD 
1H-13C HMQC NMR spectrum of the 
[Ru(phen)25mazpy]Cl2.9H2O complex in CD3OD 
(a) Absorption spectra of the [Ru(5mazpy)3](NO3)2.5H2O 
complex in Tris-base buffer (pH 7.4). Plots [DNA]/(εa-εf) vs 
[DNA]. (b) Plots of (εa-εf)/(εb-εf) vs [DNA]. 
(a) Absorption spectra of the [Ru(5mazpy)2azpy](NO3)2.4H2O        
complex in Tris-base buffer (pH 7.4). Plots [DNA]/(εa-εf)  
vs [DNA]. (b) Plots of (εa-εf)/(εb-εf) vs [DNA]. 
(a) Absorption spectra of the [Ru(5mazpy)2bpy]Cl2.6H2O                
complex in Tris-base buffer (pH 7.4). Plots [DNA]/(εa-εf)  
vs [DNA]. (b) Plots of (εa-εf)/(εb-εf) vs [DNA]. 
(a) Absorption spectra of the [Ru(5mazpy)2phen]Cl2.7H2O              
complex in Tris-base buffer (pH 7.4). Plots [DNA]/(εa-εf)  
vs [DNA]. (b) Plots of (εa-εf)/(εb-εf) vs [DNA]. 
(a) Absorption spectra of the [Ru(bpy)25mazpy]Cl2.6H2O                
complex in Tris-base buffer (pH 7.4). Plots [DNA]/(εa-εf)  
vs [DNA]. (b) Plots of (εa-εf)/(εb-εf) vs [DNA]. 
(a) Absorption spectra of the [Ru(phen)25mazpy]Cl2.6H2O              
complex in Tris-base buffer (pH 7.4). Plots [DNA]/(εa-εf)  























































a) Emission spectra of EB in Tris-base buffer in the absence            
and presence of increasing the concentrations of the 
[Ru(5mazpy)3](NO3)2.5H2O complex  
(b) Fluorescence quenching curve of EB bound to DNA by  
[Ru(5mazpy)3](NO3)2.5H2O 
(a) Emission spectra of EB in Tris-base buffer in the absence          
and presence of increasing the concentrations of the  
[Ru(5mazpy)2azpy](NO3)2.4H2O complex  
(b) Fluorescence quenching curve of EB bound to DNA by  
[Ru(5mazpy)2azpy](NO3)2.4H2O 
(a) Emission spectra of EB in Tris-base buffer in the absence          
and presence of increasing the concentrations of the  
[Ru(5mazpy)2bpy]Cl2.6H2O complex  
(b) Fluorescence quenching curve of EB bound to DNA by  
 [Ru(5mazpy)2bpy]Cl2.6H2O 
(a) Emission spectra of EB in Tris-base buffer in the absence          
and presence of increasing the concentrations of the  
[Ru(5mazpy)2phen]Cl2.7H2O complex  
(b) Fluorescence quenching curve of EB bound to DNA by  
 [Ru(5mazpy)2phen]Cl2.7H2O 
a) Emission spectra of EB in Tris-base buffer in the absence  
and presence of increasing the concentrations of the  
[Ru(bpy)25mazpy]Cl2.6H2O complex  



























































(a) Emission spectra of EB in Tris-base buffer in the absence          
and presence of increasing the concentrations of the  
[Ru(phen)25mazpy]Cl2.9H2O complex  
(b) Fluorescence quenching curve of EB bound to DNA by  
[Ru(phen)25mazpy]Cl2.9H2O 
Effects of increasing amount of the [Ru(5mazpy)3](NO3)2.5H2O,    
[Ru(5mazpy)2azpy](NO3)2.4H2O, [Ru(bpy)3]Cl2.6H2O complexes  
and EB on relative viscosities of CT DNA at 25°C
Effects of increasing amount of the [Ru(5mazpy)2bpy]Cl2.6H2O,    
[Ru(5mazpy)2phen]Cl2.7H2O, [Ru(bpy)3]Cl2.6H2O complexes  
and EB on relative viscosities of CT DNA at 25°C
Effects of increasing amount of the [Ru(bpy)25mazpy]Cl2.6H2O,    
[Ru(phen)25mazpy]Cl2.9H2O, [Ru(bpy)3]Cl2.6H2O,  
[Ru(phen)3]Cl2.7H2O  complexes and EB on 
relative viscosities of CT DNA at 25°C
Cyclic voltammograms of the [Ru(5mazpy)3](NO3)2.5H2O              
complex in 5mM Tris-base/50 mM NaCl buffer (pH 7.2)  
at scan rate 100 mVs-1 
Cyclic voltammograms of the [Ru(5mazpy)2azpy](NO3)2.4H2O      
complex in 5mM Tris-base/50 mM NaCl buffer (pH 7.2)  
at scan rate 100 mVs-1
Cyclic voltammograms of the [Ru(5mazpy)2bpy]Cl2.6H2O              
complex in 5mM Tris-base/50 mM NaCl buffer (pH 7.2)  






















































Cyclic voltammograms of the [Ru(5mazpy)2phen]Cl2.7H2O            
complex in 5mM Tris-base/50 mM NaCl buffer (pH 7.2)  
at scan rate 100 mVs-1
Cyclic voltammograms of the [Ru(bpy)25mazpy]Cl2.6H2O              
complex in 5mM Tris-base/50 mM NaCl buffer (pH 7.2)  
at scan rate 100 mVs-1      
Cyclic voltammograms of the [Ru(phen)25mazpy]Cl2.9H2O            
complex in 5mM Tris-base/50 mM NaCl buffer (pH 7.2)  
at scan rate 100 mVs-1
Electrophoresis behavior of the pBIND DNA in the presence of 
complexes on 1% agarose gel electrophoresis. Lane 0: plasmid 
DNA;  lane 1-5: plasmid DNA was incubated with 20, 40, 60, 80, 
and 100 µM of [Ru(5mazpy)2azpy](NO3)2.4H2O, respectively;  
lane 6-10: plasmid DNA was incubated with 20, 40, 60, 80, and 
100 µM of [Ru(5mazpy)3](NO3)2.5H2O respectively.  
Electrophoresis behavior of the pBIND DNA in the presence of 
complexes on 1% agarose gel electrophoresis. Lane 0: plasmid 
DNA;  lane 1-5: plasmid DNA was incubated with 20, 40, 60, 
80, and 100 µM of [Ru(5mazpy)2phen]Cl2.7H2O, respectively;  
lane 6-10: plasmid DNA was incubated with 20, 40, 60, 80, and 





















































Electrophoresis behavior of the pBIND DNA in the presence of 
complexes on 1% agarose gel electrophoresis. Lane 0: plasmid 
DNA;  lane 1-5: plasmid DNA was incubated with 20, 40, 60, 80, 
and 100 µM of [Ru(phen)25mazpy]Cl2.9H2O, respectively;  lane 
6-10: plasmid DNA was incubated with 20, 40, 60, 80, and 100 
µM of [Ru(bpy)25mazpy]Cl2.6H2O respectively.  
IC50 curves of the ctc-[Ru(azpy)2Cl2] complex against                      
a series of tumor cell lines  
(A549, CEM, IGROV, MCF-7, PC3, SK-MEL-28, WIDR) 
IC50 curves of the ccc-[Ru(azpy)2Cl2] complex against                     
a series of tumor cell lines  
(A549, CEM, IGROV, MCF-7, PC3, SK-MEL-28, WIDR) 
IC50 curves of the tcc-[Ru(azpy)2Cl2] complex against                      
a series of tumor cell lines  
(A549, CEM, IGROV, MCF-7, PC3, SK-MEL-28, WIDR) 
IC50 curves of the ctc-[Ru(5mazpy)2Cl2] complex against                 
a series of tumor cell lines  
(A549, CEM, IGROV, MCF-7, PC3, SK-MEL-28, WIDR) 
IC50 curves of the ccc-[Ru(5mazpy)2Cl2] complex against                
a series of tumor cell lines  
(A549, CEM, IGROV, MCF-7, PC3, SK-MEL-28, WIDR) 
IC50 curves of the tcc-[Ru(5mazpy)2Cl2] complex against                 
a series of tumor cell lines  

























































IC50 curves of cisplatin against a series of tumor cell lines                
(A549, CEM, IGROV, MCF-7, PC3, SK-MEL-28, WIDR) 
Cyclic voltammograms of the 5mazpy ligand in the reduction 
range with various  scan rates (50-1000 mVs-1) 
Cyclic voltammograms of the ctc-[Ru(5mazpy)2Cl2] complex         
- couple I (a),  couple II (b) in the reduction range and  
couple Ru(II/III) (c) in oxidation range with various scan rates  
(50-1000 mVs-1) 
Cyclic voltammograms of the ccc-[Ru(5mazpy)2Cl2] complex         
- couple I (a), couple II (b) in the reduction range and  
couple Ru(II/III) (c) in oxidation range with various scan rates  
(50-1000 mVs-1) 
Cyclic voltammograms of the tcc-[Ru(5mazpy)2Cl2] complex         
- couple I (a), couple II (b) in the reduction range and  
couple Ru(II/III) (c) in oxidation range with various scan rates  
 (50-1000 mVs-1) 
Cyclic voltammograms of the [Ru(5mazpy)3](PF6)2 complex           
- couple I (a), couple II (b), and couple III (c) in the reduction  
range with various scan rates (50-1000 mVs-1) 
Cyclic voltammograms of the [Ru(5mazpy)3](PF6)2 complex           
- couple IV (a), and couple V (b) in the reduction range with  
various scan rates (50-1000 mVs-1) 
Cyclic voltammograms of the [Ru(5mazpy)2azpy](PF6)2 complex   
- couple I (a), couple II (b), and couple III (c) in the reduction  

























































Cyclic voltammograms of the [Ru(5mazpy)2azpy](PF6)2 complex   
- couple IV (a), and couple V (b) in the reduction range with  
various scan rates (50-1000 mVs-1) 
Cyclic voltammograms of the [Ru(5mazpy)2bpy](PF6)2 complex     
- couple I (a), couple II (b), and couple (III) (c) in the reduction  
range with various scan rates (50-1000 mVs-1) 
Cyclic voltammograms of the [Ru(5mazpy)2bpy](PF6)2 complex     
- couple IV (a), and couple V (b) in the reduction range with  
various scan rates (50-1000 mVs-1) 
Cyclic voltammograms of the [Ru(5mazpy)2phen](PF6)2 complex   
- couple I (a),  couple II (b), and couple (III) (c) in the reduction  
range with various scan rates (50-1000 mVs-1) 
Cyclic voltammograms of the [Ru(5mazpy)2phen](PF6)2 complex   
- couple IV (a), and couple V (b) in the reduction range with 
various scan rates (50-1000 mVs-1) 
Cyclic voltammograms of the [Ru(bpy)25mazpy](PF6)2 complex     
- couple I (a), couple II (b), and couple (III) (c) in the reduction  
range with various scan rates (50-1000 mVs-1) 
Cyclic voltammograms of the [Ru(bpy)25mazpy](PF6)2 complex     
- couple IV (a), in the reduction range and couple Ru(II/III) (b) 
in oxidation range with various scan rates (50-1000 mVs-1) 
  Cyclic voltammograms of the [Ru(phen)25mazpy](PF6)2 complex   
- couple I (a), couple II (b), and couple (III) (c) in the reduction  




































Cyclic voltammograms of the [Ru(phen)25mazpy](PF6)2 complex   
- couple IV (a), in the reduction range and couple Ru(II/III) (b) in  
oxidation range with various scan rates (50-1000 mVs-1) 
 
 

























 Abbreviations and symbols 
 
 
5mazpy  5-Methyl-2-(phenylazo)pyridine 
Å  Angstrom unit (1Å = 10-10 meter) 
A.R. grade  Analytical reagent grade 
azpy  2-(Phenylazo)pyridine 
bpy  2,2′-Bipyridine 
CD3OD                   Deuterated methanol 
CDCl3       Deuterated chloroform 
CH3CN                   Acetonitrile 
CHCl3                                   Chloroform 
CH2Cl2                 Dichloromethane 
cm-1                         Wave number 
COSY        Correlation spectroscopy 
CT DNA                     Calf thymus DNA 
CV                              Cyclic voltammetry 
d                               Doublet 
dd                            Doublet of doublet 
ddd          Doublet of doublet of doublet 
DEPT  Distortionless Enhancement by Polarization Transfer 
DMF                       N,N-Dimethylformamide 
DMSO                    Dimethyl sulfoxide 
FAB MS                 Fast-atom bombardment Mass Spectrometry 
ESI          Electro spray ionization mass spectrometry 
g                              Gram 
h                              Hour 
HMQC  Heteronuclear Multiple Quantum Correlation experiment 
HOMO       Highest Occupied Molecular Orbital  
 
 
 Abbreviations and symbols (Continued) 
 
 
Hz                           Hertz 
IC50                             Inhibitory concentration of 50% 
IR                            Infrared 
J                              Coupling constant 
K                             Kelvin 
LUMO                        Lowest Unoccupied Molecular Orbital  
mL                           Milliliter 
mmol                       Millimole 
mVs-1                      Millivolt per second 
m/z                          A value of mass divided by charge 
MLCT                     Metal to ligand charge transfer 
MW                         Molecular weight 
nm                           Nanometer 
NMR                           Nuclear Magnetic Resonance 
NOESY                      Nuclear Overhauser Enhancement Spectroscopy 
phen                            1,10-Phenanthroline 
ppm                         Part per million 
Rel. Abun.              Relative abundance 
s                                  Singlet  
SCE                               Saturated Salomel reference Electrode 
t                                  Triplet 
td Triplet of doublet 
TMS                           Tetramethylsilane 
UV-Vis                       Ultraviolet-Visible 
°                                  Degree 
ε                                  Molar extinction coefficient 
δ                                  Chemical shift relative to TMS 
 




1.1  Background 
 
The ruthenium(II) complexes containing azoimine (-N=N-C=N-) and 
imine (-N=C-C=N-) functional units have been chosen for study of their chemistry. 
These two functions are isoelectronic and π-acidic in character. 
   Azoimine ligands, such as 2-(phenylazo)pyridine (azpy), which 
contain the -N=N-C=N- linkage have unusual properties (Velder et al., 2004). The 
pyridine ring is an intermediate π-accepter, and its nitrogen is a weak σ-donor. The 
azo group has low σ-donor ability to the metal, but possesses enhanced π-accepting 
ability through the azo π* orbital. The polypyridyl ligand is a symmetric bidentate 
ligand, which has σ-donor and π-accepter properties such as 2,2′-bipyridine (bpy) and 
1,10-phenantroline (phen). These ligands contain the imine moiety (-N=C-C=N-).  
   There are a variety of applications of the ruthenium(II) complexes with 
azoimine and imine ligands. In the research for antitumor-active metal complexes, 
several ruthenium complexes have been reported to be promising as anticancer drugs. 
For example, the [Ru(azpy)2Cl2] complexes show remarkably high cytotoxicity 
against a reries of tumor-cell lines (Velder et al., 2004). Furthermore, the 
[Ru(azpy)2L] complexes (L = 1,1-cyclobutanedicarboxylate, oxalate, malonate) 
display a promising cytotoxicity in the A2780 cell line (Hotze et al., 2003). The 
cytotoxicity data of the mer-[Ru(azpy)3](PF6)2, α-[Ru(azpy)2bpy](PF6)2, β-[Ru(azpy)2 
bpy](PF6)2 and [Ru(bpy)2azpy](PF6)2 complexes show a moderate activity in some 
particular cell lines (Hotze et al., 2005). In addition, the interaction of the cytotoxic α-
[Ru(azpy)2Cl2] with DNA-model base has been studied (Hotze et al., 2000). 
   Over the past decade there has been substantial interest in the design 
and study of DNA binding properties of a number of potential, substitution inert and 
redox active ruthenium(II) complexes,   in the hope of developing novel probes of the  
 
 DNA structure. Particularly, the octahedral ruthenium(II) complexes incorporating the 
aromatic ligands are suitable for application. They have many unique and convenient 
features such as strong visible absorbance which provide a convenient, sensitive and 
powerful spectroscopic for monitoring the DNA binding process. 
   Recently, a ruthenium(II) polypyridyl derivative, [Ru(bpy)2(dppz)]2+ 
(bpy = 2,2′-bipyridine; dppz = dipyrido[3,2-a:2′,3′-c]phenazine) was shown to be a 
remarkable luminescent light switch for DNA (Hartshorn and Barton, 1992). In 
addition, the [Ru(bpy)2(actatp)](ClO4)2.2H2O and [Ru(phen)2(actatp)](ClO4)2.2H2O 
(actatp = acenaphthereno[1,2-b]-1,4,8,9-tetraazariphenylence) complexes bind to 
DNA through an intercalative mode (Deng et al., 2003). Zhen et al. reported that 
[Ru(bpy)2L]2+ (L = 4,5, 9,18-tetraazaphenanthreno[9,10-b]triphenylene (taptp); 2,3-di-
phenyl-1,4,8,9-tetraazatriphenylene (dptatp)) bind enantioselectively to double-
stranded calf thymus DNA via the intercalative mode (Zhen et al., 1999).  
   In this work, our interest is to synthesize the complexes of 
ruthenium(II) with a new azoimine ligand, 5-methyl-2-(phenylazo)pyridine (5mazpy). 
The 5mazpy is similar to azpy but contains a methyl group (-CH3) at the fifth position 
on the pyridine ring is an unsymmetric bidentate N,N′-donor center. For this reason 
the [Ru(5mazpy)2Cl2] complexes can theoretically exist in five different isomeric 
forms. If the coordinating pairs of Cl, N(py), and N(azo) are considered in that order, 
the configurations of these isomers are trans-trans-trans (ttt), trans-cis-cis (tcc), cis-
trans-cis (ctc), cis-cis-trans (cct) and cis-cis-cis (ccc). From this work, only  three 
isomers of ctc, ccc and tcc are obtained.  
   Recently, the chloride atoms of α-[Ru(azpy)2Cl2] were replaced by a 
third azpy and bpy ligand and investigated this series for their cytotoxicity (Hotze et 
al, 2005). Moreover, the [Ru(azpy)2Cl2] complexes were under renewed investigation 
due to their cytotoxic activity in a series of human tumor cell lines (Velder et al., 
2004). In particular the α-configuration as this isomer displayed a very high 
cytotoxicity, stability and a reasonable solubility (Velder et al., 2000, 2004). 
Therefore, it is our interest to synthesize and to characterize the [Ru(5mazpy)2L] 
(PF6)2, [Ru(5mazpy)2L′](PF6)2, [Ru(L′)25mazpy](PF6)2 complexes (L = 2-(phenylazo) 
pyridine (azpy), 5-methyl-2-(phenylazo)pyridine (5mazpy); L′ = 2,2′-bipyridine 
 (bpy), 1,10-phenanthroline (phen)). In addition, the cytotoxicity of these complexes 
were also investigated. 
   In order to study DNA-binding properties of ruthenium complexes, the 
water solubility is required. Therefore, the complexes of [Ru(5mazpy)2L](NO3)2, [Ru 
(5mazpy)2L′]Cl2, and  [Ru(L′)25mazpy]Cl2 were synthesized and characterized. 
Besides, the DNA-binding of these complexes were carried out. 
    
 
1.2  Literature reviews 
 
  Syntheses and characterization of the ruthenium(II) complexes 
with the imine and azoimine ligands  
 
  Krause and Krause, (1980) studied the chemistry of the 2-
(phenylazo)pyridine (azpy) ligand and [Ru(azpy)2Cl2] complexes. Three isomers of 
these complexes were obtained. The isomers were assigned to be trans-cis-cis (γ), cis-
trans-cis (α) and cis-cis-cis (β) with referred to the order of coordination pairs of Cl, 
N(pyridine), N(azo), respectively. All of three isomers were characterized by infrared 
spectroscopy, UV-Visible absorption spectroscopy, and  13C NMR spectroscopy. The 
data from cyclic voltammetry showed that azpy ligand appeared to be a better ligand 
for stabilizing ruthenium(II) than 2,2′-bipyridine (bpy). 
 
  Goswami, et al., (1981) reported the two types of ruthenium 
complexes RuX2L2 (green) and [Ru(bpy)2L](ClO4)2.H2O (red) (X = Cl, Br, I; L = 2-
(phenylazo)pyridine of 2-(m-tolylazo)pyridine; bpy = 2,2′-bipyridine). Both types of 
complexes had intense t2(Ru)→π*(L) transition in the visible region. The complexes 
displayed electrochemical responses on the negative side of SCE due to ligand-based 
reductions. The azopyridine ligand system greatly stabilized the +2 oxidation state in 
ruthenium.  
 
 Krause and Krause, (1982) studied a series of ruthenium(II) complexes 
with the strong π-acceptor ligand 2-(phenylazo)pyridine (azpy), [Ru(azpy)2(AB)]n+ 
(AB = 2-(phenylazo)pyridine, 2,2′-bipyridine, 4,4′-bithiazole, 1,2-diaminoethane, 2,4-
pentanedione; X = NO2-, CN-, Br-, N3-, thiourea). Infrared spectra showed the azo 
stretching mode (N=N) to be diagostic of the coligand (AB) π-accepting behaviour. 
For a very strong π-acid coligand, the azo mode could approach the free ligand value, 
while with a π-base coligand a single bond order might be approached for the azo 
linkage.Visible spectra of the complexes appeared to be typical charge-transfer(CT) 
spectra. The CT band energy should be indicative of the metal-ligand interaction. 
Emission spectra could be obtained three compounds, one compound appearing to 
give multiple emission. Cyclic Voltammetric data supported the strong π-
stabilization. 
 
  Goswami, et al., (1983) examined the reactions of the [Ru(OH2)2L]2+ 
(L = 2-(phenylazo)pyridine and 2-(m-tolylazo)pyridine) with a number of bidentate 
ligands (2,2′-bipyridine (bpy), ethylenediamine (en) , acetylacetone (Hacac). The 
stereochemistries have been established with the help of 1H NMR data. The metal 
oxidation and ligand reduction behaviour of the complexes were studied 
electrochemically in acetonitrile.  
 
  Bag, et al., (1992) reported the Ru(RQc)(tap)2 complexes which were 
synthe- sized by reaction [Ru(OH2)2(tap)2](ClO4)2.H2O with catechols in the presence 
of base (RQc = catecholate, R = H, 4-t-Bu, 3,5-(t-Bu)2 or 3,4,5,6-Cl4; tap = 2-(m-
tolylazo)pyridine). The X-ray structure of [{Ru(RQc)(tap)2}2H2O].CH2Cl2 (R = H) 
was reported. Results from UV-Visible absorption spectra showed MLCT excitation 
Ru(dπ)→ RQc(pπ) at near 1000 nm. Besides, cyclic voltammetry was used to study 
their redox properties. The interligand charge-transfer transition (RQc(pπ)→tap(azo 









Figure 1.1  2-(m-Tolylazo)pyridine) 
 
  Choudhury, et al., (1992) studied the reaction of 2-arylpy- 
ridinecarboxaldimine [RH4C6NC(H)Py, L] with hydrated RuX3 (X = Cl, Br) in 
ethanol afforded crystals of RuX2L2. Two isomers of complex have been isolated and 
characterized by analytical and spectroscopic data. From the IR data, the green isomer 
is trans with respect to two chlorides and the other isomer has a cis-RuCl2 geometry. 
The high-resolution 1H NMR spectra of the compounds were used to examine the 
geometry of the isomeric RuX2L2. All the complexes have multiple t2→π*(L) 
transition in the visible region. The data from cyclic voltammetry showed that E0298 of 
the RuIII/RuII couple in RuCl2L2 depends on the nature of substitution (R) in the 
ligand L. 
 
Boelrijk, et al., (1995) investigated the oxidation of octyl α-D-
glucopyranoside by NaBrO3. The complexes of [Ru(azpy)2(H2O)2]2+  (azpy = 2-(phe- 
nylazo)pyridine and [Ru(naz)2(H2O)2]2+ (naz = 2-(p-nitrophenyl)azopyridine) were 
used to be active catalyst yielding octyl glucopyranoside (OGP). Results from 
reactions with cyclobutanol in combination with spectroscopic data indicated that 
Ru(IV)=O species was the active catalyst species. The two new complexes were 
synthesized, [Ru(terpy)(azpy)(H2O)](ClO4)2 and [Ru(terpy)(naz)(H2O)](ClO4)2. 
Besides the both complexes were less active than the first two complexes. 
 
  Misra, et al., (1998) synthesized the RuL2Cl2 complex which contained 
the new azoimidazoles, 1-methyl-2-(arylazo)imidazoles and 1-benzyl-2-(arylazo)- 
imidazoles (R = H, Me, OMe, Cl, NO2). Two isomers of this complex were 
chromatographyically separated. The isomeric structures were confirmed by X-ray 






 visible region. Results from cyclic voltammetry revealed that the Ru(III)/Ru(II) 
couple was shifted to more positive potential on going from azoimidazole to 
azopyridine-ruthenium(II) complexes due to the decrease π-acidity of the five-
membered heterocycle imidazole compared to the six-membered pyridine ring. 
 
R = H, Me, OMe, Cl, NO2 
                                                                  
X = CH3,  
                 
 
Figure 1.2  1-Methyl-2-(arylazo)imidazoles 
 
Santra, et al., (1999) reported the new N,N′-chelating ligands, 2-(aryl- 
azo)pyrimidine. These ligands reacted with RuCl3 in ethanol to give three isomers. 
There were trans-cis-cis (tcc), cis-trans-cis (ctc), and cis-cis-cis (ccc) configurations 
with reference to the order of coordination paire as Cl, N(pyridine), and N(azo). Two 
of the three isomeric structure (tcc-Ru(papm)2Cl2, ccc-Ru(papm)2Cl2; papm = 2-(phe- 
nylazo)pyrimidine) were confirmed by X-ray crystallography. The 1H NMR spectra 
of the ligands and complexes were compared to determine the binding mode and 
stereochemistry of the complexes. The electronic spectra of complexes exhibited 
allowed MLCT transitions in the visible region. Results from cyclic voltammetry 





R = H, 10-Me, 10-Cl                         
 
 
















 Hotze, et al., (2000) studied the α-[Ru(azpy)2(NO3)2] complex (azpy = 
2-(phe nylazo)pyridine). The structure of this complex was determined using X-ray 
crystallography. Besides, the binding of the DNA-model bases 9-ethylguanine 
(9equa) and guanosine (guo) was studied and compared with previously obtained 
results for the binding of model bases to the cis-[Ru(bpy)2Cl2] complex. The 
orientations of 9equa and guo in ruthenium complexes were proven using 2D NOESY 
NMR spectroscopy.  
 
Peneerselvam, et al., (2000) reported the crystal structures of the 
[protonated 2-(phenylazo)pyridine and protonated 2-(4-hydroxyphenylazo)pyridine 
(3:1)]tetrafluoroborate compound. The results from X-ray showed that the protonation 
occurred at N(azo) atom and it was more basic than N(pyridine). The azpy compound 
was normally liquid at room temperature but intramolecular H bonding, N-H-N, and 







Figure 1.4  Protonated azpy X = H (75%) and OH¯ (25%) 
 
Hotze, et al., (2002) found that adenine base coordinates to the 
cytotoxic α-[Ru(azpy)2Cl2] complex  in the  rare imine form, stabilized by N6, N7-
didentate coordination. In addition, the α-[Ru(azpy)2(3-MeAde-H)](PF6)2 was proven 
by X-ray crystallography (azpy = 2-(phenylazo)pyridine; 3-MeAde-H = deprotonate-3-
methyladenine)  
 
  Hotze, et al., (2002) studied the coordination of the DNA model base 
9-methyladenine (9-MeAde) with cis-[Ru(bpy)2Cl2] and α-[Ru(azpy)2(NO3)2]. The 
structure were confirmed by using 2D NMR techniques and variable-temperature 






 [Ru(bpy)2Cl2] and α-[Ru(azpy)2(NO3)2] is the same, this binding mode does not 
explain the earlier observed difference in cytotoxicity  between cis-[Ru(bpy)2Cl2] and 
α-[Ru(azpy)2Cl2].  
 
Hansongnern, et al., (2003) reported the crystal structure of 2-(4′,N,N-
Diethyl aminephenylazo)pyrimidine. The azo group, being coplanar with the attached 
benzene rings and the -N-C group of the substituent -N(CH2CH3)2  on the phenyl ring, 
supported extensive delocalization of electron density. The substituent donated 
electron to the conjugated system via benzene ring into π* orbital of the azo moiety 






Figure 1.5  2-(4′,N,N-Diethylaminephenylazo)pyrimidine (deazpym) 
 
Byabartta, (2003) isolated the [Ru(phen)(RaaiR′)2](ClO4)2 complexes 
(phen = 1,10-phenanthroline; RaaiR′ = 1-alkyl-2-(arylazo)imidazole, p-R-C6H4-N=N-
C3H2-NN-1-R′, R = H, Me, Cl and R′=Me, Et, CH2Ph). The structure of [Ru(phen) 
(RaaiR′)2](ClO4)2 was confirmed by X-ray diffraction study. Besides the structure and 
stereochemistry of the complexes were supported by 1H NMR data. The absorption 
spectra of the complexes exhibited a strong MLCT transition in visible region. 
Electrochemical properties of all the complexes were studied by cyclic voltammetry. 
 
  Lu, et al., (2003) studied the isomeric of the [RuL2Cl2] complex (L = 
1-(phenylazo)isoquinoline). The reaction of RuCl3 with 1-(phenylazo)isoquinoline 
produced two isomeric form. There were trans-cis-cis (tcc) and cis-cis-cis (ccc) in 
order of the coordinating pairs: (Cl, Cl); (N, N); (N′, N′) where  N represented 
N(isoquinoline), N′ represents N(azo). The configuration of two isomers was 












Figure 1.6  1-(Phenylazo)isoquinoline 
 
Hotze, et al., (2004) studied the synthesis and characterization of the 
new water soluble ligand, 2-phenylazopyridine-5-sulfonic acid (Hsazpy), and its 
ruthenium complexes, α and β-[NEt4]2[Ru(sazpy)2Cl2]. The compounds were 
characterized by 2D NMR spectroscopy. Only α-[NEt4]2[Ru(sazpy)2Cl2].2H2O was 
determined by single-crystal structure analysis. The α-[NEt4]2[Ru(sazpy)2Cl2] 







Figure 1.7  2-Phenylazopyridine-5-sulfonic acid (Hsazpy) 
 
Jasimuddin, et al., (2004) studied [Os(bpy)(RaaiR′)2](PF6)2 (RaaiR′ = 
1-alkyl-2-(arylazo)imidazole, p-R-C6H4-N=N-C3H2NN-1-R′, where R = H, Me, Cl, 
and R′ = Me, Et and CH3Ph; bpy = 2,2′-biypridine). The [Os(bpy)(MeaaiMe)2] 
(PF6)2.4H2O complex was confirmed by X-ray crystallography. The υ(N=N) and  
υ(C=N) appeared at 1370-1390 and 1590-1610 cm-1, respectively. UV-Visible 
absorption spectra of all complexes in acetonitrile solution displayed ligand-centred 
transitions in UV region, and metal-to-ligand charge transfer (MLCT) transition in 
visible region. The cyclic voltammogram exhibited Os(IV)/Os(III) and Os(III)/Os(II) 










 They were due to gradual addition of electron into two azoimine chelates from RaaiR′ 
and one diimine chelate ring in the complex. 
 
  Jasimuddin, et al., (2004) prepared the  [Ru(o/p-RaaiR′)3]Cl2 (RaaiR′ = 
1-alkyl-2-(arylazo)imidazole, R = H, p-Me, p-Ome, o-Ome; R′ = Me, Et, CH2Ph) by 
microwave technique. The complexes were characterized by IR, UV-Visible and 1H 
NMR spectral data. In the case of [Ru(o-OmeaaiCH2Ph)3]Cl2, single crystals were 
obtained. The metal-to-ligand charge transfer transition was observed at visible 
region. Cyclic voltammetry of the complexes showed one metal oxidation Ru(II)/ 
Ru(III) at the positive side and three successive ligand reduction couples negative to 
SCE as the reference electrode.  
 
Kooijman, et al., (2004) reported the crystal structure of the 
[Ru(dazpy)2Cl2] complex (dazpy = 2-phenylazo-4,6-dimethylpyridine). The dazpy 
ligand coordinated to ruthenium in the so-call α-configuration, meaning that the 








Figure 1.8  2-Phenylazo-4,6-dimethylpyridine (dazpy) 
 
Velders, et al., (2004) reported the fourth isomer of [Ru(azpy)2Cl2] 
(azpy = 2-(phenylazo)pyridine). The structure of this isomer was determined by 1H 
NMR spectroscopy and single-crystal X-ray diffraction analysis. Besides, the UV-
Visible and infrared spectroscopies were used to study chemistry of this isomer.  
 
  Hotze, et al., (2005) studied the complexes of [Ru(L3)](PF6)2 (L = 2-






 = 2-(phenylazo)pyridine, 2,2′-bipyridine). They were structurally characterized and 
investigated the cytotoxicity. The structures of mer-[Ru(azpy)3](PF6)2 and mer-
[Ru(tazpy)3](PF6)2 were determined by X-ray diffraction. NMR spectra of these series 
of compounds were resolved using 2D COSY and NOESY NMR spectroscopy. The 
cytotoxicity data against a series of human tumor cell lines (A498, EVSA-T, H226, 
IGROV, M19, MCF-7, and WIDR) showed a moderate cytotoxicity for these series of 
complexes. 
 
Jasimuddin, et al., (2005) reported the [Os(phen)(RaaiR′)2](PF6)2 
complexes (phen = 1,10-phenanthroline; RaaiR′ = 1-alkyl-2-(arylazo)imidazole, p-R-
C6H4-N=N-C3H2-NN-1-R′ where R = H, Me, Cl and R′ = Me, Et, CH2Ph). The single 
crystal of the complexes [Os(phen)(ClaaiEt)2](PF6)2 was obtained. In addition, the 
structure of  all complexes was confirmed by 1H NMR spectroscopy. Electronic 
spectra of the complexes showed ligand centered (LC) transitions in the UV region 
and metal-to-ligand charge transfer transition in visible region. Cyclic voltammetry of 
all complexes exhibited two metal redox couple, Os(III)/Os(II) and Os(IV)/Os(III), at 
the positive side versus SCE, and three successive ligand reductions. 
 
  Dinda, et al., (2006) reported the heteroleptic tris-chelates, [Ru(bpy)2 
(α/β-NaiR)](ClO4)2 complexes (bpy = 2,2′-bipyridine; α-NaiR = 1-alkyl-2-(naphthyl-
α-azo)imidazole; β-NaiR = 1-alkyl-2-(naphthyl-β-azo)imidazole). The electronic 
spectra of NaiR were recorded in CH3CN in the UV-Visible region. The 1H NMR 
spectra were collected in CD3CN. The structure of [Ru(bpy)2(α-NaiEt)](ClO4)2  was 
confirmed by single crystal X-ray diffraction technique. The voltammograms of all 
complexes displayed Ru(III)/Ru(II) couple at the positive side and the ligand 
reductions at the negative side to reference electrode, SCE. Three successive 
reduction may be expected to involve the ligand having the most stable lowest 
unoccupied molecular orbital, which was dominated by azo function of naphthyl 











R = H, Me, Et, CH2Ph 
 
Figure 1.9  (a) 1-Alkyl-2-(naphthyl-α-azo)imidazole (α-NaiR) 
                                       (b) 1-Alkyl-2-(naphthyl-β-azo)imidazole (β-NaiR)                                           
              
Al-Noaimi, et al., (2007)  studied three novel families of azomethine 
ligands (L) of the type C6H5N=NC(R)=N(4-YC6H4) (6), C6H5N=NC(R)=N(4-YC6H4) 
(7) and 4-ClC6H4N=NC(R)=N(4-YC6H4) (8). These ligands reacted with RuCl3, 2,2′-
bipyridine (bpy) and lithium chloride in ethanol to produce trans-[RuII(bpy)LCl2] 
complexes. These ligands were characterized by IR, 1H NMR, mass spectra and 
elemental analysis, UV-Visible spectroscopy. The structures of the two complexes,  
trans-[RuII(bpy)(C6H5N=NC(COCH3)=N(4-C10H7C6H4)Cl2].0.25C7H8 and trans-[RuII 
(bpy)(4-ClC6H4N=NC(CO2CH3)=N(4-C6H5)Cl2].0.5acetone were studied by X-ray 
crystallography. Results from crystallographic, electrochemical, electronic spectral 
data and DFT calculations were consistent with azomethine ligands possessing strong 
π-acceptor properties. 
         (6) : X = H, R = COCH3  
                (7) : X = H, R = CO2CH3 
                (8) : X = Cl, R = CO2CH3 
 
       (6, 7, 8)                                          Y= H (a), CH3 (b), Cl (c),  
                                                              Br (d),  C10H7 (e),  
                                                              OCH3 (f), NO2 (g) 



















   Byabartta, (2007) reported the [Ru(bpy)2(RaaiR′)2](ClO4)2 complexes 
(RaaiR′ = 1-alkyl-2-(arylazo)imidazole, m-R-C6H4-N=N-C3H2-NN-1-R′ where R = H, 
OMe, NO2 and R′ = Me, Et, CH2Ph; bpy = 2,2′-bipyridine). The molecular weight of 
all complexes was confirmed by FAB mass spectrum. IR spectra showed -N=N- 
stretching at 1370 cm-1 which was red shift 90 cm-1 from the free ligand value. The 
absorption spectra were studied within 200-1100 nm. The emission spectra was frozen 
glass (77K) which were sharper and considerably more intense than the room 
temperature spectra. The 1H NMR, 13C NMR, and 1H-1H COSY NMR were used to 
support the structure of complexes. In addition, the 1H-13C HMQC NMR spectrum 
was used to assign quaternary carbons. One redox couple was observed at positive to 
SCE which refered to Ru(III)/Ru(II) couple. Besides, three redox couples at negative 
to SCE were due to reductions of ligand. Electrochemical parameterisation of 
Ru(III)/Ru(II) redox potential was carried out and calculated ligand potential EL(L).  
 
The interactions of the ruthenium(II) complexes with calf thymus 
DNA (CT DNA)  
 
  Nair, et al., (1998) reported the synthesis and characterization of 
[Ru(NH3)4dppz]2+ (dppz = dipyridophenazine) and also explored the interactions of 
the complex with DNA. Results from DNA-binding studies showed that the addition 
of DNA clearly yielded an absorbance hypochromism of 13.6%, which was possibly 
associated with intercalated binding of the complexes to the helix. 
 
  Zhen, et al., (1999) reported the synthesis of the [Ru(bpy)2L]2+ 
complexes (L = 4,5,9,18-tetraazaphenanthreno[9,10-b]triphenylene (taptp), 2,3-diphe- 
nyl-1,4,8,9-tetraazatriphenylene (dptatp)) and characterization by using elemental 
analyses, 1H NMR, and mass spectra. The interactions of the complexes with calf 
thymus DNA were investigated by viscosity measurement, absorption titration, 
emission titration and circular dichroism. All data indicated that both complexes bind 
enantioselectively to double-stranded calf thymus DNA via the intercalative mode.  
   
 Vaidyanathan and Nair, (2002) reported the [Ru(bzimpy)2]Cl2 complex 
(bzimpy = 2,6-bis(benzimidazole-2-yl)pyridine). It was characterized by ESI-MS, UV 
-Visible, 1H NMR and fluorescence spectra. The interaction of this complex with calf 
thumus DNA was studied by absorption titration, thermal denaturation, viscosity 
measurement and fluorescence spectroscopy. 
 
  Deng, et al., (2003) reported the two novel ruthenium complexes, 
[Ru(bpy)2(actatp)](ClO4)2.2H2O, [Ru(phen)2(actatp)](ClO4)2.2H2O (actatp = acenaph- 
thereno-[1,2-b]-1,4,8,9-tetraazariphenylence; phen = 1,10-phenanthroline). These 
complexes were characterized by UV-Visible, 1H NMR, and mass spectra. The cyclic 
voltammetry was used to study electrochemical behavior of the two complexes. The 
interaction of the two complexes with calf thymus DNA was investigated by 
spectrophotometric methods and viscosity measurements. The experimental results 
supported that the actatp ligand strongly intercalated into the DNA helix. Besides, 
both complexes were found the photo cleavage of plasmid pBR322. 
  
  Jiang, et al., (2003) reported the synthesis of ruthenium complexes 
with the two novel tridentate ligand, 2-(2-benzimidazole-1,10-phenanthroline (PHBI), 
2-(2-naphthoimidazole-1,10-phenanthroline (PHNI). The [Ru(tpy)(PHBI)](ClO4)2. 
2H2O and [Ru(tpy)(PHNI)](ClO4)2.2H2O complexes (tpy = 2,2′:6′,2′′-terpyridyl) were 
characterized by elemental analysis, mass spectra, 1H NMR, absorption spectroscopy 
and also studied electrochemical behaviours by cyclic voltammetry. The interaction of 
these complexes with calf thymus DNA was investigated by spectroscopic methods 
and viscosity measurements. Results from DNA interaction study indicated that the 
two complexes interact with DNA in different binding mode. 
 
Deng, et al., (2005) reported the series of Ru(II) polypyridyl 
complexes, [Ru(bpy)2(ptdb)](ClO4)2, [Ru(bpy)2(ptda)](ClO4)2, [Ru(bpy)2(ptdp)] 
(ClO4)2 (bpy = 2,2′-bipyridine; ptdb = 3-(pyridine-2-yl)5,6-diphenyl-as-triazine; ptda 
= 3-(pyridine-2-yl)-as-triazino-[5,6-f]phenanthrene; ptda = 3-(pyridine-2-yl)-as-triazi- 
no-[5,6-f]acenaphthylene. They were characterized by elemental analysis, mass 
spectra, 1H NMR, and cyclic voltammetry. The structure of [Ru(bpy)2(ptdb)](ClO4)2 
 was determined. The DNA-binding properties of the complexes were investigated by 
absorption titration, luminescence spectroscopy, and viscosity measurements. The 
experimental results suggested that all complexes bind to DNA in an intercalation 
mode. 
 
  Mazumder, et al., (2005) reported a series of the [Ru(M)2U]2+ 
complexes (M = 2,2′-bipyridine, 1,10-phenanthroline; U = tpl (Ru1), 4-Cl-tpl (Ru2), 
4-CH3-tpl (Ru3), 4-CH3-O-tpl (Ru4), 4-NO2-tpl (Ru5), pai (Ru(6); tpl = thiopico- 
linanilide and pai = 2-phenylazoimidazole). All of complexes were characterized by 
IR, UV-Visible, 1H NMR, 13C NMR, FAB mass spectrophotometer, and elemental 
analysis. The complexes displayed the tumor inhibitory activity of ruthenium 
complexes against transplantable murine tumor cell line, EAC. The study of in vitro 
antibacterial activity revealed the significant activity of Ru1-Ru4 against 
microorganisms compared of the standard drug chloramphenicol. 
 
Tan, et al., (2005) synthesized and characterized the [Ru(phen)2 
(NMIP)]2+ complex (NMIP = 2′-(2′′-nitro-3′′-4′′-methylenedioxyphenyl)imidazo- 
[4′,5′-f][1,10]-phenanthroline. This complex were characterized by mass 
spectrometry, 1H NMR spectroscopy and cyclic voltammetry. Binding of the complex 
to calf thymus DNA was investigated by spectroscopic methods, viscosity and 
electrophoresis measurements. Results from this study indicated that 
[Ru(phen)2(NMIP)]2+ binds to DNA via partial intercalative mode. In addition, it was 
also found to promote cleavage of plasmid pBR322 DNA. 
  
  The cytotoxicity of the ruthenium(II) complexes  
 
Velders, et al., (2000) studied the cytotoxicity of the three isomers of 
the [Ru(azpy)2Cl2] complexes (azpy = 2-(phenylazo)pyridine). They found that these 
complexes showed different in vitro cytotoxicity. The α-[Ru(azpy)2Cl2] complex 
showed remarkably high cytotoxicity against a series of tumor-cell lines (MCF-7, 
EVSA-T, WIDR, IGROV, M19, A498, and H226). It was in contrast to the low 
 cytotoxicity of β-[Ru(azpy)2Cl2] and γ-[Ru(azpy)2Cl2] and the structurally related 
complex cis-[Ru(bpy)2Cl2] (bpy = 2,2′-bipyridine). 
 
Hotze, et al., (2003) reported  the new water-soluble bis(2-
phenylazopyridine)ruthenium(II) complexes. The α-[Ru(azpy)2(cbdca-O,O′)], α-
[Ru(azpy)2(ox)], and α-[Ru(azpy)2(mal)] (cbdca-O,O′ = 1,1-cyclobutanedicarboxyl- 
ate, ox = oxlate, mal = malonate) were synthesized and characterized. The structures 
of first two complexes were confirmed by X-ray crystallography. The cytotoxicity of 
these complexes was determined in A2780 human ovarian carcinoma and A2780cisR, 
the corresponding cisplatin-resistant cell line. Results from cytotoxicity showed that 
all the water-soluble carboxylato complexes displayed a cytotoxicity of a factor 10 
less than the α-[Ru(azpy)2Cl2] in the A2780 and A2780cisR cell lines. 
 
Hotze, et al., (2004) reported the most common isomers, α-, β-, and γ-
[RuL2Cl2] (L = o-tolylazopyridine (tazpy) and 4-methyl-2-phenylazopyridine (mazpy) 
). All complexes were synthesized and characterized by NMR spectroscopy.  The 
molecular structures of γ-[Ru(tazpy)2Cl2] and α-[Ru(mazpy)2Cl2] were investigated 
by X-ray diffraction analysis. The IC50 values of the geometrically isomeric 
[Ru(tazpy)2Cl2] and [Ru(mazpy)2Cl2] complexes were compared with those of the 
parent [Ru(azpy)2Cl2] complexes which were determined in the series of human 
tumour cell lines (MCF-7, EVSA-T, WIDR, IGROV, M19, A498 and H266). These 
data unambiguously showed for all complexes the following trend: the α isomer 
showed a very high cytotoxicity, where the β isomer was a factor 10 less cytotoxic. 
The γ isomer of [Ru(tazpy)2Cl2] and [Ru(mazpy)2Cl2] displayed a very high 
cytotoxicity comparable to that of the γ isomer of the parent compound 
[Ru(azpy)2Cl2] and to that of the α-isomer. 
 
  Chen, et al., (2006) studied the electronic and geometric structures of a 
series of isomeric complexes α, β, γ, δ, and ε-[Ru(azpy)2Cl2] using the density 
functional theory (DFT) method. The computed results showed that: (i) The main-
body (azopyridine) planes of two conjugative ligands (azpy) in γ-[Ru(azpy)2Cl2] were 
 almost located on the same plane; therefore it must be advantageous for the 
conjugative ligand to intercalate between DNA-base pairs whereas those in α- and β-
[Ru(azpy)2Cl2] were almost inter-vertical; thus it must be disadvantageous to their 
DNA-binding affinities due to their greater steric hindrance. (ii) The energies (εL) of 
the LUMO were in sequence of εL(β) > εL(α) > εL(γ). The energy differences (∆εL-H) 
between LUMO and HOMO were in sequence of ∆εL-H(γ) < ∆εL-H(α) < ∆εL-H(β). (iii) 
The total dipole moments (µ) of the isomers were in sequence of  µ(β) > µ(α) > µ(γ). 
(iv) The positive charges (QL) in the ligand azpy were in sequence of QL(γ) > QL(α) > 
QL(β). 
 
  Dougan, et al., (2006) studied the ruthenium(II) η6-arene complexes 
containing p-cymene (p-cym), tetrahydronaphthalene (thn), benzene (bz), or biphenyl 
(bip), as the arene, phenylazopyridine derivatives (C5H4NN:NC6H5R; R = H (azpy), 
OH (azpy-OH), NMe2 (azpy-NMe2)) or a phenylazopyrazole derivatives (NHC3H2 
NN:NC6H5NMe2 (azpy-NMe2)) as N,N-chelating ligands and chloride as a ligand. All 
complexes displayed intense transitions in the visible region assignable to MLCT 
from the filled 4d orbitals of Ru(II) to the empty π* ligand orbital. The structure of 
these complexes was characterized by 1H NMR spectroscopy and X-ray 
crystallography. None of the azpy complexes were cytotoxic toward A2780 human 
ovarian or A549 human lung cancer cells, but several of the azpy-NMe2, azpy-OH, 
and azpyz-NMe2 complexes were active (IC50 values 18-88 µM). 
 
 
1.3  Objectives 
 
1.  To synthesize and characterize a new bidentate ligand, 5-methyl-2-(phenylazo)- 
pyridine (5mazpy). 
2.  To synthesize and characterize the [Ru(5mazpy)2Cl2] complexes.  
3.  To synthesize and characterize the [Ru(5mazpy)2L](PF6)2, [Ru(5mazpy)2L′](PF6)2   
and  [Ru(L′)25mazpy](PF6)2 complexes (L = azpy, 5mazpy; L′ = bpy, phen). 
 4.  To synthesize and characterize the [Ru(5mazpy)2L](NO3)2,  [Ru(5mazpy)2L′]Cl2  
and   [Ru(L′)25mazpy]Cl2 complexes (L = azpy, 5mazpy; L′ = bpy, phen). 
5.  To study the interactions of the [Ru(5mazpy)2L](NO3)2,  [Ru(5mazpy)2L′]Cl2  and  
[Ru(L′)25mazpy]Cl2 complexes with calf  thymus DNA. 
6.  To test the cytotoxicity of the [Ru(5mazpy)2Cl2],  [Ru(5mazpy)2L](PF6)2, 
[Ru(5mazpy)2L′](PF6)2, [Ru(L′)25mazpy](PF6)2, [Ru(5mazpy)2L](NO3)2,  
[Ru(5mazpy)2L′]Cl2  and  [Ru(L′)25mazpy]Cl2  complexes with cell lines.  
























 CHAPTER 2 
MATERIALS AND METHODS 
 
 
2.1  Materials 
  
2.1.1  Chemical substances 
 
Materials from Fluka AG, Switzerland 
 
 6-amino-3-picoline C6H8N2, AR grade 
 Nitrosobenzene, C6H5NO, AR grade 
 2,2′-bipyridine, C10H8N2, AR grade 
 Ruthenium(III)chloride trihydrate, RuCl3.3H2O, AR grade 
Tetrabutylammonium hexafluorophosphate, C16H36F6NP, AR grade 
 Ethidium Bromide, C21H20BrN3, AR grade  
 
Materials from Merck 
 
Silica gel 60 (0.040-0.063 nm) GF254 
Sodium hydroxide, NaOH, AR grade 
  Tetra-n-butylammoniumchloride, C16H36NCl, AR grade 
 1,10-phenanthroline, C12H8N2, AR grade 
 
Materials from Aldrich Chemical Company, Inc.     
 
  Ammoniumhexafluorophosphate, NH4PF6, AR grade 
            Ferrocenemethanol,  C11H12FeO, AR grade 
 
Materials from BDH Laboratory Supplies, Poole 
 
   Silver nitrate, AgNO3, AR grade 
  Lithium chloride, LiCl, AR grade 
 
Materials from Lab-Scan analytical sciences 
 
  Sodium chloride, NaCl, AR grade 
 Hydrochloric acid, HCl, AR grade 
 
Materials from Sigma-Aldrich Laborchemkalien 
 
 Deoxyribonucleic acid (CT DNA), AR grade 
   Trisbase, C4H11NO3, AR grade 
 
 
2.1.2  Solvents 
 
 Solvents from Lab-Scan analytical sciences 
 
  Acetonitrile, CH3CN, AR grade 
  Acetone, C3H6O, AR grade  
  Benzene, C6H6, AR grade  
                       Chloroform, CHCl3, AR grade  
  Dimethylsulfoxide, C2H6OS, AR grade  
  Ethanol, C2H5OH, AR grade  
Ethyl acetate, C4H8O2, AR grade 
Methanol, CH3OH, AR grade 
N,N-dimethylformamide, C3H7NO, AR grade 
 
Solvents from Merck 
 
 Dichloromethane, CH2Cl2, AR grade 
   Hexane, C6H14, AR grade 
 The solvents for column chromatography, dichloromethane and 
hexane, were reagent grade and purified by distillation prior to use. 
 
 
2.2  Instruments 
 
2.2.1  Melting Point Apparatus 
 
              Melting Points of  the complexes were measured on an Electrothermal 
melting point apparatus (Electrothermal 9100). 
 
     2.2.2  Elemental Analysis 
 
  Elemental analysis was measured by CE Instruments Flash 1112 Series 
EA CHNS-O Analyzer. 
  
  2.2.3  The Fast-atom bombardment (FAB) Mass Spectrometry 
   
The Fast-atom bombardment (FAB) mass spectra were measured on a 
VG Autospec instrument and ESI mass spectrometry (University of Bristol, UK.). 
 
          2.2.4  Infrared Spectroscopy 
 
Infrared spectra were measured on a Perkin Elmer Spectrum GX FT-IR 
spectrophotometer from 370 to 4,000 cm-1. All samples were prepared in the KBr 
pellets. 
  
 2.2.5  UV-Visible Absorption Spectroscopy 
 
  Ultraviolet and visible absorption spectra were measured on UV-Vis 
Spectrophotometer SPECORD S100.  
 
  2.2.6  Fluorescence Spectroscopy 
 
  Emission spectra were recorded with Hellet packard L55S 
Spectrofluorometer. 
 
  2.2.7  1D and 2D Nuclear Magnetic Resonance Spectroscopy 
 
1D and 2D NMR spectra were measured in CDCl3, acetone-d6, and 
CD3OD with a Varian UNITY SNOVA 500 MHz FT-NMR  spectrometer at ambient 
temperature with Me4Si as an internal standard. 
 
 2.2.8  Cyclic Voltammetry  
 
     Electrochemical experiments were measured using MacLab (4e AD 
Instruments) with potentiostat (Serial No p068). The program was EChem 1.5.1.  A 
glassy carbon working electrode, platinum wire auxillary electrode, and platinum 
reference electrode were used in three-electrode configuration. The supporting 
electrolyte was tetra-n-butylammonium hexafluorophosphate ([NBu4]PF6) in CH3CN 
and dichloromethane. Ferrocene was added at the end of each experiment as an 
internal standard. All potentials were quoted vs the ferrocene/ferrocenium couple 
(Fc/Fc+). The solvent was used as received. The argon gas was bubbled through the 
solution prior to each measurement. 
 
   2.2.9  X-ray Diffractometer 
  
   The X-ray structures of 5-methyl-2-(phenylazo)pyridine, ctc-[Ru 
(5mazpy)2Cl2], ccc-[Ru(5mazpy)2Cl2], tcc-[Ru(5mazpy)2Cl2], and [Ru(5mazpy)2bpy] 





 2.3  Syntheses of ligands 
 
2.3.1  Synthesis of the 2-(phenylazo)pyridine (azpy) ligand        
 
The 2-(phenylazo)pyridine ligand was prepared by modified literature 
method (Krause and Krause, 1980). 
The 2-(phenylazo)pyridine ligand was prepared by literature method 
(Krause and Krause, 1980). 2-Aminopyridine (0.45 g, 4.78 mmol) reacted with 
nitrosobenzene (0.60 g, 5.60 mmol) in the mixture of 20 M NaOH 13.5 mL and 10 
mL of benzene with stirring. The reaction mixture was heated on the water bath for 45 
min. The reaction mixture was extracted five times with 5 mL portions of benzene, 
then the solvent was removed by rotary evaporation. The residue was purified by 
column chromatography on a silica gel. A mixture of hexane and ethyl acetate as the 
eluting solvent.  The orange band was collected.  The yield was 35%. 
    
2.3.2  Synthesis of the 5-methyl-2-(phenylazo)pyridine (5mazpy) 
ligand 
 
   The 5-methly-2-(phenylazo)pyridine ligand was prepared by using 
literature procedure (Changsaluk and Hansongnern, 2005). 6-Amino-3-picoline (0.34 
g, 3.13 mmol) was added to  the benzene solution and the mixture was stirred on 
water bath. Then NaOH was added to the reaction.  Nitrosobenzene (0.34 g, 3.16 
mmol) in small portions was added to the reaction then the reaction mixture was 
refluxed for 8 h. The green solution became brown. The  product was extracted with 
benzene and evaporated to dryness. The residue was purified by column 
chromatography on silica gel. The orange band was eluted with the mixture of CH2Cl2 






 2.4  Syntheses of the ruthenium complexes 
 
2.4.1  Synthesis of the [Ru(5mazpy)2Cl2] complex 
 
The [Ru(5mazpy)2Cl2] complex was prepared by modified literature 
method (Krause and Krause, 1980).  
The ruthenium complex, [Ru(5mazpy)2Cl2], was prepared by the 
reaction between RuCl3.3H2O (0.05 g, 0.24 mmol) and 5mazpy (0.10 g, 0.53 mmol) 
in ethanol. After the mixture was refluxed for 6 h, the solution was evaporated to 
dryness. The dried product was dissolved in a small volume of CHCl3 and purification 
of the compound was carried out by column chromatography on silica gel by using a 
mixture of chloroform and hexane (9:1) as the eluting solvent. Three isomers were 
collected as blue (% yield =  28), purple (% yield = 20), and green (% yield = 35) 
isomers. 
 
 2.4.2  Synthesis of the cis-[Ru(bpy)2Cl2] complex 
 
The cis-[Ru(bpy)2Cl2] complex was prepared by using literature 
method (Sullivan et al., 1978).  
  The RuCl3.3H2O (0.10 g, 5 mmol),  2,2′-bipyridine (1.56 g, 10 mmol), 
and LiCl (2.12 g, 50 mmol) were heated by refluxing in dimethylformamide (25 mL) 
for  4 h. The reaction was stirred magnetically throughout this period. The reaction 
mixture was cooled to room temperature and a mixture of 200 mL 1:1 acetone-water 
was added. Dark green solid was  obtained by filtration. The product  was washed 
with water and ether, and then it was dried by suction. The yield was 80%.  
 
 2.4.3  Synthesis of the cis-[Ru(phen)2Cl2] complex 
 
The cis-[Ru(phen)2Cl2] complex was prepared by using literature 
method (Sullivan et al., 1978).  
        The RuCl3.3H2O (0.50 g, 2.4 mmol),  1,10-phenanthroline (0.99 g, 5 
mmol), and LiCl (0.03 g, 0.6 mmol) were heated at  reflux in dimethylformamide (30 
 mL) for  4 h. After the reaction mixture was cooled to room temperature,  70 mL of 
acetone  was added and the resultant solution cooled at 0°C overnight. The  solid was  
filtered and washed with 75 mL of water followed by 75 mL of  diethyl ether. The 
yield was 33.8%.  
 
 2.4.4  Synthesis of the [Ru(5mazpy)3](PF6)2 complex 
 
ctc-[Ru(5mazpy)2Cl2] (0.07 g, 0.13 mmol), and AgNO3  (0.05 g, 0.29 
mmol) were suspended in 50 mL of  methanol. After the solution was refluxed 2 h,  
AgCl was removed by filtration. The 5-methyl-2-(phenylazo)pyridine (0.03 g, 0.16 
mmol) ligand was added into the solution mixture. Then the solution was refluxed for 
7 h, AgCl was removed by filtration. The aqueous solution of NH4PF6 (0.042 g, 0.27 
mmol) was added to the filtrate. The solvent was removed by rotary evaporation, the 
resulting precipitate from methanol was separated by filtration, washed with hexane 
and ether, respectively. Thenit was dried at 80 °C. The yield was 79%.   
 
2.4.5  Synthesis of the [Ru(5mazpy)2azpy](PF6)2 complex 
 
This complex was synthesized by using the same method as the  
[Ru(5mazpy)3](PF6)2  complex, but the 5-methyl-2-(phenylazo)pyridine ligand was 
replaced by 2-(phenylazo)pyridine. The yield was 75%.   
 
 2.4.6  Synthesis of the [Ru(5mazpy)2bpy](PF6)2 complex 
 
This complex was synthesized by using the same method as the 
[Ru(5mazpy)3](PF6)2  complex, but the 5-methyl-2-(phenylazo)pyridine ligand was 
replaced by 2,2′-bipyridine ligand. The yield was 76%. 
 
2.4.7  Synthesis of the [Ru(5mazpy)2phen](PF6)2 complex 
   
  This complex was synthesized by using the same method as the 
[Ru(5mazpy)3](PF6)2 complex, but the 5-methyl-2-(phenylazo)pyridine ligand was  
  
replaced  by 1,10-phenanthroline ligand. The yield was 78%. 
 
 2.4.8  Synthesis of the [Ru(bpy)25mazpy](PF6)2 complex 
 
               The cis-[Ru(bpy)2Cl2] complex (0.05 g, 0.13 mmol), and AgNO3  (0.05 
g, 0.29 mmol) were suspended in 50 mL of  methanol. After the solution was refluxed 
2 h,  AgCl was removed by filtration. The 5-methyl-2-(phenylazo)pyridine (0.03 g, 
0.16 mmol) ligand was added into the solution mixture. Then the solution was 
refluxed for 10 h, AgCl was removed by filtration. The aqueous solution of NH4PF6 
(0.042 g, 0.27 mmol) was added to the filtrate. The solvent was removed by rotary 
evaporation, the resulting precipitate from methanol was separated by filtration, 
washed with hexane and ether respectively, and dried at 80 °C. The yield was 85%. 
  
 2.4.9  Synthesis of the [Ru(phen)25mazpy](PF6)2 complex 
 
  This complex was synthesized by using the same method as the  
[Ru(bpy)25mazpy](PF6)2 complex, but the cis-[Ru(bpy)2Cl2] was replaced by cis-
[Ru(phen)2Cl2]. The yield was 86%.  
 
 2.4.10  Synthesis of the [Ru(5mazpy)3](NO3)2.5H2O complex 
 
ctc-[Ru(5mazpy)2Cl2] (0.07 g, 0.13 mmol), and AgNO3  (0.05 g, 0.29 
mmol) were suspended in 50 mL of  methanol. After the solution was refluxed 2 h,  
AgCl was removed by filtration. The 5-methyl-2-(phenylazo)pyridine (0.03 g, 0.16 
mmol) ligand was added into the solution mixture. Then the solution was refluxed for 
7 h, AgCl was removed by filtration. The solid was obtained by slow diffusion of 
ether in to a mixture of acetone and ethanol.  The product was washed with hexane 
and ether respectively, and dried at 75 °C. The yield was 72%.   
 2.4.11  Synthesis of the [Ru(5mazpy)2azpy](NO3)2.4H2O complex 
 
   This complex was synthesized by using the same method as the 
[Ru(5mazpy)3] (NO3)2 complex, but the 5-methyl-2-(phenylazo)pyridine ligand was 
replaced by 2-(phenylazo)pyridine  ligand. The yield was 70%.  
 
 2.4.12  Synthesis of the [Ru(5mazpy)2bpy]Cl2.6H2O complex 
 
The saturated tetra-n-butylammoniumchloride in acetone was added 
into the solution of [Ru(5mazpy)2bpy](PF6)2 in a small volumn of acetone. After the 
solution was centrifuged, the solid was obtained. The product was washed with 
acetone and diethyl ether, respectively and dried at 50 °C. The yield was 72%.   
 
2.4.13  Synthesis of the [Ru(5mazpy)2phen]Cl2.7H2O complex 
 
This complex was synthesized by using the same method as the 
[Ru(5mazpy)2bpy]Cl2 complex, but the [Ru(5mazpy)2bpy](PF6)2 complex was 
replaced by  [Ru(5mazpy)2phen](PF6)2. The yield was 72%. 
 
2.4.14  Synthesis of the [Ru(bpy)25mazpy]Cl2.6H2O complex 
 
This complex was synthesized by using the same method as the 
[Ru(5mazpy)2bpy]Cl2 complex, but the [Ru(5mazpy)2bpy](PF6)2 complex was 
replaced by  [Ru(bpy)25mazpy](PF6)2. The yield was 73%. 
 
2.4.15  Synthesis of the [Ru(phen)25mazpy]Cl2.9H2O complex 
 
 This complex was synthesized by using the same method as the 
[Ru(5mazpy)2bpy]Cl2 complex, but the [Ru(5mazpy)2bpy](PF6)2 complex was replaced 
by  [Ru(phen)25mazpy](PF6)2. The yield was 74%. 
 
 
2.5  DNA-binding and cleavage experiments 
 
 The DNA-binding and cleavage experiments were performed at room 
temperature. Concentrated stock solutions of DNA were prepared in buffer and 
sonicated for 25 cycles, where each cycle consisted of 30 s with 1 min intervals 
(Maheswari and Palaniandavar, 2004). The DNA concentration was determined by 
absorption spectroscopy using the known molar extinction coefficient value of 6,600 
M-1cm-1 at 260 nm (Reichmann et al., 1954). Solutions of calf thymus DNA in the 
buffer gave a ratio of UV absorbance at 260 and 280 nm in the range 1.8 to 1.9 : 1 
indicating that DNA is free form protein (Marmur, 1961). 
 
       2.5.1  Absorption titration 
 
This experiments were carried out in 10 mM Tris buffer pH 7.4. The 
absorption titration was carried out by keeping the concentration of the complex (40 
µM) and varying the concentration of CT DNA (3 to 300 µM). The metal-to-ligand 
charge transfer (MLCT) bands were monitored to follow the interaction of the 
complexes with CT DNA. Ruthenium-DNA solutions were allowed to incubate for 10 
min before the absorption spectra were recorded. 
 
       2.5.2  Competitive binding  
 
  Fluorescence quenching experiments were conducted by adding small 
aliquots of 20 µM Ru(II) complexes solution to the samples containing 2 µM 
ethidium bromide (EB) and 40 µM CT DNA in buffer. This experiment was carried 
out using 5mM Tris base and 50 mM NaCl pH 7.1. Samples were excited at 340 nm 
and fluorescence spectra were recorded between 500-670 nm.  
 
 2.5.3  Viscosity measurements  
 
  This experiment was carried out using 5 mM Tris base and 50 mM 
NaCl pH 7.1 and maintained at a constant temperature at 29 °C. Data were presented 
as (η/η0)1/3 versus binding ration, where η is the viscosity of calf thymus DNA alone. 
 Viscosity values were calculated from the observed flow time of DNA containing 
solution (t) corrected for that of buffer alone (t0), η=(t-t0)/t0.  
 
 2.5.4  Cyclic voltammetry 
 
The supporting electrolyte was 50 mM NaCl and 5 mM Tris base 
buffer at pH 7.1. Solutions were deoxygenated by purging with argon gas for 15 min 
prior to the measurements; during the measurements, a stream of argon was passed 
over the solution. The experiments were carried out in 0.5 mM ruthenium(II) 
complexes in the absence and presence of  2.5 mM CT DNA. 
 
2.5.5  DNA cleavage study 
 
  In this experiment, supercoiled pBIND DNA (0.5 µg/8 µL) was treated 
with ruthenium(II) complexes (20, 40, 60, 80 and 100 µM). The samples were 
analysed by electrophoresis for 1 h at 75 V on a  1% agarose gel in TAE buffer. The 
gel was stained with ethidium bromide and photographed under UV light. 
 
 
2.6  Cytotoxicity assay 
 
The cell lines used were the phoenix amphotropic packing cell lines 
(φNX-A cells). Cells were grown as adherent monolayers in medium (DMEM, RPMI-
1640) plus 10% (v/v) supplemented hyclone cosmic calf serum, 100 µg/mL penicillin 
and 100 µg/mL streptomycin in a humid atmosphere of 5 % CO2 at 37°C and unless 
otherwise stated. The cell lines used here were human breast cancer (MCF-7), human 
colon cancer (WiDr), human melanoma (sk-mel-28), human ovarian cancer (Igrov), 
human prostate cancer (PC3), human lung cancer (A549), and leukemia (CEM). 
Cells were counted and seeded into 96 well at 1000 cells/well in 100 
µL complete medium. Cells were allowed to attach for approximately 12 h. Each 
complex was added in a dilution series of 2 fold concentration steps to quadruplicate 
 wells in a final volume. 100 µL medium cells were allowed to 4 days when cells in 
control wells still subconfluent. Cells were lysed in a hypotonic buffer with detergent, 
(200 mM Tris pH 8.0, 50 mM EDTA, 2% triton X-100), also containing the nucleic 
acid stain Sybr I green (1:1000 molecular Probes). Fluorescence was read on a victor2 
1420 multilabel counter (wallac) with 485 nm excitation and 530 nm emission filters.  
Because the ruthenium(II) complexes in this work are poorly water-
soluble, a DMSO stock solution was used for all compounds to perform a proper 
comparison between the compounds. The positive control is cisplatin (0.25, 0.5, 1.0, 
























 CHAPTER 3 
RESULTS AND DISCUSSION 
 
 
3.1  Syntheses of the 5mazpy ligand and the [Ru(5mazpy)2Cl2] complexes 
 
The 5-methyl-2-(phenylazo)pyridine (5mazpy) is used as ligand. The 
5mazpy was synthesized by using literature procedure (Changsaluk and Hansongnern, 
2005). This ligand was generally obtained by the condensation of nitrosobenzene with 
6-amino-3-picoline in the presence of sodium hydroxide in dry benzene under 
refluxing condition for 8 h. Purification was carried out by column chromatography 
on silica gel. The reaction are shown in equation (1).  
   
 
    NaOH     (1) 
       +                            Benzene, ∆ 
 




  The yield of the 5mazpy ligand was 62%. The 5mazpy is a new 
bidentate ligand and acts as  an unsymmetrical bidentate chelating ligand.  
  Ethanolic solutions of 5mazpy with RuCl3.3H2O under reflux afford  
three isomers of the [Ru(5mazpy)2Cl2] complex (equation (2)). There are ctc, ccc, and 
tcc-[Ru(5mazpy)2Cl2]. Because the 5mazpy has unsymmetric bidentate N,N′-donor 
centres, the pseudo-octahedral dichloro species, [Ru(5mazpy)2Cl2], can occur in five 
geometrically isomeric forms: trans-cis-cis (tcc); trans-trans-trans (ttt); cis-trans-cis 
(ctc); cis-cis-trans (cct); cis-cis-cis (ccc) (Figure 3.1). Two (tcc and ttt) of these have 
the RuCl2 group in the trans geometry and the other three (ctc, cct, and ccc) have the 











 in the case of one blue isomer (herein refered to as the C2 isomer, owing to the 
nominal two fold symmetry of the complex), while the other (the C1 isomer) appeares 
to be of the ccc variety (Goswami et al., 1981).  
 


























































 The physical properties of the 5mazpy ligand and its complexes are 
summarized in Table 3.1.  
 
Table 3.1  The physical properties of the 5mazpy ligand and the [Ru(5mazpy)2Cl2]     
complexes 
 
 Physical properties 
Compounds 
Appearance  Color Melting point (°C) 
5mazpy Solid Red orange 77-78 
ctc-[Ru(5mazpy)2Cl2] Solid Blue 320-322 
ccc-[Ru(5mazpy)2Cl2[ Solid Purple 327-328 




3.2  Characterization of the 5mazpy ligand and the [Ru(5mazpy)2Cl2] complexes 
 
The chemistry of the 5mazpy ligand and the [Ru(5mazpy)2Cl2] 
complexes were investigated by using following techniques:  
 
 3.2.1  Elemental analysis 
 3.2.2  FAB mass spectrometry 
 3.2.3  Infrared spectroscopy 
 3.2.4  UV-Visible absorption spectroscopy 
 3.2.5  1D and 2D Nuclear Magnetic Resonance spectroscopy 
 3.2.6  Cyclic voltammetry 




 3.2.1  Elemental analysis 
  
Elemental analysis is a technique to investigate the composition of 
elements in the compounds. Results from this technique show that the analytical data 
of the compounds correspond to the calculated values. The elemental analysis data of 
the 5mazpy ligand and the ctc, ccc, and tcc-[Ru(5mazpy)2Cl2] complexes are listed in 
Table 3.2.  
 





3.2.2  Fast Atom Bombardment (FAB) mass spectrometry 
 
FAB mass spectrometry is a technique to confirm molecular mass of 
the compounds. The FAB mass spectra of 5mazpy, ctc-[Ru(5mazpy)2Cl2], ccc-[Ru 
(5mazpy)2Cl2], and  tcc-[Ru(5mazpy)2Cl2] are displayed in Figure 3.2, 3.3, 3.4 and 
3.5, respectively. The results from FAB mass spectrometric data of the 5mazpy ligand 





%C %N %H 
Compounds 
Calc. Found Calc. Found Calc. Found 
5mazpy 73.08 72.66 21.30 22.53 5.62 5.54 
ctc-[Ru(5mazpy)2Cl2] 50.89 50.82 14.84 15.27 3.91 3.96 
ccc-[Ru(5mazpy)2Cl2] 50.89 50.71 14.84 15.40 3.91 3.99 
tcc-[Ru(5mazpy)2Cl2] 50.89 50.79 14.84 14.99 3.91 3.89 
 Table 3.3  FAB mass spectrometric data of the 5mazpy ligand and  
                  the [Ru(5mazpy)2Cl2] complexes  
 
m/z Stoichiometry Equivalent species Rel. Abun. (%) 

























































L  = Molecular weight of the 5mazpy ligand = 197.21 g/mol 
M = Molecular weight of the [Ru(5mazpy)2Cl2]complex = 566.45 g/mol 
 
 The FAB mass spectrum of the 5mazpy ligand is shown in Figure 3.2 
From the data, the most intense peak at m/z 76, which give 100% relative abundance 
 is assigned to the one protonation phenyl ring. The peak at m/z 197 consistents with 
the molecular weight of the 5mazpy ligand. 
 The molecular weight of the ctc-[Ru(5mazpy)2Cl2] complex  is 566 
g/mol and the mass spectrum exhibits peak at m/z 566. It means that the peak at m/z 
566 is used to confirm the molecular weight of this complex.  
 In the mass spectrum of the  ccc-[Ru(5mazpy)2Cl2] complex, The peak 
at m/z 495 (54%)  is observed which is assigned to this complex lost two chloride 
atoms from molecule. 
  The tcc-[Ru(5mazpy)2Cl2] complex gives the intense peak at m/z 567 























 3.2.3  Infrared spectroscopy 
 
Infrared spectroscopy is a technique to study functional groups in the 
compounds. Infrared spectra were recorded in a KBr pellet in the range 4000-370 cm-1 
region. The infrared spectroscopic data of the 5mazpy ligand and the ctc, ccc, and  
tcc-[Ru(5mazpy)2Cl2] complexes are listed in Table  3.4.  
 




s = strong, m = medium, w = weak 
 
The free 5mazpy ligand shows the medium peaks at  1605-1440 cm-1, 
corresponds to C=C and C=N stretching in the pyridine ring and phenyl ring in the 
free ligand. The sharp band at 1389 cm-1 is assigned to the N=N stretching, which 
occurs at a lower frequency than that in azpy ligand (1421 cm-1) (Krause and Krause, 
1980). The stretching frequencies of the C=C and C=N modes in the three isomers 
display three medium peaks in the range 1599-1452 cm-1. The most  important peak is 
Frequencies (cm-1) 
Vibration modes 5mazpy 
(L) 
































 the N=N stretching mode which is used to be considered the π-acid property in the 
azo complexes. The  ctc, ccc, and tcc-[Ru(5mazpy)2Cl2] complexes exhibit υ(N=N) at 
1334, 1299, and 1307 cm-1, respectively, red shifted by 55-90 cm-1 from the free 
5mazpy ligand. This suggests that less double-bond character in the N=N group in the 
complexes. This is strong evidence for substantial π-bonding to ruthenium through an 
azo nitrogen (Krause and Krause, 1980). The infrared spectra of the 5mazpy ligand 
and the ctc, ccc, and tcc-[Ru(5mazpy)2Cl2] complexes are shown in Figure 3.6, 3.7, 

























 3.2.4  UV-Visible absorption spectroscopy 
 
UV-Visible absorption spectroscopy is a technique to study the 
electronic transitions of compounds. UV-Visible spectral studies of the compounds 
revealed absorptions within the range 200-800 nm in CH2Cl2, CHCl3, CH3CN, 
DMSO, and DMF. The UV-Visible absorption spectroscopic data of the 5mazpy 
ligand and the ctc, ccc, and tcc-[Ru(5mazpy)2Cl2] complexes are summarized in Table 
3.5.  
 
Table 3.5  UV-Visible absorption spectroscopic data of the 5mazpy (L) ligand and the 
[Ru(L)2Cl2] complexes  
 
λmax nm, (εa × 10-4 M-1cm-1) 
Compounds 



















































a Molar extinction coefficient 
 
In CH2Cl2, the 5mazpy ligand exhibits transition at 448 nm (ε ∼ 600 M-
1cm-1) and 324 nm (ε ∼ 42,500 M-1cm-1), corresponds to intraligand transitions, n→π* 
and π→π*, respectively, centred primarily on the azo group. Therefore, the transitions 
in the complexes at around 400 nm are probably of ligand origin and are not 
considered further. The trans (tcc) complex shows an intense band (ε ∼ 12,000 M-
 1cm-1) in the region 636-640 nm, are assigned to the t2(Ru)→π*(L) MLCT transition, 
where the π* orbital has a large azo character (Santra et al., 1999). The cis complexes 
(ctc and ccc-[Ru(5mazpy)2Cl2]) exhibit hightly intense (ε ∼ 9,000-17,000 M-1cm-1) 
MLCT transitions at higher energies compare to the trans complex. The cis complexes 
display two different intense band characters. The most intense bands are in the range 
318-342 nm and the less intense bands are in the range 576-594 nm while the 
spectrum of trans complex shows two similar band characters. The ccc-
[Ru(5mazpy)2Cl2] isomer exhibits a transition at a higher energy (∼ 10 nm) than that 
of the ctc-[Ru(5mazpy)2Cl2] isomer. The UV-visible absorption spectra of the 5mazpy 
ligand and the ctc, ccc, and tcc-[Ru(5mazpy)2Cl2] complexes in CH2Cl2 are shown in 






















 3.2.5  1D and 2D Nuclear Magnetic Resonance spectroscopy 
 
The Nuclear Magnetic Resonance spectroscopy is a technique to 
support the structure of compounds. The NMR spectra of compound were carried out 
in CDCl3 and the tetramethylsilane (Si(CH3)4) was used as an internal reference. The 
structures of compound were explained by using 1D and 2D NMR spectroscopic 
techniques (1H NMR, 13C NMR, DEPT 135 NMR, 1H-1H COSY NMR, and 1H-13C 
HMQC NMR).  The NMR spectroscopic studies of each compound were described as 
below. 
 
(a) Nuclear Magnetic Resonance spectroscopy of the 5mazpy ligand 
 
The 1H and 13C NMR spectroscopic data of the 5mazpy ligand are 










δ (ppm) J (Hz) Number of H 
13C NMR  
δ (ppm) 
6 8.56 (d) 2.0 1 149.81 
8, 8′ 8.04 (dd) 7.5, 2.0 2 123.48 
3 7.76 (d) 8.5 1 115.23  
4 7.69 (dd) 8.0, 2.0 1 138.74 
9, 9′, 10 7.52 (m) - 3 129.11, 131.88 













8' 9'  
 Table 3.6  (continued) 
 
d = doublet, dd = doublet of doublet, m = multiplet and s = singlet 
 
 The 1H NMR spectrum of 5mazpy is shown in Figure 3.14. There are 
two types of protons, aliphatic proton and aromatic proton. The 1H NMR spectrum 
exhibited six signals for eleven protons. The detail of each proton signal could be 
explained below. 
   The proton H3 appears at 7.76 ppm as doublet because of coupling 
with H4 (J = 8.5 Hz). The proton H4 locates next to H3, the signal of H4 appears at 
7.69 ppm which doublet of doublet peak is observed due to coupling with H3 (J = 8.0 
Hz) and long range coupling with H6 (J = 2.0 Hz). The signals of proton H6 exhibit at 
8.56 ppm. The splitting pattern is doublet (J = 2.0 Hz) by long range coupling with 
proton H4. The proton H6 locates next to nitrogen atom on pyridine ring, therefore 
this signal appears at the most downfield. The proton H8 and H8′ are two equivalent 
proton on the phenyl ring. The signal shows doublet of doublet peaks at 8.04 ppm. 
This signal appears at the lower field than other proton (H9, H9′, H10) on the phenyl 
ring because it locates close to the azo nitrogen. The signal of proton H9 occurs at 
7.52 ppm. The splitting pattern is multiplet at the same position of proton H10. In 
comparison, the 5-methyl-2-(phenylazo)pyridine (5mazpy), 2-(phenylazo)pyridine 
(azpy) (Changsaluk and Hansongnern, 2005) and 5-Clazpy-2-(phenylazo)pyridine 
(Clazpy) ligands (Sahavisit and Hansongnern, 2005), the proton signals in 5mazpy 
appear at the highfield than azpy and Clazpy due to the effect of donating group 
(methyl group) in pyridine ring. The signal of protons on methyl  group is observed at 
2.43 ppm. In addition, all proton resonance signals are confirmed by 1H-1H COSY 
NMR experiments and the 1H-1H COSY NMR spectrum is given in Figure 3.15.  
1H NMR 
H-C Position 
δ (ppm) J (Hz) Number of H
13C NMR  
δ (ppm) 
Quaternary Carbons 161.07, 152.42, 135.58  
 The results from 13C NMR spectrum (Figure 3.16) correspond to the 
results from DEPT 135 NMR spectrum (Figure 3.17). The 13C NMR spectrum of the 
5mazpy ligand shows ten signals for twelve carbons. The signals at 138.74 ppm (C4) 
and 115.23 ppm (C3) are observed. The signals of carbon C6 (149.81 ppm) occur  at 
lower field than that of other methine carbons because is located next to the nitrogen 
atom on pyridine ring. The carbons C8 and C9 (123.48 and 129.11 ppm) in phenyl 
ring  resonate symmetrically at different position. The carbon signal at 131.88 ppm is 
attributed to the carbon C10. The methyl carbon appears at the highest field 18.39 
ppm. Furthermore, the 1H-13C HMQC NMR spectroscopy was used to assign all 
signals. Contour peaks in the 1H-13C HMQC NMR spectrum (Figure 3.18) in 5mazpy 
ligand, the absence of any contours at 161.07, 152.42, and 135.58 ppm assign them to 





















 (b) Nuclear Magnetic Resonance spectroscopy of the ctc-[Ru(5mazpy)2Cl2] 
complex 
 
 The 1H and 13C NMR spectroscopic data of the ctc-[Ru(5mazpy)2Cl2] 
















δ (ppm) J (Hz) Number of H
13C NMR  
δ (ppm) 
6 9.13 (d) 1.5 1 150.93 
3 8.37 (d) 8.0 1 126.10 
4 7.75 (dd) 8.5, 2.0 1 137.94 
10 7.25 (td) 7.5, 7.5 1 129.72 
9, 9′ 7.10 (dd) 8.5, 7.5 2 128.36 
8, 8′ 6.80 (dd) 8.5, 1.0 2 121.92 
11 2.35 (s) - 3 19.24 






















 d = doublet, dd = doublet of doublet, s = singlet, and  td = triplet of doublet 
 
The 1H NMR spectrum of the ctc-[Ru(5mazpy)2Cl2]  complex  is 
shown in Figure 3.19. The signals of protons on the ctc-[Ru(5mazpy)2Cl2] complex 
appear only one set of ligand peaks, indicating two equivalent 5mazpy ligands, so the 
complex must be symmetric due to its C2 axis. The assignment was made with the use 
of 1H-1H COSY NMR spectroscopy (Figure 3.20). The 1H NMR spectrum shows that 
the pyridine protons are mostly affected when compares to the phenyl protons. The 
aromatic protons at 9.13, 8.37, 7.75, 7.25, 7.10, and 6.80 ppm are attributed to H6, 
H3, H4, H10, H9,9′, and H8,8′, respectively on the basis of  1H-1H COSY NMR 
spectrum. The signals of proton H3, H4, and H6 are shifted to downfield while H8,8′, 
H9,9′, H10, and H11 are shifted upfield from those of the free ligand. The signal of 
proton H6 in pyridine rings occurs at the lowest field because of the influence of 
coordinated nitrogen atoms. One methyl signal is observed at 2.35 ppm (singlet). This 
indicates that the ctc-[Ru(5mazpy)2Cl2] complex has C2-symmetry. 
  The results of 13C NMR (Figure 3.21) correspond to the DEPT 135 
NMR (Figure 3.22). The 13C NMR spectrum contains ten signals from twenty-two 
carbons. Three signals of quaternary carbon at 164.62, 155.31, and 136.61 ppm are 
assigned as quaternary carbon C2, C7, and C5, respectively. The methine carbons on 
the pyridine rings appear at the lower field than that the phenyl rings. It is due to the 
effected of nitrogen atoms. The methine carbons display at 150.93, 126.10, 137.94, 
129.72, 128.36, and 121.92 ppm which are assigned to carbon C6, C3, C4, C10, 
C9,9′, and C8,8′ positions, respectively. In addition, the 1H-13C HMQC NMR 







 (c) Nuclear Magnetic Resonance spectroscopy of the ccc-[Ru(5mazpy)2Cl2] 
complex 
 
The 1H and 13C NMR spectroscopic data of the ccc-[Ru(5mazpy)2Cl2] 















δ (ppm) J (Hz) Number of H 
13C NMR  
δ (ppm) 
6A 9.58 (s) - 1 149.48 
3A 8.40 (d) 8.0 1 124.19 
3B 8.27 (d) 8.0 1 125.82 
4A 7.93 (dd) 8.0, 1.5 1 139.62 
8, 8′B 7.77 (dd) 8.5, 1.5 2 125.61 
4B 7.69 (dd) 8.0, 1.0 1 139.27 
10B 7.45 (td) 7.5, 7.5 1 130.87 
9, 9′B 7.38 (dd) 8.5, 1.0 2 127.60 










































δ (ppm) J (Hz) Number of H 
13C NMR  
δ (ppm) 
9, 9′A 7.18 (dd) 8.0, 7.5 2 128.71 
6B 7.00 (s) - 1 148.14 
8, 8′A 6.68 (dd) 8.5, 1.0 2 121.34 
11A 2.56 (s) - 3 19.63 
11B 2.20 (s) - 3 19.02 
Quaternary Carbons 
165.16, 163.45, 157.24, 
155.40, 136.80, 136.18, 
 
d = doublet, dd = doublet of doublet, s = singlet, and  td = triplet of doublet 
 
The 1H NMR spectrum of the ccc-[Ru(5mazpy)2Cl2] complex is 
displayed in Figure 3.24. The spectrum of the ccc-[Ru(5mazpy)2Cl2] complex is more 
complex than that of the ctc-[Ru(5mazpy)2Cl2] complex. The peaks assignments are 
supported by using simple correlation 1H-1H COSY NMR spectroscopy (Figure 3.25). 
The 1H NMR spectrum of ccc-[Ru(5mazpy)2Cl2] shows twice the number of signals, 
as this isomer has no C2 axis, which results in two inequivalent 5mazpy ligands. From 
all 5 theoretically possible isomers only the ccc isomer has no C2 axis; so already 
from this 1H NMR spectrum the configuration has been proven. This is also 
confirmed by the methyl signals in aliphatic region. From the parent complex, 
[Ru(azpy)2Cl2], only ccc-isomer has C1-symmetry (Seal and Ray et al., 1984). Thus, 
the ccc-configuration should exhibit two CH3 signals of equal intensities. From the 1H 
NMR spectrum CH3 signals appear as singlet at 2.56 ppm for proton 11A and 2.20 
ppm for proton 11B. The H3(A, B) and H6(A) signals are shifted to downfield while 
H6(B), H8,8′(A,B), H9,9′(A, B) and H10(A, B) are shifted to upfield from those of 
the free ligand. The proton H6(A) appears at the lower filed than H6(B) because it is 
 trans to the N=N mode (electron withdrawing group) while proton H6(B) is trans to 
chloride (Velder et al., 2004). This is similar to the result of ccc-[Ru(azpy)2Cl2] which 
was carried out in the same solvent (CDCl3) (Changsaluk and Kanidtha, 2005). In 
comparison between ccc-[Ru(5mazpy)2 Cl2] and ccc-[Ru(azpy)2Cl2] in the same 
solvent (CDCl3), the proton signals of the 5mazpy complex occur at the higher field 
relative to azpy complex because of the electron donating substituent (CH3 group) on 
the pyridine ring.  
The 13C NMR spectrum (Figure 3.26) contains twelve methine 
carbons, six quaternary carbons, and two methyl carbons. This results support with 
the DEPT 135 NMR spectrum (Figure 3.27) which present only signal of methine 
carbons (14 signals) and methyl carbons (2 signals). The carbon C8,8′ C9,9′ in phenyl 
ring A and B in this complex resonate symmetrically at different position. The signals 
of carbon C6 occur at a lower field than that of other methine carbons because it is 
located next to the nitrogen atoms on pyridine ring. The carbon C6(A), C3(A), C3(B), 
C4(A), C8,8′(A), C4(B), C10(B), C9,9′(B), C10(A), C9,9′(A), C6(B), and C8,8′(A) 
are found at 149.48, 124.19, 125.82, 139.62, 125.61, 139.27, 130.87, 127.60, 129.63, 
128.71, 148.14, and 121.34 ppm, respectively. The signal carbons of CH3 appear at 
the highest field 19.02 ppm (ligand B) and 19.63 ppm (ligand A). The quaternary 
carbons are observed at 136.80, 136.18, 157.24, 155.40, 165.16, and 163.45 ppm. In 
addition, the 13C NMR signal assignments are based on the 1H-13C HMQC NMR 











 (d) Nuclear Magnetic Resonance spectroscopy of the tcc-[Ru(5mazpy)2Cl2] 
complex 
 
The 1H and 13C NMR spectroscopic data of the tcc-[Ru(5mazpy)2Cl2] 














δ (ppm) J (Hz) Number of H 
13C NMR  
δ (ppm) 
6 8.76 (s) - 2 148.92 
3 8.48 (d) 7.0 2 124.38 
4 7.98 (d) 7.0 2 141.31 
8, 8′ 7.52 (d) 7.0 4 122.85 
10 7.16 (m) - 2 129.43 
9, 9′ 6.97 (m) - 4 128.15 
11 2.55 (s) - 6 19.40 
Quaternary Carbons 164.33, 157.72, 134.73  
 






















 The 1H NMR spectrum of the tcc-[Ru(5mazpy)2Cl2] complex (Figure 
3.29) is similar to  the ctc-[Ru(5mazpy)2Cl2] complex which is simpler than that of 
the ccc-[Ru(5mazpy)2Cl2] complex. The two 5mazpy ligands in this complex are 
magnetically equivalent because this molecule also has C2-symmetry. The proton 
spectrum is clearly divided in two portions; the downfield part is due to pyridine 
protons (H3, H4, and H6) and the upfield signals refer to phenyl protons (H8,8′, 
H9,9′, and H10). The pyridine protons in the complex are shifted downfield by 0.20-
0.72 ppm compare to the free ligand values. This supports the tight binding of Ru(II) 
with heterocyclic-N. The singlet signal at approximately 8.76 ppm refers to H6 
because of the closest position to the metal centre and deshielding effect of nearby Cl 
ligand follow by the H3 (8.48 ppm, J = 7 Hz) and H4 shows doublet at approximately 
7.98 ppm (doublet, J = 7 Hz). The proton H8,8′ (7.52 ppm, doublet, J = 7 Hz) appears 
at lower field compare to proton H9,9′ (6.97 ppm, multiplet) and H10 (7.16 ppm, 
multiplet) due to the closest position of the electron withdrawing azo group. This 
complex displays single CH3 signal (2.55 ppm), suggesting that the C2-symmetry is 
retained. This complex is also confirmed by using simple correlation 1H-1H COSY 
NMR spectroscopy (Figure 3.30).  
The 13C NMR spectrum is given in Figure 3.31. Ten carbon signals are 
observed in the spectrum. The signals of methine carbons and quaternary carbons are 
supported by the results from DEPT 135 NMR spectrum (Figure 3.32). The methine 
carbon signals appear in the range 122-149 ppm. The quaternary carbons C5, C7, and 
C2 are observed at 134.73, 157.72, and 164.33 ppm, respectively. The highfield 
resonance at 19.40 ppm belongs to methyl carbon (C11). In addition, the resonances 
have been assigned using 1H-13C HMQC NMR spectroscopy and this spectrum is 








 3.2.6  Cyclic voltammetry 
 
Electron transfer properties of the 5mazpy ligand and the 
[Ru(5mazpy)2Cl2] complexes have been investigated by using cyclic voltammetry in 
dichloromethane (0.1 M TBAH). In this experiment, the working electrode is glassy 
carbon. The reported potential data were compared with the values for the 
ferrocenium-ferrocene couple, under our experimental conditions. The 
voltammograms displayed metal oxidations at the positive side and the ligand 
reductions at the negative side. Voltammetric data are collected in Table 3.10 and 
representative voltammograms are displayed in Figure 3.34, 3.35, 3.36, and 3.37.  
In order to check the couple or redox reaction, the different scan rate 
were used. The couple which have almost equal anodic and cathodic current was 
refered as reversible couple. While, the unequal currents were refered to the unequally 
transfer of electron in reduction and oxidation. This is irreverible couple. In addition, 
the different scan rates were applied, these currents gave anodic and cathodic currents 
at the higher scan rate. This led to quasi-reversible couple.  
 
Table 3.10  Cyclic voltammetrica data of the 5mazpy ligand and  
                    the [Ru(5mazpy)2 Cl2] complexes in CH2Cl2 (0.1 M TBAH)  
                    at scan rate 100 mVs-1 
E1/2 (V) (∆Ep (mV)) 
Compounds 
Oxidation Reduction 
5mazpy -     -1.62 (94) 
ctc-[Ru(5mazpy)2Cl2] 0.65 (65) -1.17 (95)             -1.65 b 
ccc-[Ru(5mazpy)2Cl2] 0.60 (85) -1.16 (95)             -1.61b 
tcc-[Ru(5mazpy)2Cl2] 0.47 (90) -1.20 (115)            -1.57b 
 
a E1/2 = (Epa+Epc)/2, where Epa and Epc are anodic and chathodic peak potentials, 
respectively; ∆Ep = Epa-Epc; b cathodic peak 
 
 Oxidation Range 
 
In the potential range 0 to 1.0 V, the 5mazpy shows no signal in this 
potential range and the complexes display a one-electron cyclic voltammetric 
response due to the electrode reactions shown in equation (3). 
 
          [Ru(5mazpy)2Cl2]+  +  e-       Æ      [Ru(5mazpy)2Cl2]                                   (3) 
 
  The data reveal that the ctc-isomer and ccc-isomer exhibit higher 
potentials by 0.13-0.18 V than the tcc-isomer. The ctc-isomer displays a slightly 
higher Ru(III)/ Ru(II) couple (0.65 V, ∆Ep = 65 mV) than that the ccc-isomer (0.60 V, 
∆Ep = 85 mV). In the [Ru(5mazpy)2Cl2] complexes, the ability of the 5mazpy ligand 




  In the potential range 0 to -2.0 V at the scan rate 100 mVs-1 in 
dichloromethane, all complexes display one reversible to quasireversible (peak-to-
peak separation peak ∆Ep = 65-90 mV) and one irreversible peak. It is believed that 
the reduction peaks correspond to the reduction of the organic ligand possibility at the 
azo function. The free ligand displays one quasireversible two electron response with 
peak-to-peak separation at 94 mV, corresponds to the couple in equation (4). 
         
     2e- 
                                    5mazpy    Æ   5mazpy2-                                                           (4) 
 
The free ligand, 5mazpy displays one reduction wave at -1.62 V (∆Ep 
= 94 mV). This value is slightly lower than azpy (-1.60 V) by 0.02 V and higher than 
4-methyl-2-(phenylazo)pyridine (4mazpy) (-1.68 V, ∆Ep = 94 mV) (Muaksang, K., 
2005). All the three complexes exhibit one quasireversible and one irreversible peak 
of one electron. In addition, the potential shows a positive shifted from the free ligand 
 value. The first reduction couple of ccc-[Ru(5mazpy)2Cl2] (-1.16 V, ∆Ep =95 mV) 
occurs at the higher potential than that in tcc-[Ru(5mazpy)2Cl2]  (-1.20 V, ∆Ep = 115 
mV) and comparable to ctc-[Ru(5mazpy)2Cl2] (-1.17 V, ∆Ep = 95 mV). This results 
can be implied that the ccc isomer accepts electron better than the tcc isomer and 
comparable to ctc isomer. Table 3.11 lists the cyclic voltammetric data of the 4mazpy, 
and 5mazpy and its complexes in  dichloromethane at 100 mVs-1. 
  
Table 3.11  Cyclic voltammetric data of 4mazpy, and 5mazpy and its complexes in  
CH2Cl2 at scan rate 100 mVs-1 
 
Compounds Reduction potential (V) 
5mazpy -1.62 (94) 
[Ru(5mazpy)2Cl2] (-1.16) to (-1.20) 
4mazpy -1.68 (94) 
[Ru(4mazpy)2Cl2] (-1.02) to (-1.22) 
 
 
In comparison with the 5mazpy and 4mazpy complexes (Table 11), the 
[Ru(4mazpy)2Cl2] complexes exhibit the first reduction couple in the range -1.02 V to 
-1.22 V, while the [Ru(5mazpy)2Cl2] complexes display at -1.16 to -1.20 V. So the 
4mazpy complexes show the higher potential than the 5mazpy complexes. The π-









 3.2.7  X-ray crystallography 
 
The X-ray crystallography is the most important technique to identify 
the structure of compounds, 5mazpy, ctc-, ccc-, and tcc-[Ru(5mazpy)2Cl2]. 
 
(a) X-ray structure of the 5-methyl-2-(phenylazo)pyridine ligand 
 
  The single crystals of 5mazpy were grown by slow diffusion of hexane 
into ethanol solution of the 5mazpy ligand. The detailed measurement consitions and 
the crystal data are listed in Table 3.12. The selected bond lengths and bond angles 
are given in Table 3.13. Figure 3.38 shows the ORTEP and atom numbering scheme 
for the 5mazpy ligand.  
 
Table 3.12  Crystallographic data of the 5mazpy ligand 
 
    Empirical formula C12 H11 N3 
    Formula weight  197.24 
    Crystal system monoclinic     
    Z 4 
    Space group P21/c 
    a = 6.3957(7)Å      α = 90o 
    b = 8.4112(9)Å     β = 95.430(2)o 
    c = 19.931(2)Å      γ  = 90o 
    Temperature  293(2)K 
    Radiation Mo Kα (λ = 0.71073 Å) 
    Crystal size 0.269 x 0.197 x 0.138 mm 
    Volume  1067.4(2)Å3 
    Density (calculated) 1.227 Mg/m3 
    F(0 0 0)  416 
    Goodness-of-fit on F2  1.083  
    Completeness to theta 25.00o 
 Table 3.12  (continued) 
     
    Reflections collected    7434 
    Refinement method: Full-matrix least-squares on F2 
    R indices (all data)                                       R1 = 0.0560; wR2 = 0.1386 
    Measurement: Bruker SMART CCD diffractometer 
    Program system: SHELX-97 
    Structure determination: Direct methods (SHELXS-97) 
    Refinement: full-matrix least-squares (SHELXL-97) 
 
 
Table 3.13  Selected bond lengths (Å) and bond angles (°) of the 5mazpy ligand 
 
          N(1)-C(5)                                1.329(2)                 N(1)-C(1)                      1.330(3) 
          N(2)-N(3)                               1.228(2)                  N(2)-C(5)                     1.442(3) 
          N(3)-C(6)                               1.445(3)                 C(1)-C(2)                      1.381(3) 
          C(2)-C(3)                                 1.382(3)                  C(2)-C(12)                    1.500(3) 
          C(3)-C(4)                                 1.373(3)                  C(4)-C(5)                      1.385(3) 
          C(6)-C(7)                                 1.379(3)                   C(6)-C(11)                    1.381(3) 
          C(7)-C(8)                                 1.379(3)                  C(8)-C(9)                      1.378(4) 
          C(9)-C(10)                              1.376(4)                  C(10)-C(11)                  1.371(3) 
 
          C(5)-N(1)-C(1)              116.45(18)                N(3)-N(2)-C(5)              112.75(17) 
           N(2)-N(3)-C(6)             113.70(18)                N(1)-C(1)-C(2)               125.8(2) 
          C(1)-C(2)-C(3)              115.75(19)                C(1)-C(2)-C(12)             121.8(2) 
          C(3)-C(2)-C(12)            122.5(2)                   C(4)-C(3)-C(2)               120.44(19) 
          C(3)-C(4)-C(5)              118.38(19)                N(1)-C(5)-C(4)               123.13(19) 
           N(1)-C(5)-N(2)              111.88(17)               C(4)-C(5)-N(2)               125.00(18) 
           C(7)-C(6)-C(11)             120.0(2)                        C(7)-C(6)-N(3)                   115.1(2)                 
           C(7)-C(6)-C(11)            120.0(2)                   C(7)-C(6)-N(3)               115.1(2) 
           C(11)-C(6)-N(3)            124.90(19)               C(8)-C(7)-C(6)               120.0(2) 
 
 Table 3.13  (continued) 
  
        C(9)-C(8)-C(7)              119.9(2)                C(10)-C(9)-C(8)             119.8(2) 
        C(11)-C(10)-C(9)          120.6(3)                C(10)-C(11)-C(6)           119.6(2) 
 
 
In the molecule, the benzene ring (C6, C7, C8, C9, C10, C11), azo 
(N2, N3), and C12 atom lie in a plane. The C-N=N-C in 5mazpy is trans-
conformation. The pyridine ring is also planar and the maximum deviation of any 
atom from mean plane passing through the ring is 0.008(3)Å for C3. In addition, atom 
C8 of benzene ring deviates from C6-C7-C8-C9-C10-C11 by 0.010(4)Å. The azo(N2, 
N3) is in the same plane as benzene ring with torsion angle N1-C5-N2-N3 is 
172.73(17)° and C7-C6-N3-N2 is 170.89(19)°. In addition, the azo (N2, N3) is 
coplanar with pyridine ring. This is also reflected in the angle between planes of 
pyridine ring and benzene ring is 17.31(1)°. Then electrons from substituent can 
delocalize into the conjugated system in the molecule. This can give the some 
property of this compound for coordinating with metal ions in the future study. 
The N2-N3 distance of the title compound is 1.228(2)Å, shorter than 
that of the protonated azpy (1.248(4)Å) due to the hydrogen bond interaction between 
N(azo) and the protonated proton (Panneerselvam et al., 2000). This results in 
decreasing the electron density in azo moiety and lengthening the azo bond. 
According to Harada et al, there are an orientation disorder in azobenzene, resulting 
in a shortening of the N=N bond and elongation of N-Ph bond. From this result the 
5mazpy ligand could be orientation disorder in the crystal but we carried out the 
experiment only at room temperature (Harada et al, 1997).  In addition, the 
C5(pyridine)-N2(azo) bond distance (1.442(3)Å) is comparable to N3(azo)-
C6(benzene) (1.445(3)Å) which indicateds the same interaction of azo with pyridine 
and benzene group. However, in the case of 2-phenylazo-5-nitro-6-methyl-pyridine, 
both bond lengths are different (1.430(4), 1.421(4)Å) which were confirmed by 
density functional theory (DFT) calculation (Michalski et al, 2005). Moreover, result 
from vibrational dynamics showed that vibration of the -CNNC- core are strongly 
 coupled with the vibrations of the pyridine, phenyl and their substituents. This means 
that strong π electron aromatic systems influence the vibrations of the azo-bridging 






























 (b) X-ray structure of the ctc-[Ru(5mazpy)2Cl2] complex   
 
The single crystals of the ctc-[Ru(5mazpy)2Cl2] complex were grown 
by slow diffusion of hexane into chloroform solution of the complex. The molecular 
structure of ctc-[Ru(5mazpy)2Cl2] is shown in Figure 3.39. Table 3.14 lists the 
crystallographic data of  ctc-[Ru(5mazpy)2Cl2] and relevant bond distances and angles 
are given in Table 3.15.    
 
Table 3.14  Crystallographic data of the ctc-[Ru(5mazpy)2Cl2] complex 
 
    Empirical formula  C24H22Cl2N6Ru 
    Formula weight  566.49 
    Crystal system  Monoclinic 
    Z 4 
    Space group  C2/c 
    a = 10.9692(5)Å α = 90o 
    b = 15.6115(7)Å β = 91.0011(10)o  
    c = 14.4450(7)Å γ = 90o  
    Temperature  293(2) K 
    Wavelength  0.71073 Å 
    Volume 2473.3(2)Å3 
    Density (calculated) 1.521 Mg/m3 
    Absorption coefficient 0.874 mm-1 
    F(000) 1144 
    Goodness-of-fit on F2 1.05 
    Reflections collected 2707 
    Refinement method Full-matrix least-squares on F2 
    Completeness to theta   28.05o   
    R indices (all data)    R1 = 0.035, wR2 = 0.042      
    Measurement: Bruker SMART CCD diffractometer 
    Program system: SHELX-97 
 Table 3.14  (continued) 
 
     Structure determination: Direct methods (SHELXS-97) 
     Refinement: full-matrix least-squares (SHELXL-97) 
 
 
Table 3.15  Selected bond lengths (Å) and bond angles (°) of  
                    the ctc-[Ru(5mazpy)2 Cl2]  complex 
 
    Ru(1)-Cl(1)                      2.4102(7)               Ru(1)-N(1)                      2.043(2)                                
    Ru(1)-N(3)                       1.972(2)                 Ru(1)-Cl(1)                     2.4102(7)                               
    Ru(1)-N(1)                       2.043(2)                 Ru(1)-N(3)                      1.972(2)                                 
    N(2)-N(3)                         1.284(3)                 N(1)-C(1)                        1.344(3)                                 
    N(1)-C(6)                         1.356(3)                 N(2)-C(6)                        1.391(3)                                 
    N(3)-C(7)                         1.439(3)         
 
    Cl(1)-Ru(1)-N(1)             88.70(6)                  Cl(1)-Ru(1)-N(3)            171.64(6)                               
    Cl(1)-Ru(1)-Cl(1)            91.24(2)                  Cl(1)-Ru(1)-N(1)            95.53(6)                                 
    Cl(1)-Ru(1)-N(3)             85.17(6)                  N(1)-Ru(1)-N(3)             99.14(8)                                
    N(1)-Ru(1)-Cl(1)             95.53(6)                  N(1)-Ru(1)-N(1)             173.96(8)                             
    N(1)-Ru(1)-N(3)              76.87(8)                  N(3)-Ru(1)-Cl(1)            85.17(6)                                
    N(3)-Ru(1)-N(1)              76.87(8)                  N(3)-Ru(1)-N(3)             99.36(8)                                
    Cl(1)-Ru(1)-N(1)             88.70(6)                  Cl(1)-Ru(1)-N(3)            171.64(6)                               
    N(1)-Ru(1)-N(3)              99.14(8)                                                   
                                                                                                  
 
The Ru(II) ion is six coordinated with four nitrogen atoms of bidentate 
ligand  and two chloride atoms  in a distorted octahedron geometry. The atomic 
arrangement around the ruthenium center involved sequentially two cis-chlorides, 
trans-N(pyridine), and cis-N(azo). If the coordinating pairs Cl, N(py), and N(azo) are 
considered in that order, the configuration of this complexes is cis-trans-cis (ctc), the 
so-called α-configuration. In the coordianation octahedra, the Ru-Cl distances are 
 2.410(1)Å, it is similar to those found in ctc-[Ru(azpy)2Cl2] (2.399(1)Å) (Seal and 
Ray, 1987). The Ru-N(azo) distances (1.972(2) Å) are shorter than those of Ru-
N(pyridine) (2.043(2)Å). The  shortening may be due to greater π-backbonding, 
dπ(Ru) → π*(azo), offered by the azo group. Moreover, in the title complex the 
average N=N distance of 5mazpy  is 1.284(3)Å which is slightly longer than that of 
the free 5mazpy (N=N 1.228(2)Å). The coordination of azoimine ligand leads to a 
decrease in the N=N bond order due to the σ-donor and the π-acceptor character of 
the ligand. The angle Cl-Ru-Cl in this complex (91.24(2)°) is slightly bigger than in 
ctc-[Ru(azpy)2Cl2] (89.52(6)°) (Seal and Ray, 1987). The chelate angles extended by 
5mazpy were 76.87(8)° reveal a considerable distorsion of octahedron, as was found 
for the complexes [Ru(azpy)2Cl2] (76.3(2)°), [Ru(azpy)2(NO3)2] (76.5(1)°) (Hotze et 
al., 2000), and [Ru(Hsazpy)2Cl2] (77.2(3)°) (Hotz et al., 2004). As a consequence of 



















 (c) X-ray structure of the ccc-[Ru(5mazpy)2Cl2] complex   
 
The single crystals of the ccc-[Ru(5mazpy)2Cl2] complex were 
obatined by slow diffusion of hexane into chloroform solution of the complex. The 
molecular structure of ccc-[Ru(5mazpy)2Cl2] is shown in Figure 3.40. Tthe 
crystallographic data and selected bond lengths and bond angles for  ccc-
[Ru(5mazpy)2Cl2] are given in Table 3.16 and 3.17, respectively.    
 
Table 3.16  Crystallographic data of the ccc-[Ru(5mazpy)2Cl2] complex   
 
    Empirical formula  C24H22Cl2 N6 Ru 
    Formula weight  566.49  
    Crystal system  monoclinic 
    Z 4 
    Space group  P21/c 
    a = 14.3480(6)Å             α = 90° 
    b = 12.7046(5)Å             β = 111.1790(10)° 
    c = 13.9682(6)Å              γ = 90°  
    Temperature  293(2) K 
    Wavelength  0.71073Å 
    Volume 2374.22(17)Å3 
    Density (calculated) 0.396 Mg/m3 
    Crystal size 0.157 x 0.102 x 0.069 mm3 
    Absorption coefficient 0.228 mm-1 
    F(000) 286 
    Reflections collected 27888 
    Completeness to theta  28.04° 
    Refinement method Full-matrix least-squares on F2 
    Goodness-of-fit on F2 0.91 
    R indices (all data) R1 = 0.0486, wR2 = 0.1217 
     
 Table 3.16  (continued) 
     
    Measurement: Bruker SMART CCD diffractometer  
    Program system: SHELX-97 
    Structure determination: Direct methods (SHELXS-97) 
    Refinement: full-matrix least-squares (SHELXL-97) 
 
 
Table 3.17  Selected bond lengths (Å) and bond angles (°) of  
                    the ccc-[Ru(5mazpy)2Cl2] complex  
 
    Ru(1)-N(1)               2.028(3)                      Ru(1)-N(3)                           2.009(3)                                  
    Ru(1)-N(4)               2.060(3)                      Ru(1)-N(6)                   1.982(3)                                  
    Ru(1)-Cl(1)              2.397(1)                      Ru(1)-Cl(2)                  2.397(1)                                  
    N(1)-C(1)                1.339(4)                      N(1)-C(6)                    1.355(5)                                 
    N(2)-N(3)                1.286(4)                      N(2)-C(6)                    1.387(4)                                  
    N(3)-C(7)                1.446(4)                      N(4)-C(13)                            1.347(4)                                  
    N(4)-C(18)                1.344(5)                     N(5)-N(6)                               1.288(5)                                 
    N(5)-C(18)                         1.386(5)                     N(6)-C(19)                             1.433(4)                                                  
     
    N(1)-Ru(1)-N(3)           76.8(1)                       N(1)-Ru(1)-N(4)               96.6(1)                                   
    N(1)-Ru(1)-N(6)           89.5(1)                       N(1)-Ru(1)-Cl(1)             88.59(9)                                  
    N(1)-Ru(1)-Cl(2)          177.58(8)                   N(3)-Ru(1)-N(4)               171.9(1)                                  
    N(3)-Ru(1)-N(6)           98.6(1)                       N(3)-Ru(1)-Cl(1)             90.98(9)                                  
    N(3)-Ru(1)-Cl(2)          100.83(8)                   N(4)-Ru(1)-N(6)               76.6(1)                                    
    N(4)-Ru(1)-Cl(1)          93.46(9)                     N(4)-Ru(1)-Cl(2)             85.79(8)                                 
    N(6)-Ru(1)-Cl(1)          169.59(9)                   N(6)-Ru(1)-Cl(2)              90.65(9)                                  
    Cl(1)-Ru(1)-Cl(2)         91.65(4)                                                
   
                  
The ruthenium(II) ion is six coordinated with four nitrogen atoms of 
bidentate ligand  and two chloride atoms  in a distorted octahedron geometry. The 
 atomic arrangement around the ruthenium center involved sequentially two cis-
chlorides, cis-N(pyridine), and cis-N(azo). Therefore, the configuration of this 
complex is cis-cis-cis (ccc). The mononuclear complex is a neutral molecule  due to 
the two coordinated chloride ions. The chelate angles extended by 5-methyl-2-
(phenylazo)pyridine were 76.82(7)° and 76.4(7)° and deviate considerably from the 
ideal geometry (90°). As a consequence of the constraint of the bite angle, the ligands 
are bent back from the coordinated chlorides. The cis-chloro angle of 91.65(4)° is 
very nearly the ideal octahedral angle and is comparable to the reported values (Seal 
and Ray, 1984). The angles between the pyridine ring and phenyl ring of complex are 
39.146° and 44.545°. In the complex ccc-[Ru(5mazpy)2Cl2], the phenyl rings are 
inclined at angles of 40.591° and 44.625° relative to the chelated azo pyridine plane. 
The N-N distances of azo function are 1.286(4) and 1.288(5)Å. The Ru-N(azo) 
distances (1.982(3), 2.009(3)Å) are shorter than those of Ru-N(pyridine) (2.028(3), 
2.060(3) Å). The  shortening may be due to greater π-backbonding, dπ(Ru) → 
π*(azo), offer by the azo group. The average N-N distance is 1.287 Å which is longer 
than some reported values of free azo ligands (N-N ~ 1.248 Å) (Panneerselvam et al., 
2000). The coordination can lead to decrease in the N-N bond order due to both σ-
donor and π-accepter characters of the ligand. Thus, the elongation of the N-N 
distance and shortening of Ru-N(azo) bond length are an indication of the existance of 
considerable Ru-5mazpy π-bonding with major involvement of the azo group. The 
Ru-Cl distance in this complex (2.397(1)Å, 2.397(1)Å) is comparable with the 
reported values in ccc-[Ru(azpy)2Cl2] (2.401(4)Å, 2.410(3)Å) (Seal and Ray, 1987) 









 (d) X-ray structure of the tcc-[Ru(5mazpy)2Cl2] complex   
 
  The single crystals of the tcc-[Ru(5mazpy)2Cl2] complex were grown 
by slow diffusion of acetonitrile into chloroform solution of the complex. The 
molecular structure of tcc-[Ru(5mazpy)2Cl2] is shown in Figure 3.41. The 
crystallographic data of tcc-[Ru(5mazpy)2Cl2] are listed in Table 3.18 and the relevant 
bond distances and angles are given in Table 3.19.    
 
Table 3.18  Crystallographic data of the tcc-[Ru(5mazpy)2Cl2] complex 
 
    Empirical formula  C28H28Cl2N8Ru 
    Formula weight  648.55 
    Crystal system  Monoclinic 
    Z 4 
    Space group  C2/c  
    a = 14.8241(16) Å α = 90o 
    b = 13.8388(15) Å β = 117.020(2)o 
    c = 15.2462(16) Å γ = 90o 
    Temperature  293(2) K 
    Wavelength  0.71073 Å 
    Volume 2786.3(5) Å3 
    Density (calculated) 1.546 Mg/m3 
    Absorption coefficient 0.788 mm-1 
    F(000) 1320 
    Goodness-of-fit on F2 1.138 
    Crystal size 0.134 x 0.105 x 0.06 mm3 
    Completeness to theta  26.37o   
    Reflections collected 10996 
    Refinement method Full-matrix least-squares on F2 
    R indices (all data) R1 = 0.0800, wR2 = 0.1905 
     
 Table 3.18  (continued) 
 
    Measurement: Bruker SMART CCD diffractometer  
    Program system: SHELX-97 
    Structure determination: Direct methods (SHELXS-97) 
    Refinement: full-matrix least-squares (SHELXL-97) 
 
 
Table 3.19  Selected bond lengths (Å) and bond angles (°) of  
                    the tcc-[Ru(5mazpy)2 Cl2] complex 
  
      Ru(1)-N(3)                    1.990(5)             Ru(1)-N(3)#1                1.990(5) 
      Ru(1)-N(1)                        2.102(5)                Ru(1)-N(1)#1                  2.102(5) 
      Ru(1)-Cl(1)#1                   2.377(2)                Ru(1)-Cl(1)                     2.377(2) 
      N(1)-C(6)                          1.342(7)                N(1)-C(1)                        1.344(8) 
      N(2)-N(3)                          1.286(7)                N(2)-C(6)                        1.390(8) 
      N(3)-C(7)                          1.448(8)                N(4)-C(14)                      0.784(19) 
 
      N(3)-Ru(1)-N(3)#1            105.2(3)               N(3)-Ru(1)-N(1)             75.5(2) 
      N(3)#1-Ru(1)-N(1)            179.31(19)           N(3)-Ru(1)-N(1)#1         179.31(19) 
      N(3)#1-Ru(1)-N(1)#1        75.5(2)                 N(1)-Ru(1)-N(1)#1         103.9(3) 
      N(3)-Ru(1)-Cl(1)#1           95.26(15)             N(3)#1-Ru(1)-Cl(1)#1    88.40(14) 
      N(1)-Ru(1)-Cl(1)#1           91.33(14)             N(1)#1-Ru(1)-Cl(1)#1    84.94(14) 
      N(3)-Ru(1)-Cl(1)               88.40(14)             N(3)#1-Ru(1)-Cl(1)        95.27(15) 
      N(1)-Ru(1)-Cl(1)               84.94(14)             N(1)#1-Ru(1)-Cl(1)        91.33(14) 
      Cl(1)#1-Ru(1)-Cl(1)          173.97(9) 
 
 
The crystal structure of the tcc-[Ru(5mazpy)2Cl2] complex consists of 
a tcc-[Ru(5mazpy)2Cl2] and a lattice CH3CN molecule. The central ruthenium(II) ion 
is six-coordinated by four nitrogen donors of two 5mazpy molecules and two chloride 
anions. The atomic arrangement in tcc-[Ru(5mazpy)2Cl2] involves sequentially trans-
 chlorides, cis-N(pyridine), and cis-N(azo) and corresponds to a tans-cis-cis (tcc) 
configuration. The ruthenium ion forms two five membered chelated rings with two 
5mazpy ligands. The bite angles N3-Ru1-N1 and N3A-Ru1-N1A (75.52(2)°) reveal a 
considerable distortion in octhahedral around ruthenium and are similar ones found 
for tcc-[Ru(azpy)2Cl2]. The trans chloride angle is 173.97(9)° and is corroborates with 
a distorted octhahedral structure. The Ru-N(azo)  bond (1.990(5)Å) is shorter than the 
Ru-N(pyridine) (2.102(5)Å). The shortening may be due to greater π-back-bonding, 
dπ(Ru)→π*(azo) (Bag et al., 1992). In the tcc-[Ru(azpy)2Cl2] complex, the N-N 
distance is 1.286(7)Å which longer than that the free 5mazpy ligand (1.228(2)Å). This 
suggests that the coordination can lead to a decrease in the N-N bond order due to 
both σ-donor and π-acceptor character of the ligands. The Ru-Cl distance is 



















 3.3  Syntheses of the [Ru(5mazpy)2L](PF6)2, [Ru(5mazpy)2L′](PF6)2 and 
[Ru(L′)25mazpy](PF6)2 complexes (L = azpy, 5mazpy; L′= bpy, phen) 
 
The series of the [Ru(5mazpy)2L](PF6)2 and [Ru(5mazpy)2L′](PF6)2 
complexes were prepared from the reaction of the ctc-[Ru(5mazpy)2Cl2] complex  
with L ligands (L = 2-(phenylazo)pyridne (azpy), 5-methly-2-(phenylazo)pyridne 
(5mazpy); L′ = 2,2′-bipyridine  (bpy), and 1,10-phenanthroline (phen)) in refluxing 
methanol in the presence of AgNO3 to afford [Ru(5mazpy)2L]2+ and [Ru(5mazpy)2 
L′]2+, respectively. These complexes were isolated as the PF6¯ salts, [Ru(5mazpy)2L] 
(PF6)2, and [Ru(5mazpy)2L′](PF6)2. The synthetic reaction is shown in equation (5).
   
                    AgNO3, NH4PF6 
ctc-[Ru(5mazpy)2Cl2]       [Ru(5mazpy)2L](PF6)2, [Ru(5mazpy)2L′](PF6)2      (5)                        
                     MeOH, L or L′          
 
For the series of the [Ru(L′)25mazpy](PF6)2 complexes (L′= bpy, 
phen), the cis-[Ru(bpy)2Cl2] and  cis-[Ru(phen)2Cl2] complexes were used as 
precursor for synthesis of the [Ru(bpy)25mazpy](PF6)2 and  [Ru(phen)25mazpy](PF6)2 
complexes, respectively. The reactions of the cis-[Ru(bpy)2Cl2] or  cis-[Ru(phen)2Cl2] 
complexes with 5mazpy ligand in methanol in the presence of NH4PF6 generated the 
[Ru(bpy)25mazpy](PF6)2 and [Ru(phen)25mazpy](PF6)2 complexes, respectively. The 
synthetic detail is shown in equation (6).    
  
           AgNO3, NH4PF6 
         cis-[Ru(L′)2Cl2]                     [Ru(L′)25mazpy](PF6)2                (6) 
            MeOH, 5mazpy 
 
The structures of the ligands, 2-(phenylazo)pyridine (azpy), 5-methly-
2-(phenylazo)pyridne (5mazpy), 2,2′-bipyridine (bpy), 1,10-phenanthroline (phen), in 
this work are illustrated in Figure 3.42. The physical properties of the complexes of 
 [Ru(5mazpy)2L](PF6)2, [Ru(5mazpy)2L′](PF6)2 and [Ru(L′)25mazpy](PF6)2 are 






      2-(phenylazo)pyridine  (azpy)               5-methyl-2-(phenylazo)pyridine (5mazpy) 
 
 
   
 
               2,2′-bipyridine (bpy)                                    1,10-phenanthroline (phen) 
                            
Figure 3.42  The structure of the 2-(phenylazo)pyridine (azpy), 5-methyl-2- 
(phenylazo)pyridine (5mazpy), 2,2′-bipyridine (bpy), and 1,10-
phenanthroline (phen) ligands     
 
                                                 
Table 3.20  The physical properties of the [Ru(5mazpy)2L](PF6)2,  
[Ru(5mazpy)2L′](PF6)2  and [Ru(L′)25mazpy](PF6)2 complexes 
 
 Physical properties 
Complexes 
Appearance Color Melting point  (°C) 
[Ru(5mazpy)3](PF6)2 Solid Red-brown 293-296 
[Ru(5mazpy)2azpy](PF6)2 Solid Red-brown 288-290 
[Ru(5mazpy)2bpy](PF6)2 Solid Dark-Red 298-300 
[Ru(5mazpy)2phen](PF6)2 Solid Dark-Red 331-333 
[Ru(bpy)25mazpy](PF6)2 Solid Red-brown 325-328 










 Table 3.20  (continued) 
 
 Physical properties 
Complexes 
Appearance Color Melting point (°C) 
[Ru(phen)25mazpy](PF6)2 Solid Red-brown 330-333 
 
 
3.4  Characterization of the [Ru(5mazpy)2L](PF6)2, [Ru(5mazpy)2L′](PF6)2  and 
[Ru(L′)25mazpy](PF6)2 complexes (L = azpy, 5mazpy; L′= bpy, phen) 
 
The chemistry of the [Ru(5mazpy)2L](PF6)2, [Ru(5mazpy)2L′](PF6)2 
and [Ru(L′)25mazpy](PF6)2 complexes (L = azpy, 5mazpy, bpy; L′= bpy, phen) was 
studied by following techniques.  
 
3.4.1 Elemental analysis 
 3.4.2 ESI mass spectrometry 
 3.4.3 Infrared spectroscopy 
 3.4.4 UV-visible absorption spectroscopy 
 3.4.5 1D and 2D Nuclear Magnetic Resonance spectroscopy 
 3.4.6 Cyclic voltammetry 
 3.4.7 X-ray Crystallography 
 
3.4.1  Elemental analysis  
 
  Elemental analysis data are consistent with the general formula of the 
complexes, [Ru(5mazpy)3](PF6)2, [Ru(5mazpy)2azpy](PF6)2, [Ru(5mazpy)2bpy] 
(PF6)2, [Ru(5mazpy)2phen](PF6)2, [Ru(bpy)25mazpy](PF6)2, and [Ru(phen)25mazpy] 
(PF6)2. Results  from elemantal analysis are listed in Table 3.21. 
 
 
 Table 3.21  Elemental analysis data of the [Ru(5mazpy)2L](PF6)2, 
[Ru(5mazpy)2L′](PF6)2 and [Ru(L′)25mazpy](PF6)2 complexes 
 
 
3.4.2  Electro Spray Ionization (ESI) mass spectrometry 
 
The results from ESI mass spectrometry supported the molecular 
weight of complexes. The ESI mass spectrometric data are summarized in Table 3.22 
and ESI mass spectra are illustrated in Figure 3.43, 3.44, 3.45, and 3.46.  
 
Table 3.22  ESI mass spectrometric data of the [Ru(5mazpy)2L](PF6)2 and  
[Ru(5mazpy)2L′](PF6)2 complexes 
 












%C %N %H 
Complexes 
Calc. Found Calc. Found Calc. Found 
[Ru(5mazpy)3](PF6)2 43.99 43.81 12.83 13.05 3.36 3.25 
[Ru(5mazpy)2azpy](PF6) 43.39 43.38 13.02 13.15 3.20 3.04 
[Ru(5mazpy)2bpy](PF6)2 43.35 43.76 11.90 12.10 3.19 3.15 
[Ru(5mazpy)2phen](PF6)2 44.76 44.93 11.60 11.62 3.11 3.20 
[Ru(phen)25mazpy](PF6)2 45.57 44.62 10.34 10.53 2.85 2.49 
[Ru(bpy)25mazpy](PF6)2 42.64 43.66 10.89 10.40 3.02 3.17 
 Table 3.22  (continued) 
 





























M = Molecular weight (MW) of each complex 
MW of  [Ru(5mazpy)3](PF6)2 (M) = 982.07 g/mol 
MW of  [Ru(5mazpy)2azpy](PF6)2 (M) = 968.07 g/mol 
MW of  [Ru(5mazpy)2bpy](PF6)2 (M) = 941.07 g/mol 
MW of  [Ru(5mazpy)2phen](PF6)2 (M) = 965.07 g/mol 
 
   The maximum molecular peak of the [Ru(5mazpy)3](PF6)2 complex is 
observed at m/z 346 (100 %), which corresponds to the molecular ion, 
[Ru(5mazpy)3]2+.  In addition,  this complex exhibits peak at m/z 838 (10 %) which is 
assigned to the [Ru(5mazpy)3](PF6)]+ ion. In the ESI mass spectrum of the 
[Ru(5mazpy)2azpy](PF6)2 complex shows the base peak at m/z 339 due to the 
complex cation, [Ru(5mazpy)2azpy]2+. This complex also shows a peak at m/z 824 
(11.4 %) which corresponds to the [Ru(5mazpy)2azpy](PF6)]+ ion pair. For the 
[Ru(5mazpy)2bpy](PF6)2 complex, its spectrum exhibits two major peaks at m/z  797 
and 326 of which the response at 797 is assigned to [M-PF6¯+H+] (23.1 %) while, that 
 at 326 is due to the [M-2PF6¯]2+ (100%). Similar to [Ru(5mazpy)2bpy](PF6)2, the mass 
spectrum of [Ru(5mazpy)2phen](PF6)2 also shows two major ions, the most  intense 
peak at m/z 821 is due to the [M-PF6¯+H+] (100%), the second intense peak at m/z 





























 3.4.3  Infrared Spectroscopy 
 
  The important functional groups in the complexes, [Ru(5mazpy)2L] 
(PF6)2, [Ru(5mazpy)2L′](PF6)2 and [Ru(L′)25mazpy](PF6)2 (L = azpy, 5mazpy; L′ = 
bpy, phen), are N=N, C=N, C=C, and PF6¯. The characteristic group frequencies are 
collected in Table 3.23.  
 
Table 3.23  Infrared spectroscopic data of the  [Ru(5mazpy)2L](PF6)2,   
[Ru(5mazpy)2L′](PF6)2  and  [Ru(L′)25mazpy](PF6)2 complexes 
 
 
s = strong, m = medium 
  


































































PF6− 835 840 834 836 840 834 
   For IR spectrum of all complexes shows medium peak at 1601-1429 
cm-1, corresponding to C=C and C=N stretching frequencies. The N=N stretching 
frequencies of free ligand, 5mazpy, occur at 1389 cm-1 which appear at a lower 
frequencies than that in azpy (Changsaluk, U., 2002). This stretching mode is used to 
be consider the π-acid property in azo complexes. The N=N stretching frequencies of 
the azpy, 5mazpy ligands, the ctc-[Ru(5mazpy)2Cl2], [Ru(5mazpy)2L](PF6)2, [Ru 
(5mazpy)2L′](PF6)2 and  [Ru(L′)2 5mazpy](PF6)2 complexes are listed in Table 3.24.   
 
Table 3.24  The N=N stretching frequency in the azpy, 5mazpy ligands,  
                    the ctc-[Ru(5mazpy)2Cl2], [Ru(5mazpy)2L](PF6)2, [Ru(5mazpy)2L′](PF6)2 
and [Ru(L′)25mazpy](PF6)2 complexes 
 












The azoimine orbitals in these compounds are strongly involved in π-
interactions. Thus the υ(N=N) stretching frequencies in the complexes of 5mazpy are 
appreciably lower as compare to that for the free 5mazpy. In the precursor complex, 
ctc-[Ru(5mazpy)2Cl2], the N=N stretching frequencies appear at 1334 cm-1 which 
 lower energy than of mixed ligand complexes, [Ru(5mazpy)2L](PF6)2. In addition, the 
N=N stretching mode in the [Ru(5mazpy)3](PF6)2 and [Ru(5mazpy)2azpy](PF6)2 
complexes occurs at the higher frequencies than those of the [Ru(5mazpy)2bpy](PF6)2 
and [Ru(5mazpy)2phen](PF6)2 complexes. These may be due to better π-acceptor 
properties of 5mazpy, azpy, bpy, and phen. It results in less π back donation to the azo 
function.  
  As the employed coligand becomes a better π-acceptor, there is 
competition for the ruthenium t2g electrons and less π back donation to the azo ligand 
raising the azo bond order. Thus, with a very strong π-acid coligand, the azo mode 
could approach the free ligand value, while with a low π-acid coligand a single bond 
order might be approached for the azo linkage. In comparison of 
[Ru(5mazpy)2L](PF6)2, [Ru(5mazpy)2L′](PF6)2  and [Ru(L′)25mazpy](PF6)2, the 
υ(N=N) in [Ru(L′)25mazpy] (PF6)2 (L′ = bpy, phen) appears at the lower frequencies 
than that the [Ru(5mazpy)2L](PF6)2 (L′= bpy and phen) because the [Ru(L′)25mazpy] 
(PF6)2 complexes contain one azo ligand. The infrared spectra of the [Ru(5mazpy)2 
L](PF6)2, [Ru(5mazpy)2L′](PF6)2 and [Ru(L′)25mazpy](PF6)2 complexes are shown in 















 3.4.4  UV-Visible absorption spectroscopy 
 
  The complexes of [Ru(5mazpy)2L](PF6)2, [Ru(5mazpy)2L′](PF6)2 and 
[Ru(L′)25mazpy](PF6)2 (L = azpy, 5mazpy; L′ = bpy, phen),  appear to be typical 
charge-transfer (CT) spectra with molar extinction coefficients of the lowest energy 
band near 104 M-1cm-1. Absorption spectroscopic data of solutions of the complexes 
in MeOH, EtOH, CH3CN, DMSO, and CH2Cl2 are reported in Table 3.25. 
 
Table 3.25  UV-Visible absorption spectroscopic data of the [Ru(5mazpy)2L](PF6)2, 
[Ru(5mazpy)2L′](PF6)2 and [Ru(L′)25mazpy](PF6)2 complexes in CH3CN 
 
λmax nm, (εa × 10-4 M-1cm-1) Complexes 














































































 Table 3.25  (continued) 
 
λmax nm, (εa × 10-4 M-1cm-1) Complexes 












































a Molar Extinction coefficient 
 
  The electronic spectra of the complexes were recorded in the range 
200-800 nm reveal that the absorptions <400 nm are due to n→π* and π→π* 
transitions. The visible region of the spectrum shows one high intense absorptions 
near 500 nm. The transitions are of typical metal-to-ligand charge transfer type 
(MLCT) with high molar extinction coefficients (ε ∼ 104 M-1cm-1). The absorption 
spectra of [Ru(5mazpy)3](PF6)2, [Ru(5mazpy)2azpy](PF6)2, [Ru(5mazpy)2bpy](PF6)2, 
and [Ru(5mazpy)2phen](PF6)2 in CH3CN displays intense bands at λmax 496, 496, 514, 
and 506 nm, respectively. The MLCT band for the [Ru(5mazpy)3](PF6)2 and  
[Ru(5mazpy)2azpy](PF6)2 complexes occurs at the higher energies than that the 
[Ru(5mazpy)2bpy](PF6)2, and [Ru(5mazpy)2phen](PF6)2 complexes. Owing to the 
azoimine ligands (5mazpy and azpy) are good π-acceptor ligand, and back bonding 
from Ru(II) to 5mazpy or azpy results in stabilization of the dπ levels relative to 
π*(bpy and phen) and an increase in the MLCT band energy. The π* orbital of 
azoimine ligand is lower than in imine ligand (Krause and Krause, 1980). Then, the 
lowest energy of each complexes is attributable to the MLCT transition 
 d(Ru)→π*(azomine ligand). The lowest energy of MLCT absorptions bands of 
complexes in acetonitrile is listed in Table 3.26. 
 
Table 3.26  The lowest energy of MLCT absorption bands of the 
[Ru(5mazpy)2L](PF6)2, [Ru(5mazpy)2L′](PF6)2  and 
[Ru(L′)25mazpy](PF6)2 complexes in CH3CN 
 






[Ru(bpy)3](PF6)2 b 450 
[Ru(phen)25mazpy](PF6)2 495 
[Ru(phen)3](PF6)2 c 446 
 
a Molar Extinction coefficient 
b (Tempiam, S., 2002); c (Rattanawit, N., 2002) 
 
According to MLCT bands in visible region of the [Ru(bpy)25mazpy] 
(PF6)2 complex only one intense band is observed in the visible region. In comparison 
of the MLCT band in this complex with [Ru(bpy)3](PF6)2 (450 nm), the 
[Ru(bpy)25mazpy](PF6)2 (494 nm) complex displays at the lower energy than 
[Ru(bpy)3](PF6)2 (Tempiam, S., 2002). Besides, the MLCT band in  [Ru(phen)2 
5mazpy](PF6)2 was compared with [Ru(phen)3](PF6)2.  The complex of  [Ru(phen)2 
5mazpy](PF6)2 (495 nm) has MLCT band at the lower energy than that [Ru(phen)3] 
(PF6)2 (446 nm) (Rattanawit, N., 2002). For the [Ru(bpy)25mazpy](PF6)2 and [Ru 
 (phen)25mazpy](PF6)2 complexes, they are expected that the π* levels of 5mazpy are 
lower than that bpy and phen. Therefore, the energy of the d(Ru)→π*(azomine 
ligand) transition shifts to the red when compares with [Ru(bpy)3](PF6)2, and 
[Ru(phen)3](PF6)2, respectively. The absorption spectra of [Ru(5mazpy)2L](PF6)2, 
[Ru(5mazpy)2L′](PF6)2 and [Ru(L′)25mazpy](PF6)2 complexes are shown in Figure 



























 3.4.5  1D and 2D Nuclear Magnetic Resonance spectroscopy 
 
  The 1H, 13C, DEPT 135, 1H-1H COSY, and  1H-13C HMQC NMR 
spectrum of the complexes, [Ru(5mazpy)2L](PF6)2, [Ru(5mazpy)2L′](PF6)2 and [Ru 
(L′)25mazpy](PF6)2 (L = azpy, 5mazpy; L′ = bpy phen), were carried out in acetone-d6 
(500 MHz) and tetramethylsilane (Si(CH3)4) was used as internal reference. The 1D 
and 2D NMR studies of the [Ru(5mazpy)2L](PF6)2, [Ru(5mazpy)2L′](PF6)2 and [Ru 
(L′)25mazpy] (PF6)2 complexes were described as below.  
                
(a) Nuclear Magnetic Resonance spectroscopy of the [Ru(5mazpy)3](PF6)2   
complex 
  
The 1H and 13C NMR spectroscopic data are listed in Table 3.27.  













δ (ppm) J (Hz) Number of H 
13C NMR  
δ (ppm) 
3C 9.14 (d) 8.5 1 132.05 
6C 8.67 (s) 8.0 1 153.59 


























































δ (ppm) J (Hz) Number of H
13C NMR  
δ (ppm) 
3B 8.59 (d) 8.0 1 131.23 
4C 8.50 (d) 8.0 1 143.14 
6A 8.42 (s) - 1 151.65 
4B 8.34 (d) 8.0 1 143.31 
4A 8.26 (d) 8.0 1 143.27 
6B 8.21 (s) - 1 152.39 
10A 7.63 (t) 8.0, 8.0 1 134.15 
10C 7.61 (t) 8.0, 8.0 1 134.09 
9,9′A, 10B 7.51 (m) - 3 130.86, 134.09 
9,9′C, 8,8′A 7.44 (m) - 4 130.80, 123.64 
8,8′C 7.37 (dd) 8.5, 1.0  2 123.55 
9,9′B 7.32 (dd) 8.0, 8.5 2 130.96 
8,8′B 7.04 (dd) 9.0, 1.0 2 123.39 
11C 2.52 (s) - 3 18.56 
11 2.48 (s) - 3 18.44 
11 2.47 (s) - 3 18.40 
Quaternary Carbons 
163.42, 163.13, 162.45, 
156.60, 153.52, 152.94, 
144.86, 144.71, 144.34 
 
d = doublet, dd = doublet of doublet, m = multiplet, s = singlet, and t = triplet 
 
  The 1H NMR spectrum of [Ru(5mazpy)3](PF6)2 is shown in Figure 
3.59. As the complex of [Ru(5mazpy)3](PF6)2 has C1 symmetry, all the three 5mazpy 
 ligands are inequivalent, resulting in eighteen resonances in aromatic region, which 
have been fully assigned using 1H-1H COSY NMR spectroscopy (Figure 3.60). From 
1H-1H COSY NMR, the three sets of 5mazpy pyridine signals and three sets of 
5mazpy phenyl signals have been distinguished. The protons on pyridine ring (H3, 
H4, and H5) appear at lower field than phenyl ring (H8, H9, and H10) due to the 
electron withdrawing, N atom on pyridine. Since two of the three 5mazpy pyridine 
ring (A, B) are trans to each other, the positions of protons are slightly different 
similar to the situation of the [Ru(azpy)3](PF6)2 complex (Hotze et al., 2005). While, 
the chemical shifts of the protons of 5mazpy pyridine ring C appear at the lowest 
field, because this pyridine ring trans to N=N azo function. The complex of 
[Ru(5mazpy)3](PF6)2 contains three 5mazpy ligands in molecule. Thus, this complex 
is expected to exhibit three methyl signals of equal intensities at 2.52, 2.48, and 2.47 
ppm. In addition, the methyl signal at 2.52 ppm is due to the methyl on the pyridine 
ring C because trans to N=N azo group. 
The 13C NMR spectrum (Figure 3.61)  provides direct information 
about the carbon skeleton of the molecule. The 13C NMR signals have been fully 
assigned using 1H-13C HMQC NMR spectroscopy (Figure 3.63) which is generally 
used for studing large and complicated molecules. The 13C NMR spectrum shows 
eighteen signals from twenty-four methine carbons, three signals from three methyl 
carbons, and nine signals from nine quaternary carbons which support by the results 
from DEPT 135 NMR spectrum (Figure 3.62).  The carbon atoms neighbouring the 
nitrogen atom shift to downfield due to a decrease electron density resulting from the 
presence of electronegative nitrogen atom. The quaternary carbons are found at 
163.42, 163.13, 162.45, 156.60, 153.52, 152.94, 144.86, 144.71, and 144.34 ppm 
which refer to the C2, C7, and C5, respectively. These results correlate with 1H-13C 
HMQC NMR spectrum which it absence of any contours at these positions. The 
carbons signals at 18.56, 18.44, and 18.40 ppm refer to methyl carbons from three 
5mazpy ligands. These signals are due to their interaction with proton resonances at 
2.52, 2.48, and 2.47 ppm. It is noted that chemicals shifts of the complex move to 
downfield compared to those of the free ligand. 
 
 (b) Nuclear Magnetic Resonance spectroscopy of the [Ru(5mazpy)2azpy](PF6)2 
complex 
 
















δ (ppm) J (Hz) Number of H
13C NMR  
δ (ppm) 
3(azpy) 9.26 (d) 8 1 130.97 
6(azpy) 8.77 (d) 5.5 1 153.63 
4(azpy) 8.69 (ddd) 8, 8, 1.5 1 143.12 
3(5mazpy) 8.62 (d) 8 1 131.63 
3(5mazpy) 8.61 (d) 8 1 131.44 
6(5mazpy) 8.43 (d) 2 1 151.81 
4(5mazpy) 8.35 (dd) 8, 1.5 1 143.39 
4(5mazpy) 8.27 (dd) 8, 1.5 1 143.21 
6(5mazpy) 8.22 (d) 2 1 152.49 























































δ (ppm) J (Hz) Number of H 
13C NMR  
δ (ppm) 
10 7.66 (t) 8 1 134.36 
10 7.61 (t) 8 1 134.17 
9,9′ 7.54 (d) 8 2 130.97 
10B(5mazpy) 7.52 (t) 8 1 134.17 
8,8′,  8,8′,  9,9′ 7.42 (m) - 6 123.73, 123.46, 130.56 
9,9′B(5mazpy) 7.33 (d) 8 2 130.47 
8,8′B(5mazpy) 7.06 (d) 8 2 123.39 
11A 2.51 (s) - 3 19.18 
11B 2.48 (s) - 3 19.13 
Quaternary Carbons 
164.33, 163.38, 163.04, 
156.73, 153.03, 152.31 
 144.91, 144.89 
 
d = doublet, dd = doublet of doublet, ddd = doublet of doublet of doublet,  
m = multiplet, s = singlet, and t = triplet 
 
  The 1H NMR spectrum (Figure 3.64) of [Ru(5mazpy)2azpy](PF6)2 
shows three sets of pyridine ring signals and three set of phenyl ring signals. The 
assignments of all signals were made from 1H-1H COSY NMR spectroscopy (Figure 
3.65). The 1H NMR spectrum of this complex in acetone-d6 contains nineteen signals 
from twenty-five aromatic protons and two signals from aliphatic protons. The signals 
of pyridine ring appear in the range 7.99-9.26 ppm and signals of phenyl ring are 
observed in the range 7.06-7.66 ppm. The methyl signals (2.51 and 2.48 ppm) are 
particularly useful to account for the configuration of N(py) and N(azo) orientation 
from starting complex, ctc-[Ru(5mazpy)2Cl2]. The proton H3 (9.26 ppm, doublet, J = 
 8 Hz) on pyridine ring of azpy ligand occurs at the lowest field which is due to trans 
to azo group. The methyl groups are useful to support the structure of the complexes. 
Two 5mazpy ligands in this complex give two sets of separate signals of methyl 
which resonances at 2.51 and 2.48 ppm. This suggests that the ligands chelated 
around Ru(II) are unsymmetrically disposed. 
  The 13C NMR spectrum (Figure 3.66) displays nineteen methine 
carbons, two methyl carbons, and eight quaternary carbons. The signals of quaternary 
can not be observed in DEPT 135 NMR spectrum (Figure 3.67) which support 13C 
NMR results. Eight quaternary carbons, C2A, C5A, C7A, C2B, C5B, C7B, C2(azpy), 
and C7(azpy),  are observed. The carbon C2(azpy) occurs at the lowest field because 
this position  located next to N=N azo group and the pyridine ring C trans to N=N azo 
group of 5mazpy (B) ligand. In addition, the quaternary carbons unable to show any 
direct 1H-13C heteronuclear multiple quantum coherence. The [Ru(5mazpy)2azpy] 
(PF6)2 complex contains two 5mazpy ligands, thus two methyl carbons are observed 
at 19.18 and 19.13 ppm. This results consist with  the proton of methyl group. This is 
because, they belong to the non-proonated carbon atoms on the pyridine, phenyl rings. 















 (c) Nuclear Magnetic Resonance spectroscopy of the [Ru(5mazpy)2bpy](PF6)2 
complex 
 














δ (ppm) J (Hz) Number of H 
13C NMR  
δ (ppm) 
3(bpy) 8.97 (d) 8.0 1 126.34 
3(5mazpy) 8.66 (d) 8.5 1 130.22 
4(bpy) 8.44 (ddd) 8.0, 8.0, 1.0 1 141.28 
6(bpy) 8.38 (d) 5.5 1 153.90 
6(5mazpy) 8.32 (s) - 1 150.97 
4(5mazpy) 8.22 (dd) 8.0, 2.0 1 142.24 
5(bpy) 7.77 (td) 7.5, 5.5 1 129.79 
10(5mazpy) 7.57 (m) - 1 133.58 
9,9′,  8,8′(5mazpy) 7.41 (m) - 2 130.31, 123.45 























































δ (ppm) J (Hz) Number of H 
13C NMR  
δ (ppm) 
Quaternary Carbons 
163.96, 156.11,  
153.97,  143.53 
 
d = doublet, dd = doublet of doublet, ddd = doublet of doublet of doublet,  
m = multiplet, s = singlet, and td = triplet of doublet 
 
  The 1H NMR spectrum of [Ru(5mazpy)2bpy](PF6)2 (Figure 3.69) 
shows ten signals in aromatic region and one signal in aliphatic region. Due to the C2 
axis present in this complex, the two 5mazpy ligands are equivalent. The spectrum 
displays distinct eleven signals corresponding to one 5mazpy ligand and one pyridine 
ring of bpy ligand. The proton on pyridine ring in 5mazpy ligand exhibits at the 
higher field than in bpy ligand. Owing to the 5mazpy contains the methyl group 
which is electron donating group. This may be increase electron density on pyridine 
ring of 5mazpy. In addition, the bpy ligand is trans to N=N electron withdrawing 
group, azo(N=N). The proton H3 and H6 of bpy appear as doublet at 8.97, and 8.38 
ppm, respectively. This H6 (J = 5.5 Hz) is easily recognised from the smaller J 
coupling in comparison to the J coupling of the H3 (J = 8 Hz). The signal of proton 
H6 of 5mazpy is found at 8.32 ppm as singlet. The methyl signal (2.87 ppm) is 
observed only one signal due to the symmetry of molecule. The 1H-1H COSY NMR 
spectrum in acetone-d6 is displayed in Figure 3.70. 
  The 13C NMR spectrum (Figure 3.71) shows ten methine carbons, one 
methyl carbon, and four quaternary carbons. These data are confirmed by using DEPT 
135 NMR (Figure 3.72). The methyl carbon, appears at 2.87 ppm. In addition, the 
signal of quaternary carbons occurs at 163.96, 156.11, 153.97, and 143.53 ppm. The 
13C NMR signal assignments were based on the 1H-13C HMQC NMR spectroscopy 
(Figure 3.73). The observed peak at 19.06 ppm is assigned  to the methyl carbon, due 
to the symmetry of molecule. Only one carbon from methyl group is found. 
 (d) Nuclear Magnetic Resonance spectroscopy of the [Ru(5mazpy)2phen](PF6)2 
complex 
 















δ (ppm) J (Hz) Number of H 
13C NMR  
δ (ppm) 
3(5mazpy) 9.08 (d) 8 1 130.73 
3(5mazpy) 9.05 (d) 8 1 130.52 
7(phen) 8.97 (dd) 8, 1.5 1 140.59 
5(phen) 8.69 (d) 8 1 139.57 
2(phen) 8.65 (d) 5 1 153.40 
4(5mazpy) 8.55 (dd) 8, 1.5 1 143.88 
4(5mazpy) 8.33 (d) 8 1 143.37 
6(phen) 8.29 (d) 8 1 128.91 
















































δ (ppm) J (Hz) Number of H
13C NMR  
δ (ppm) 
4(phen) 8.14 (d) 9.5 1 128.81 
6(5mazpy) 8.12 (s) - 1 151.19 
8(phen) 8.10 (dd) 8.5, 5.5 1 128.40 
9(phen) 8.01 (dd) 5.5, 1.5 1 152.72 
3(phen) 7.99 (dd) 8.5, 5.5 1 127.86 
10(5mazpy) 7.69 (t) 8 1 133.46 
9, 9′(5mazpy) 7.62 (dd) 8, 8 2 130.95 
8, 8′(5mazpy) 7.39 (dd) 8, 1.5 2 123.62 
10(5mazpy) 7.04 (t) 8 1 131.95 
9, 9′(5mazpy) 6.80 (dd) 8, 8 2 129.32 
8, 8′(5mazpy) 6.36 (dd) 8, 1.5 2 121.73 
11 2.49 (s) - 3 19.24 
11 2.18 (s) - 3 18.92 
Quaternary Carbons 
164.39, 162.78, 158.19, 
153.92, 146.71, 146.37, 
143.35, 142.55, 131.49, 
131.41 
 
d = doublet, dd = doublet of doublet, m = multiplet, s = singlet, and t = triplet  
  
The 1H NMR spectrum (Figure 3.74) of the [Ru(5mazpy)2phen](PF6)2 
complex shows many sharp resonances. In total twenty-two resonances are observed 
for thirty hydrogens present in this complex. The 1H NMR spectrum shows two sets 
of 5mazpy signals, and one set of phen signals which is indicated that this molecules 
 lack C2 symmetry. The assignment of all signals is made from 1H-1H COSY NMR 
spectroscopic data (Figure 3.75). The pyridine protons appear in the range 9.08-7.99 
ppm and the phenyl protons display in the range 7.69-6.36 ppm. The proton H3 of 
both 5mazpy ligands occurs at 9.08 and 9.05 ppm as doublet (J = 8.0 Hz). The methyl 
signal of the 5mazpy ligand is particularly useful to confirm the number of 5mazpy 
ligand. This spectrum shows two methyl signals at 2.49 and 2.18 ppm which equal 
heights. The appearance of two signals refer to the presence of two 5mazpy ligands in 
this molecule, resulting in nonequivalent 5mazpy ligands.  
  The 13C NMR signals (Figure 3.76) are assigned and compared with 
DEPT 135 NMR spectrum (Figure 3.77). The assignments of carbons on ligands are 
based on 1H-13C HMQC NMR spectroscopy (Figure 3.78). Ten quaternary carbons 
are observed at 164.39, 162.78, 158.19, 153.92, 146.71, 146.37, 143.35, 142.55, 
131.49, and 131.41 ppm. In addition, the two methyl carbon signals appear at 19.24 
and 18.92 ppm which are corroborated with the presence of two 5mazpy ligands in 


















 (e) Nuclear Magnetic Resonance spectroscopy of the [Ru(bpy)25mazpy](PF6)2 
complex 
 















δ (ppm) J (Hz) Number of H 
13C NMR  
δ (ppm) 
3(bpy) 8.94 (d) 8 1 126.20 
3(bpy) 8.92 (d) 8 1 125.88 
3(5mazpy) 8.90 (d) 8.5 1 129.65 
3(bpy) 8.62 (d) 8 1 125.34 
3(bpy) 8.47 (d) 8 1 125.08 
4(bpy), 4(bpy), 
4(bpy), 6(bpy) 
8.35 (m) - 4 
141.13, 140.82,  
140.62, 154.20 
4(5mazpy) 8.26 (d) 8 1 141.82 
6(5mazpy) 8.19 (s) - 1 151.89 


















































δ (ppm) J (Hz) Number of H
13C NMR  
δ (ppm) 
6(bpy), 6(bpy) 7.99 (d) 5.5 2 151.89, 151.63 
5(bpy), 5(bpy), 
5(bpy), 6(bpy) 
7.71 (m) - 4 
128.96, 129.14, 
129.37, 153.34 
5(bpy) 7.53 (dd) 8, 6 1 129.71 
10(5mazpy) 7.40 (t) 8 1 131.80 
9,9′(5mazpy) 7.23 (dd) 8, 8 2 130.04 
8,8′(5mazpy) 7.15 (d) 8 2 123.01 
11 2.31 (s) - 3 19.19 
Quaternary Carbons 
165.38, 157.76, 157.29, 
157.04, 156.03, 155.54, 
141.85 
 
d = doublet, dd = doublet of doublet, ddd = doublet of doublet of doublet,  
m = multiplet, s = singlet, and t = triplet  
 
  The 1H NMR spectrum of the [Ru(bpy)25mazpy](PF6)2 complex 
(Figure 3.79) shows signals in aromatic region and aliphatic region. Five sets of 
pyridine ring and one set of phenyl ring are observed. Due to the C1 axis present in 
this complex, the two bpy ligands are nonequivalent. In each pyridine ring, proton H3 
appears at the most downfield. The resonances have been assigned using 1H-1H 
COSY NMR spectroscopy (Figure 3.80). The resonances corresponding to the H6 of 
both 5mazpy and bpy ligands have a smaller J coupling than the resonances 
corresponding to the H3. The proton H6 on 5mazpy ligand appears at 8.19 ppm as 
singlet. This is due to absence of any proton near proton H6. The resonance at 2.31 
ppm (singlet), which is attributable to the proton at the methyl group from 5mazpy. 
   The 13C NMR spectrum (Figure 3.81) of the two bpy ligands are 
nonequivalent resulting in twenty-two methine carbons, one methyl carbon, and seven 
quaternary carbons. This results support by DEPT 135 NMR spectroscopy (Figure 
3.82). The chemical shift of methyl carbon of 5mazpy is observed at 19.19 ppm which 
high field than that free 5mazpy ligand. The 13C NMR signals assignments were based 
on the 1H-13C HMQC NMR spectrum (Figure 3.83), which exhibit correlation 

























 d) Nuclear Magnetic Resonance spectroscopy of the [Ru(phen)25mazpy](PF6)2 
complex 
 















δ (ppm) J (Hz) Number of H 
13C NMR  
δ (ppm) 
7(phen) 9.03 (d) 8.5, 1.5 1 140.04 
4(phen) 8.99 (dd) 8.5, 1.5 1 139.58 
2(phen) 8.98 (d) 5.5 1 155.59 
3(5mazpy) 8.93 (dd) 8 1 128.84 
4(phen) 8.90 (dd) 8, 1.5 1 139.58 
7(phen) 8.63 (dd) 8.5, 1 1 138.70 
5, 6(phen) 8.50 (m) - 2 129.30, 129.16 
5(phen) 8.33 (dd) 8 1 128.86 
9(phen) 8.28 (dd) 5.5, 1.5 1 154.68 











































δ (ppm) J (Hz) Number of H 
13C NMR  
δ (ppm) 
4(5mazpy) 8.24 (d) 8 1 141.70 
6(phen) 8.21 (d) 8 1 129.49 
9(phen), 
6(5mazpy) 
8.16 (m) - 2 
151.26,  
153.73 
8(phen) 8.15 (dd) 8, 8 1 127.94 
3(phen) 8.09 (dd) 8, 8 1 128.02 
3(phen) 7.84 (dd) 8, 8 1 127.58 
8(phen) 7.66 (dd) 8, 8 1 127.31 
10(5mazpy) 7.17 (t) 8 1 131.34 
8,8′(5mazpy) 7.07 (dd) 8, 1.5 2 122.55 
9,9′(5mazpy) 6.99 (t) 8, 8 2 129.57 
11 2.19 (s) - 3 19.57 
Quaternary Carbons 
165.67, 155.46, 148.18, 
147.83, 147.58, 146.77, 
141.64, 132.47, 132.34, 
131.89, 131.63 
 
d = doublet, dd = doublet of doublet, m = multiplet, t = triplet, s = singlet 
 
  The 1H NMR spectrum of [Ru(phen)25mazpy](PF6)2 is depicted in 
Figure 3.84. As this complex has C1 symmetry, two phen ligands are inequivalent, 
resulting in twenty-two resonances in aromatic region, which have been fully assigned 
using 1H-1H COSY NMR spectroscopy (Figure 3.85). From 1H-1H COSY NMR 
spectrum the 5mazpy signals display at the highest field which separate from the 
pyridine signal. In the spectrum, a singlet corresponding to three protons is observed 
 at 2.19 ppm. Appearance of the protons of methyl group as a singlet suggest that one 
5mazpy ligand in this complex. The high field shift of the methyl group (0.23 ppm) 
compares to the free ligand indicated a position of this group in the shielding region 
of the pyridine ring of phen. 
  The 13C NMR spectrum (Figure 3.86) consists with the DEPT 135 
NMR spectrum (Figure 3.87). This suggests that eleven quaternary carbons in 
molecule. The carbon signal at 19.57 ppm is assigned to methyl carbon. The carbon 
chemical shifts of this complex have been assigned by using 1H-13C HMQC NMR 
























 3.4.6  Cyclic voltammetry 
 
The electrochemical activity of the [Ru(5mazpy)2L](PF6)2, [Ru 
(5mazpy)2L′](PF6)2 and [Ru(L′)25mazpy](PF6)2 complexes (L = azpy, 5mazpy; L′ = 
bpy, phen), was studied in CH3CN solution by cyclic voltammetry at a scan rate of 
100 mVs-1. The voltammetric data are given in Table 3.33 and representative 
voltammograms are shown in Figure 3.89 to 3.94. Voltammograms of complexes 
display metal oxidation on the positive potential and ligand reductions on the negative 
potential with respect to ferrocene. The one electron nature of oxidation or reduction 
is establihsed by comparing its current heights with those of standard ferrocene-
ferrocenium couple under identical experiment. 
 
Table 3.33  Cyclic voltammetric data of the [Ru(5mazpy)2L](PF6)2,  
                    [Ru(5mazpy)2L′](PF6)2  and [Ru(L′)25mazpy](PF6)2 complexes  
                    in CH3CN (0.1 M TBAH) at scan rate 100 mVs-1 
 





























































 Table 3.33  (continued) 
 
















n = cannot be observed; a = E1/2 = (Epa +Epc)/2, where Epa and Epc are anodic and 
chathodic peak potentials, respectively; ∆Ep = Epa-Epc 
 
 
 Oxidation potential 
 
The oxidation potenial range 0 to +1.50 V at scan rate 100 mVs-1 one 
redox couple is observed for the [Ru(L′)25mazpy](PF6)2 (L′ = bpy, phen) complexes 
while the [Ru(5mazpy)2L](PF6)2, [Ru(5mazpy)2L′](PF6)2  (L = azpy, 5mazpy; L′ = 
bpy, phen) complexes are not observed because the redox of Ru(II)/Ru(III) is too 
positive to be observed within the solvent window.  
For the [Ru(bpy)25mazpy](PF6)2 complex, the oxidation couple at 1.14 
V is reversible which is nature as in evident from the peak-to-peak separation, ∆Ep ≤ 
100 mV while the redox potential of Ru(II)/Ru(III) in [Ru(bpy)3](PF6)2 (Tempiam, S., 
2002) are found to be reversible at 0.91 V (∆Ep = 85 mV)   which lower than that [Ru 
(bpy)25mazpy](PF6)2. The [Ru(phen)25mazpy](PF6)2 complex undergo oxidation at 
1.11 V (∆Ep = 100 mV). The response is attributed to the Ru(II)/Ru(III) couple. The 
oxidation potential of this complex is compared with [Ru(phen)3](PF6)2. Results show 
that the potential of [Ru(phen)25mazpy](PF6)2 more positive than that in the 
[Ru(phen)3](PF6)2 (0.89 V, ∆Ep = 75 mV) (Rattanawit, N., 2002). The results from 
this study and the reported oxidation potential values demonstrate that π acceptance of 
5mazpy is greater than bpy and phen. Thus the azopyridine ligand (L) can act as a 
 much better stabiliser of Ru(II) ion compare to the bpy and phen ligand, which is of 
course due to the stronger π-acid property of L. This results is in accordance with the 




The reduction potential range 0 to -2.65 V at scan rate 100 mVs-1. Four 
or five successive reductions are observable within this potential window. The 
azopyridines are well known electron-transfer centres. Thus each ligand can 
accommodate two electrons in one electrochemically accessible lowest unoccupied 
molecular orbital (LUMO) which is primarily azo character (Goswami et al., 1983). 
In addition, the bpy ligand can successively accept two electrons in its lowest 
unoccupied molecular orbital. Since the ruthenium complexes contain three 
electroactive ligands, in principle, six successive reductions are expected for each 
complex. 
For the [Ru(5mazpy)2L](PF6)2 and [Ru(5mazpy)2L′](PF6)2  complexes, 
only five of the six couples are detected in this experiment. The interpretation of CV 
data may be carried out on comparison with the redox properties of ctc-[Ru(5mazpy)2 
Cl2], [Ru(azpy)3](PF6)2 (Changsaluk, U., 2002), [Ru(bpy)3](PF6)2, [Ru(bpy)2azpy] 
(PF6)2 (Tempiam, S., 2002), [Ru(phen)3](PF6)2, [Ru(phen)2azpy](PF6)2 (Rattanawit, N., 
2002 ). These are assigned to reductions of the coordinated ligands. Redox data in 
Table 3.34 reveal that the first reduction potential of the coordinated ligand occurs at a 
much less negative potential than that of other response and the oxidation potential of 
metal ion. The first reduction may be expected to involve the ligand having the most 
stable lowest unoccuiped molecular orbital (Dinda et al., 2006), which is dominated by 
azo function of azpy and 5mazpy than bpy and phen. The formal potential of the first 
reduction of the [Ru(5mazpy)3](PF6)2, [Ru(5mazpy)2azpy](PF6)2, [Ru(5mazpy)2bpy] 
(PF6)2, and [Ru(5mazpy)2phen](PF6)2 complexes is -0.52 V (∆Ep = 60 mV), -0.49 V 
(∆Ep = 60 mV), -0.64 V (∆Ep = 60 mV) and -0.68 V (∆Ep = 100 mV), respectively.  
Five couples at negative side of [Ru(L′)25mazpy](PF6)2 are assigned to gradual 
addition of electron into one azoimine chelate from 5mazpy and two imine chelates 
ring in the complexes. In addition, the first reduction potential in [Ru(bpy)25mazpy] 
 (PF6)2 and  [Ru(phen)25mazpy](PF6)2 is -1.03 V (∆Ep = 70 mV) and -1.07 V (∆Ep = 65 
mV), respectively.  
 
Table 3.34.  Cyclic voltammetric data of the ruthenium complexes with the azoimine 
and  imine ligands in CH3CN (0.1 M TBAH) at scan rate 100 mVs-1 
 






ctc-[Ru(5mazpy)2Cl2] 0.65 (65) -1.17 (95) 
[Ru(5mazpy)3](PF6)2 n -0.52 (60) 
[Ru(azpy)3](PF6)2 a n -0.44 (70) 
[Ru(bpy)25mazpy](PF6)2 1.14 (65) -1.03 (65) 
[Ru(bpy)2azpy](PF6)2 b  1.21 (100) -0.87 (65) 
[Ru(bpy)3](PF6)2 b 0.91 (85) -1.14 (85) 
[Ru(phen)25mazpy](PF6)2 1.11 (100) -1.07 (70) 
[Ru(phen)2azpy](PF6)2 c 1.20 (105) -0.88 (70) 
[Ru(phen)3](PF6)2 c 0.89 (72) -1.93 (100) 
 
n = can not be observed, a (Changsaluk, U., 2002),  
b (Tempiam, S., 2002), c (Rattanawit, N., 2002) 
 
The first reduction potential in all ruthenium complexes, [Ru(5mazpy)2 
L](PF6)2, [Ru(5mazpy)2L′](PF6)2 and [Ru(L′)25mazpy](PF6)2, is more positive than 
the free 5mazpy ligand (-1.62 V, ∆Ep = 94 mV) which due to the positive charge of 
the metal ion. In the presence of methyl group (in 5mazpy) may shift ligand 
dominated orbitals to higher energy side than azpy ligand. From this table shows that, 
the relative values of the potential suggest that the  π-acidity order is azpy > 5mazpy  
 > bpy ∼ phen. 
The reduction potentials data of [Ru(5mazpy)3](PF6)2 are listed in 
equation (7)-(11).  
 
[RuII(5mazpy)(5mazpy)(5mazpy)]2+ + e- → [RuII(5mazpy)(5mazpy)(5mazpy1-)]+               (7)  
[RuII(5mazpy)(5mazpy)(5mazpy1-)]+ + e- → [RuII(5mazpy)(5mazpy1-)(5mazpy1-)]0             (8)  
[RuII(5mazpy )(5mazpy1-)(5mazpy1-)]0 +e- → [RuII(5mazpy1-)(5mazpy1-)(5mazpy1-)]-          (9)    
[RuII(5mazpy1-)(5mazpy1-)(5mazpy1-)]- +e- →[RuII(5mazpy1-)(5mazpy1-)(5mazpy2-)]2-       (10)   
[RuII(5mazpy1-)(5mazpy1-)(5mazpy2-)]2- +e-→[RuII(5mazpy1-)(5mazpy2-)(5mazpy2-)]3-      (11)        
                    
Another one expected reduction is not observed presumably due to 
solvent cut off. The reduction for [Ru(5mazpy)2azpy](PF6)2 have been observed. The 
reductions are actually observed in experiments, equations (12)-(16). 
 
[RuII(5mazpy)(5mazpy)(azpy)]2+ + e- → [RuII(5mazpy)(5mazpy)(azpy1-)]+              (12)  
[RuII(5mazpy)(5mazpy)(azpy1-)]+  +  e- →  [RuII(5mazpy)(5mazpy1-)(azpy1-)]0                   (13) 
 [RuII(5mazpy )(5mazpy1-)(azpy1-)]0 + e- → [RuII(5mazpy1-)(5mazpy1-)(azpy1-)]-                      (14) 
[RuII(5mazpy 1-)(5mazpy1-)(azpy1- )]-  +e- → [RuII(5mazpy1- )(5mazpy1- )(azpy2- )]2-      (15)        
[RuII(5mazpy1-)(5mazpy1-)(azpy2-)]2-  +e- →[RuII(5mazpy1-)(5mazpy2-)(azpy2-)]3-           (16) 
 
   The reduction potentials of the [Ru(5mazpy)2L′](PF6)2 complexes (L′ 
= bpy, phen) are listed in equation (17)-(21).  
 
[RuII(L′)(5mazpy)(5mazpy)]2+ + e-  →  [RuII(L′)(5mazpy)(5mazpy1-)]+                   (17) 
[RuII(L′)(5mazpy)(5mazpy1-)]+ + e-   →   [RuII(L′)(5mazpy1-)(5mazpy1-)]0                          (18) 
[RuII(L′ )(5mazpy1-)(5mazpy1-)]0  + e-  →   [RuII(L′ )(5mazpy1-)(5mazpy2-)]-                          (19) 
[RuII(L′ )(5mazpy1-)(5mazpy2-)]-    + e-  →   [RuII(L′ )(5mazpy2-)(5mazpy2-)]2-               (20) 
[RuII(L′ )(5mazpy2-)(5mazpy2-)]2-  + e- → [RuII(L′ -1)(5mazpy2-)(5mazpy2-)]3-                       (21) 
 
The reduction potentials data of the [Ru(L′)25mazpy](PF6)2 (L′ = bpy, 
phen) complexes only four reductions are observed with one electron transfer in each 
equation (22)-(25). 
  
[RuII(L′)2(5mazpy)]2+   +  e-   →   [RuII(L′)2(5mazpy1-)]+                (22) 
[RuII(L′)2(5mazpy1-)]+ +  e-   →   [RuII(L′)2(5mazpy2-)]0                                                     (23) 
[RuII(L′)2(5mazpy2-)]0   +  e-  →    [RuII(L′ )(L′1-)(5mazpy2-)]-                                            (24) 
[RuII(L′ )(L′1-)(5mazpy2-)]-    +  e-  →    [RuII(L′1- )2(5mazpy2-)]2-                                            (25) 
 
The first reduction potential of the [Ru(5mazpy)2L](PF6)2 and [Ru 
(5mazpy)2L′](PF6)2 complexes (L = azpy, 5mazpy; L′ = bpy, phen) was compared. 
Therefore, the [Ru(5mazpy)2azpy](PF6)2 complex could accept electron better than 
the [Ru(5mazpy)3](PF6)2 and [Ru(5mazpy)2bpy](PF6)2 ≈ [Ru(5mazpy)2phen](PF6)2 
complexes, respectively. This is in accorded with the π-acidity order of the ligands: 





















 3.4.7  X-ray Crystallography 
 
  The structure of the [Ru(5mazpy)2bpy](PF6)2 complex was confirmed 
by X-ray crystallographic technique. 
 
(a) X-ray structure of the [Ru(5mazpy)2bpy](PF6)2 complex 
 
The single crystals of [Ru(5mazpy)2bpy](PF6)2 were grown by slow 
diffusion of ethanol into acetone solution of the [Ru(5mazpy)2bpy](PF6)2 complex. 
The detailed measurement consitions and the crystal data are listed in Table 3.35. The 
selected bond lengths and bond angles are given in Table 3.36. Figure 3.95 shows the 
ORTEP and atom numbering scheme for the [Ru(5mazpy)2bpy](PF6)2 complex. This 
complex was crystallized from methanol 
 
Table 3.35  Crystallographic data of the [Ru(5mazpy)2bpy](PF6)2complex   
 
    Empirical formula  C34H30F12P6N8Ru 
    Formula weight  941.73 
    Crystal system  Monoclinic 
    Z 4 
    Space group  C2/c  
    a = 24.3405(15) Å α = 90o 
    b = 14.0049(8) Å β = 123.86(1)o 
    c = 16.3346(10) Å γ = 90o 
    Temperature  293(2) K 
    Wavelength  0.71073 Å 
    Volume 4626.3(8) Å3 
    Density (calculated) 1.352 Mg/m3 
    Completeness to theta  24.00o   
    Goodness-of-fit on F2 1.169 
    Refinement method Full-matrix least-squares on F2 
 Table 3.35  (continued) 
 
    R indices (all data) R1 = 0.0780, wR2 = 0.107 
    Measurement: Bruker SMART CCD diffractometer 
    Program system: SHELX-97 
    Structure determination: Direct methods (SHELXS-97) 
    Refinement: full-matrix least-squares (SHELXL-97) 
 
 
Table 3.36  Selected bond lengths (Å) and bond angles (°) of the  
                  [Ru(5mazpy)2bpy](PF6)2 complex 
  
     Ru(1)-N(1)       2.15(2)                     Ru(1)-N(2)                 2.06(2)                               
     Ru(1)-N(4)       2.05(2)                     C(7)-C(71)                     1.56(6)                                
     N(1)-C(1)       1.30(5)                     N(1)-C(5)        1.30(3)                               
     N(2)-C(6)        1.37(4)                     N(2)-C(10)       1.26(3)                              
     C(10)-N(3)       1.38(5)                     N(3)-N(4)        1.26(3)                               
     N(4)-C(11)                         1.40(5)                      
                                                      
N(1)-Ru(1)-N(1)       78.1(7)                     N(2)-Ru(1)-N(4)       74.2(9)                               
N(2)-Ru(1)-N(2)      169.5(8)                   N(1)-Ru(1)-N(4)      174.8(8)                   
N(1)-Ru(1)-N(4)      100.4(9)                   N(1)-Ru(1)-N(2)      100.5(9)                   
N(1)-Ru(1)-N(2)      87.7(8)                     N(2)-Ru(1)-N(4)       97.4(9)                 
     N(4)-Ru(1)-N(4)       81.7(9)                                                    
      
 
The ruthenium ion of this complex is six-coordinated. The 
coordination geometry around ruthenium(II) is distorted octahedral with coordinating 
from two N-donor centers of bpy and four N-donor centers of two 5mazpy units. The 
pyridine rings of 5mazpy are at the cis position and the two pyridine rings of bpy 
ligand are trans to the azo groups of the 5mazpy ligands. The trans-angles around the 
ruthenium center in the plane ranged from 169.5(8) to 174.8(8)° indicating distortions 
 from the rectilinear geometry. The chelate angles extended by two 5mazpy and one 
bpy are 74.2(9), and 78.1  (7)°, respectively. 
               The Ru-N(azo) (2.05(2)Å) distances are shorter than Ru-N(pyridine) of 
5mazpy (2.06(2)Å). The shortening  may be due to greater π-backbonding, dπ(Ru) 
→π* (azo). In this complex the N-N distances of 5mazpy are 1.264(3)Å which are 
slightly longer than those of free 5mazpy ligand (N=N 1.228(2)Å, and azpy (N=N 
1.248(2)Å, Panneerselvam et al., 2000). In addition, the N=N distances of 5mazpy in 
tris complex, [Ru(5mazpy)2bpy](PF6)2, are shorter than that in starting complex, ctc-
[Ru(5mazpy)2Cl2] (N=N 1.284(3)Å). The coordination could lead to a decrease in the 
N-N bond order due to σ-donor and π-acceptor character of the ligands. The Ru-
N(pyridine) of bpy is 2.15(2)Å which longer than Ru-N(pyridine) distances in 
5mazpy. Owing to pyridine rings of bpy is trans to azo function of 5mazpy. The 
results from the molecular structure of the this complex confirm that 5mazpy is a 
better π-acceptor than bpy. The chelate angles extend by 5mazpy were 74.2(9)° reveal 
a considerable distorsion of octahedron, as was found for the complexes [Ru(azpy)2 
bpy](PF6)2 (75.7(16)°, 76.8(17)°) (Kanidtha et al., 2007). As a consequence of the 
















 3.5  Syntheses of the [Ru(5mazpy)2L](NO3)2, [Ru(5mazpy)2L′]Cl2, and       
[Ru(L′)25mazpy]Cl2 complexes (L = azpy, 5mazpy; L′ = bpy, phen) 
 
Reaction of the ctc-[Ru(5mazpy)2Cl2] complex with L ligands (azpy, 
5mazpy) in the presence of AgNO3 in methanol afforded tris-complexes, 
[Ru(5mazpy)2L](NO3)2, as shown in equation (26). 
 
                  AgNO3 
     ctc-[Ru(5mazpy)2Cl2]       [Ru(5mazpy)2L](NO3)2                  (26) 
                 MeOH, L 
 
  The [Ru(5mazpy)2L′]2+ complexes (L′ = bpy, phen) were isolated as 
chloride salt, [Ru(5mazpy)2L′]Cl2, by the reaction of [Ru(5mazpy)L′](PF6)2 with tetra 
-n-butylammoniumchloride in acetone. The synthetic route is shown in equation (27). 
 
                   NBu4Cl 
     [Ru(5mazpy)2L′](PF6)2         [Ru(5mazpy)2L′]Cl2                      (27) 
                   acetone 
 
Addition of the saturated tetra-n-butylammoniumchloride in acetone to 
an acetone solution of the complexes [Ru(L′)25mazpy](PF6)2 (L′ = bpy, phen) had 
eliminated PF6¯ and gave [Ru(L′)25mazpy]Cl2 (equation (28)). 
 
                               NBu4Cl 
     [Ru(L′)25mazpy](PF6)2            [Ru(L′)25mazpy]Cl2                   (28) 
                    acetone 
 
The complexes of [Ru(5mazpy)2L](NO3)2, [Ru(5mazpy)2L′]Cl2, and 
[Ru(L′)25mazpy]Cl2 (L = 2-(phenylazo)pyridine (azpy), 5-methyl-2-(phenylazo)pyri- 
dine (5mazpy), L′ = 2,2′-bipyridine (bpy), 1,10-phenanthroline (phen)) are readily 
soluble in water. These complexes were synthesized to study DNA-binding. All the 
 experiments involving the interaction of the complexes with DNA which were carried 
out using Tris buffer. The physical properties of these complexes are listed in Table 
3.37.  
 
Table 3.37  The physical properties of the [Ru(5mazpy)2L](NO3)2, 
[Ru(5mazpy)2L′]Cl2, and [Ru(L′)25mazpy]Cl2 complexes 
 
 Physical properties 
Complexes 
Appearance Color Melting point (°C) 
[Ru(5mazpy)3](NO3)2.5H2O Solid Red-brown 230-232 
[Ru(5mazpy)2azpy](NO3)2.4H2O Solid Red-brown 232-235 
[Ru(5mazpy)2bpy]Cl2.6H2O Solid Dark-Red 245-248 
[Ru(5mazpy)2phen]Cl2.7H2O Solid Dark-Red 280-253 
[Ru(bpy)25mazpy]Cl2.6H2O Solid Red-brown 242-244 
[Ru(phen)25mazpy]Cl2.9H2O Solid Red-brown 248-252 
 
 
3.6 Characterization of the [Ru(5mazpy)2L](NO3)2, [Ru(5mazpy)2L′]Cl2, and  
       [Ru(L′)25mazpy]Cl2 complexes (L = azpy, 5mazpy; L′ = bpy, phen) 
 
All complexes were characterized by following techniques: 
 
3.6.1 Elemental analysis 
 3.6.2 Infrared spectroscopy 
 3.6.3 1D and 2D Nuclear Magnetic Resonance spectroscopy 
 
 
 3.6.1  Elemental analysis  
 
The elemental analysis data of the complexes were in very good 
agreement with the calculated values and thus confirmed the composition. The results 
are summarized in Table 3.38.  
 
Table 3.38  Elemental analysis data of the [Ru(5mazpy)2L](NO3)2,    
[Ru(5mazpy)2L′]Cl2, and [Ru(L′)25mazpy]Cl2 complexes 
 
%C %N %H  
Complexes 
 Calc. Found Calc. Found Calc. Found 
[Ru(5mazpy)3](NO3)2.5H2O 47.08 47.85 17.26 17.74 4.63 4.21 
[Ru(5mazpy)2azpy](NO3)2.4H2O 48.05 48.84 17.61 17.71 4.49 4.43 
[Ru(5mazpy)2bpy]Cl2.6H2O 49.16 49.58 13.49 13.86 5.10 4.95 
[Ru(5mazpy)2phen]Cl2.7H2O 49.54 49.99 12.84 12.50 5.08 5.68 
[Ru(bpy)25mazpy]Cl2.6H2O 48.67 48.61 12.41 11.76 4.97 4.50 




3.6.2  Infrared Spectroscopy  
 
IR spectral data were collected in the range 4000-370 cm-1 using KBr 
discs and characteristic group frequencies are given in Table 3.39. The IR spectra of 
the [Ru(5mazpy)3](NO3)2.5H2O, [Ru(5mazpy)2azpy](NO3)2.4H2O, [Ru(5mazpy)2bpy] 
Cl2.6H2O, [Ru(5mazpy)2phen]Cl2.7H2O, [Ru(bpy)25mazpy]Cl2.6H2O, and [Ru(phen)2 
5mazpy ]Cl2.9H2O complexes are shown in Figure 3.96 to 3.101. 
 
 
Table 3.39  Infrared spectroscopic data of the [Ru(5mazpy)2L](NO3)2,  
                     [Ru(5mazpy)2L′]Cl2, and [Ru(L′)25mazpy]Cl2 complexes 
 
[Ru(5mazpy)2L](NO3)2 [Ru(5mazpy)2L′]Cl2 [Ru(L′)25mazpy]Cl2  Vibration 
modes 
























































NO3¯ 1386(s) 1384(s) - - - - 
 
s = strong, m = medium 
 
The IR spectral data of the [Ru(5mazpy)2L](NO3)2, [Ru(5mazpy)2L′] 
Cl2, and [Ru(L′)25mazpy]Cl2 complexes (L = azpy, 5mazpy; L′ = bpy, phen)  were 
recorded in the range 4000-370 cm-1. The complexes exhibit a broad bands assignable 
to the water in molecule. at 3500-3400 cm-1 The IR spectra of the [Ru(5mazpy)2L] 
(NO3)2, [Ru(5mazpy)2L′]Cl2 complexes have compared with the spectra of ctc-
[Ru(5mazpy)2Cl2]. An intense band observes in the range 1604-1429 cm-1 corresponds 
to C=C, C=N stretching modes.  
The N=N stretching band of [Ru(5mazpy)3](NO3)2.5H2O, [Ru 
(5mazpy)2azpy](NO3)2.4H2O, [Ru(5mazpy)2bpy]Cl2.6H2O, and  [Ru(5mazpy)2phen] 
Cl2.5H2O is observed at 1363, 1360, 1341, and 1338 cm-1, respectively. In ctc-
[Ru(5mazpy)2Cl2], the N=N band appears at 1334 cm-1. However, this band shifts to 
 higher in the [Ru(5mazpy)2L](NO3)2, and  [Ru(5mazpy)2L′]Cl2 complexes. This 
results can be implied that the third ligand is competition for the ruthenium t2g 
electron and less π back-bonding to azo ligand raising the N=N bond order. 
The  [Ru(L′)25mazpy]Cl2 complexes contain one azoimine ligand an 
two imine ligands. From the previous works, the azoimine ligand is the better π-
acceptor than that the imine ligand. Therefore, we have observed that the N=N 
stretching mode in these complexes shifts to lower frequencies than that free 5mazpy 
ligand (1389 cm-1) and [Ru(5mazpy)2L](NO3)2, [Ru(5mazpy)2L′]Cl2.  
The [Ru(5mazpy)2L′]Cl2, and [Ru(L′)25mazpy]Cl2 complexes were 
synthesized from the reaction of tetra-n-butylammoniumchloride in acetone solution 
and the [Ru(5mazpy)2L′](PF6)2, and [Ru(L′)25mazpy](PF6)2 complexes, respectively. 
The υ(PF6¯) in complexes of [Ru(5mazpy)2L′]Cl2, and [Ru(L′)25mazpy]Cl2 
disappears in the IR spectra. This results can be used to confirm that the PF6¯ counter 


















 3.6.3  1D and 2D Nuclear Magnetic Resonance spectroscopy 
  
  The 1H, 13C, DEPT 135, 1H-1H COSY, and 1H-13C HMQC NMR 
spectra of the [Ru(5mazpy)2L](NO3)2, [Ru(5mazpy)2L′]Cl2, and [Ru(L′)25mazpy]Cl2 
complexes were carried out in CD3OD (500 MHz) and tetramethylsilane (SiMe4) was 
used as internal reference. The 1D and  2D NMR data of these complexes were 
described as below. 
  
a) Nuclear Magnetic Resonance spectroscopy of the [Ru(5mazpy)3](NO3)2.5H2O 
complex 
 















δ (ppm) J (Hz) Number of H 
13C NMR 
δ (ppm) 
3C 9.10 (d) 8 1 132.40 
3A 8.50 (d) 8 1 131.67 



























































δ (ppm) J (Hz) Number of H 
13C NMR 
δ (ppm) 
4C 8.41 (d) 8 1 143.81 
6C 8.33 (d) 1 1 153.45 
4B 8.22 (dd) 8, 1 1 143.69 
4A 8.15 (dd) 8.5, 1.5 1 143.44 
6A 8.09 (s) - 1 151.38 
6B 7.96 (s) - 1 152.83 
10C 7.57 (t) 8 1 134.53 
10A 7.55 (t) 8 1 134.53 
9,9′C 7.46 (dd) 8, 8 2 131.21 
10B 7.44 (t) 8 1 134.42 
9,9′A 7.37 (dd) 8, 8 2 130.82 
8,8′A 7.27 (d) 8 2 123.79 
9,9′B 7.22 (dd) 8, 8 2 130.63 
8,8′C 7.21 (d) 8 2 123.75 
8,8′B 6.85 (dd) 8 2 123.59 
11C 2.52 (s) - 3 19.25 
11A 2.51 (s) - 3 19.19 
11B 2.49 (s) - 3 19.07 
Quaternary Carbons 
164.01, 163.74, 162.97, 
157.06, 152.48, 134.56, 
145.48, 145.14, 144.99 
 
d = doublet, dd = doublet of doublet, s = singlet, and t = triplet 
   The 1H NMR spectrum (Figure 3.102) of the [Ru(5mazpy)3](NO3)2. 
5H2O complex shows three sets of pyridine ring and three sets of phenyl ring signals. 
As this complex has C1 symmetry, all three 5mazpy ligands are inequivalent, resulting 
in eighteen resonances in aromatic region and three resonances in aliphatic region. 
The pyridine protons appear at the lower field (9.10 to 7.96 ppm) than that the phenyl 
protons (7.57 to 6.85 ppm). The proton H3 (9.10 ppm) in pyridine  ring C occurs at 
the lowest field because this pyridine ring is trans to azo group. The protons H6 of 
5mazpy ligand exhibit at 8.33 (doublet, J = 1 Hz), 8.09 (singlet), and 7.96 ppm 
(singlet) which are easily recognised from the smaller J coupling in comparison to the 
J coupling of the proton H3 and appear at 9.10 (doublet, J = 8 Hz), 8.50 (doublet, J = 
8 Hz), and 8.47 ppm (doublet, J = 8 Hz). The methyl resonances of 5mazpy ligand in 
this complex are observed at 2.52, 2.51, and 2.49 ppm. The methyl signal has been 
particularly confirm that this complex contains three 5mazpy ligands. The assignment 
of all signals was made from 1H-1H COSY NMR spectroscopic data. The 1H-1H 
COSY NMR spectrum is shown in Figure 3.103. Results from 2D NMR, the three 
sets of 5mazpy pyridine signals and three sets of 5mazpy phenyl signals have been 
distinguish. 
  The 13C NMR spectrum (Figure 3.104) shows eighteen methine 
carbons, nine quaternary carbons, and three methyl carbons which supports by the 
results from DEPT 135 NMR spectrum (Figure 3.105). Carbon atom neighbouring the 
nitrogen atom shifts to downfield due to the electronegative nitrogen atom. The 
protonated carbon atoms at C6 of 5mazpy moiety are shifted to downfield in the 
spectrum (153.45, 151.38, and 152.83 ppm). These signals are used to confirm that 
this molecule contains three 5mazpy ligand. The assignment of all signals was made 
from 1H-13C HMQC NMR spectroscopic data. Figure 3.106 displays 1H-13C HMQC 
NMR spectrum of the [Ru(5mazpy)3](NO3)2.5H2O complex. The 1H-13C HMQC 
NMR spectrum provides information regarding the interaction between the protons 
and the carbon atoms which they are directly attached. In the present complex, the 
absence of any countours assign to the quaternary carbons. Therefore, this result 
corresponds to the 13C NMR and DEPT 135 NMR spectroscopic data. 
 
 b) Nuclear Magnetic Resonance spectroscopy of the [Ru(5mazpy)2azpy](NO3)2. 
4H2O complex 
 















δ (ppm) J (Hz) Number of H 
13C NMR 
δ (ppm) 
3(azpy) 9.22 (d) 8 1 134.74 
4(azpy) 8.59 (dd) 8, 8 1 143.52 
6(azpy) 8.53 (dd) 5.5, 1 1 153.56 
3(5mazpy) 8.51 (d) 8 1 131.77 
3(5mazpy) 8.48 (d) 8 1 131.74 
4(5mazpy) 8.21 (d) 8 1 143.74 
4(5mazpy) 8.14 (d) 8 1 143.42 
6(5mazpy) 8.13 (s) - 1 152.59 























































δ (ppm) J (Hz) Number of H
13C NMR 
δ (ppm) 
5(azpy) 7.86 (dd) 7.5, 6 1 131.25 
10(5mazpy) 7.59 (t) 7.5 1 134.74 
10(azpy) 7.55 (t) 8 1 134.57 
9,9′A(5mazpy),  
10(5mazpy) 
7.46 (m) - 3 131.20, 134.62 
9,9′(azpy) 7.36 (dd) 8, 8 2 130.70 
8,8′B(5mazpy), 
8,8′(azpy), 7.26 (m) 8 4 
123.96, 
123.74 
9B(5mazpy) 7.23 (dd) 8, 8 2 130.86 
8B(5mazpy) 6.88 (d) 8 2 123.68 
11A 2.50 (s) - 3 19.10 
11B 2.49 (s) - 3 19.03 
Quaternary Carbons 
165.01, 164.01, 163.66,  
157.21, 153.51, 152.89, 
145.55, 145.35 
 
d = doublet , dd = doublet of doublet, m = multiplet, s = singlet, and t = triplet 
 
  The 1H NMR spectrum of [Ru(5mazpy)2azpy](NO3)2.4H2O (Figure 
3.107) in CD3OD contains twenty-one proton resonances, which indicates the 
formation of the mixed-ligand complex. The pyridine protons appear at the lower 
field (9.22 to 7.86 ppm) than that phenyl protons (7.59 to 6.88 ppm) due to the 
nitrogen atom in pyridine ring. The protons on pyridine ring of azpy ligand occur at 
the lower field than protons on pyridine ring of 5mazpy due to trans to N=N azo 
 group. In addition, the 5mazpy ligand contains methyl group which is electron 
donating group. The signal at 9.22 ppm (doublet, J = 8 Hz) is assigned to the proton 
H3 of the azpy ligand because this signal has a bigger J coupling than the resonances 
corresponding to the proton H6 (8.53 ppm, doublet of doublet, J = 5.5, 1 Hz). Besides, 
the protons H3 on pyridine ring of the both 5mazpy ligand exhibit (8.51, 8.48 ppm) at 
the downfield than the other protons on pyridine ring. The assignment of individual 
proton resonances have been assigned using 1H-1H COSY NMR spectroscopy (Figure 
3.108). The both pyridine rings of 5mazpy ligand in parent complex, ctc-
[Ru(5mazpy)2Cl2], are trans. If the third ligand (unsymmetric ligand) coordinates to 
ruthenium ,the [Ru(5mazpy)2azpy](NO3)2.4H2O complex lacks of C2-symmetry. 
Therefore, two methyl signals are observed (2.50 and 2.49 ppm).  
  The 13C NMR spectrum (Figure 3.109) shows nineteen methine 
carbons, eight quaternary carbons, and two methyl carbons. This results are supported 
with DEPT 135 NMR spectroscopy (Figure 3.110). The two carbon signals in 
aliphatic region are observed at 19.10 and 19.03 ppm which are assigned to methyl 
carbons. All signals have been assigned using 1H-13C HMQC NMR spectroscopy. The 
















 c) Nuclear Mmagnetic Resonance spectroscopy of the[Ru(5mazpy)2bpy]Cl2.6H2O  
complex 
 















δ (ppm) J (Hz) Number of H 
13C NMR 
δ (ppm) 
3(bpy) 8.90 (d) 8 1 126.73 
3(5mazpy) 8.58 (d) 8 1 130.63 
4(bpy) 8.35 (ddd) 8, 8, 1 1 141.69 
6(bpy) 8.14 (d) 5 1 153.70 
4(5mazpy) 8.12 (dd) 8, 1.5 1 142.61 
6(5mazpy) 7.93 (s) - 1 150.68 
5(bpy) 7.66 (dd) 8, 5 1 130.06 
10(5mazpy) 7.52 (t) 8 1 134.04 























































δ (ppm) J (Hz) Number of H 
13C NMR 
δ (ppm) 
8(5mazpy) 7.23 (d) 8 2 123.69 
11 2.39 (s) - 3 19.05 
Quaternary Carbons 
164.53, 156.52, 154.53, 
144.03 
 
d = doublet, dd = doublet of doublet, ddd = doublet of doublet  of doublet, s = singlet,  
and t = triplet 
 
  The 1H NMR spectrum of the [Ru(5mazpy)2bpy]Cl2.6H2O complex 
(Figure 3.112) displays eleven protons resonances from thirty protons in molecule. 
Due to the C2 axis present in this complex, the two 5mazpy ligands are equivalent 
(A=B) and even the two pyridine rings of bpy ligand are indistinguishable. Form 1H-
1H COSY NMR spectrum (Figure 3.113), the two sets of pyridine (bpy and 5mazpy) 
are observed. They can be assigned using 1H-1H COSY NMR spectroscopy. The 
proton H3 (doublet, J = 8 Hz) of bpy ligand is easily recognised from the J coupling 
in comparison to the proton H6 (doublet, J = 5.5 Hz). The signal at 7.93 ppm (singlet) 
is assigned to proton H6 of 5mazpy, as this resonance exhibits weak COSY NMR 
cross peak with proton H4 (8.12 ppm, doublet, J = 1.5 Hz). The assignment of the 
resonances at 7.52 ppm (triplet, J = 8 Hz), 7.33 ppm (doublet of doublet, J = 8, 8 Hz), 
7.23 ppm (doublet, J = 8 Hz) as proton H10, H9,9′, and H8,8′, respectively. Only one 
methyl signal iss observed at 2.39 ppm (singlet) because the effective C2 symmetry is 
retained.  
The 13C NMR spectrum is illustrated in Figure 3.114. The DEPT 135 
NMR spectrum (Figure 3.115) agrees with  the carbon spectrum. As [Ru(5mazpy)2 
bpy]Cl2.6H2O has C2 symmetry, ten methine carbons, four quaternary carbons and 
one methyl carbon are observed. The carbon signals at 153.70 and 150.68 ppm are 
 expected carbon C6(bpy) and C6(5mazpy), respectively. The 1H-13C HMQC NMR 
spectrum is shown in Figure 3.116. This 1H-13C HMQC NMR data are in 






























 d) Nuclear Magnetic Resonance spectroscopy of the [Ru(5mazpy)2phen]Cl2.7H2O 
complex 
 
















δ (ppm) J (Hz) Number of H 
13C NMR 
δ (ppm) 
4(phen) 8.94 (dd) 8, 1 1 140.77 
3(5mazpy) 8.61 (d) 8 1 130.71 
2(phen) 8.60 (dd) 5, 1 1 154.90 
5 (phen) 8.43 (s) - 2 129.74 
4(5mazpy) 8.06 (dd) 8, 1 1 142.51 
3(phen) 8.01 (dd) 8, 8 1 128.36 
6(5mazpy) 7.65 (d) 1.5 1 150.85 
10(5mazpy) 7.53 (t) 8 1 133.92 
9,9′(5mazpy) 7.37 (dd) 8, 8 2 130.65 















































δ (ppm) J (Hz) Number of H 
13C NMR 
δ (ppm) 
11(5mazpy) 2.19 (s) - 3 18.82 
Quaternary Carbons 
164.52, 154.59, 146.82  
143.91, 133.06 
 
d = doublet, dd = doublet of doublet, ddd = doublet of doublet of doublet,  
m = multiplet, s = singlet, and t = triplet 
 
The  1H NMR spectrum of the [Ru(5mazpy)2phen]Cl2.7H2O complex 
(Figure 3.117) shows one set of 5mazpy and four protons of phen. The coordination 
of phen ligand (symmetric ligand) to the isomeric bis(ligand) complex, ctc-
[Ru(5mazpy)2], results in a complex that has C2 axis, resulting in equivalent 5mazpy 
ligand. The assignment of all signals was made from 1H-1H COSY NMR 
spectroscopic data. This spectrum is shown in Figure 3.118. The protons of pyridine 
ring from 5mazpy and phen are assigned by using 1H-1H COSY NMR spectroscopic 
technique, and  NMR spectroscopic data of parent complex, ctc-[Ru(5mazpy)2Cl2]. 
The resonances corresponding to the proton H6 of 5mazpy (7.65 ppm, doublet, J = 
1.5 Hz) and proton H2 (8.60 ppm, doublet of doublet, J = 5, 1 Hz) of phen have a 
smaller  J coupling than resonances corresponding to the proton H3 of 5mazpy (8.61 
ppm, doublet, J = 8 Hz) and proton H4 of phen (8.94 ppm, doublet of doublet, J = 8, 1 
Hz). The proton H4 (8.94 ppm) of phen ligand occurs at the lowest field because of 
trans to the azo nitrogen of the 5mazpy ligand. The phenyl protons of 
[Ru(5mazpy)2phen]Cl2.7H2O display at the downfield (7.53 ppm (H10), 7.37 ppm 
(H9,9′), 7.31 ppm (H8,8′)) when compared with the ctc-[Ru(5mazpy)2Cl2] (7.25 ppm 
(H10), 7.10 ppm (H9,9′), 6.80 ppm (H8,8′)). This results can be implied that the 
coordination of phen ligand. The phen ligand is σ-donor and π-acceptor while the Cl 
 ligand is σ-donor. Only one single sharp methyl signal is observed at 2.19 ppm 
(singlet). It is then resonable to assume that the effective C2 symmetry is retained.  
The 13C NMR spectrum is displayed in Figure 3.119 which is used to 
support with DEPT 135 NMR spectrum (Figure 3.120).  Ten methine carbons, five 
quaternary carbons and one methyl carbon are found. The carbon C2(phen) appears at 
154.90 ppm and carbon C6(5mazpy) exhibits at 150.85 ppm due to the coordination 
of nitrogen atom to ruthenium. The carbon signal at 18.82 ppm is assigned to the 
methyl carbon. Appearance of the carbons of methyl group as one signal suggest that 
two methyl groups of this complex are magnetically equivalent. This observation is 
consistent with the 1H, DEPT 135, 1H-1H COSY and 1H-13C HMQC NMR 






















 e) Nuclear Magnetic Resonance spectroscopy of the [Ru(bpy)25mazpy]Cl2.6H2O 
complex  
 














δ (ppm) J (Hz) Number of H 
13C NMR 
δ (ppm) 
3(bpy) 8.82 (d) 8 1 126.35 
3(bpy) 8.81 (d) 8 11 126.03 
3(5mazpy) 8.80 (d) 8 1 129.09 
3(bpy) 8.47 (d) 8 1 125.43 
3(bpy) 8.33 (d) 8 1 125.27 
4(bpy), 4(bpy) 8.25 (m) - 2 140.92 
4(bpy) 8.21 (dd) 8, 8 1 140.74 
4(5mazpy) 8.16 (d) 8 1 12.35 
6(bpy) 8.15 (d) 6.5 1 154.04 


















































δ (ppm) J (Hz) Number of H
13C NMR 
δ (ppm) 
6(5mazpy) 7.86 (s) - 1 150.25 
6(bpy), 6(bpy) 7.74 (d) 8 2 153.22, 152.44 
5(bpy), 5(bpy) 
5(bpy) 
7.59 (m) - 3 
129.68, 129.56, 
 129.37 
6(bpy) 7.46 (d) 6 1 151.69 
5(bpy) 7.44 (dd) 8, 8 1 129.31 
10(5mazpy) 7.33 (t) 8 2 131.98 
9,9′(5mazpy) 7.16 (dd) 8, 8 2 130.15 
8,8′(5mazpy) 7.16 (dd) 8, 8 2 123.04 







d = doublet, dd = doublet of doublet, ddd = doublet of doublet of doublet,  
m = multiplet, s = singlet, and t = triplet 
 
  The downfield region (8.82 to 7.44 ppm) of 1H NMR spectrum (Figure 
3.122) exhibits five sets of pyridine ring. The fact that the two bpy ligand are non-
equivalent upon coordination of 5mazpy. With the use of 1H-1H COSY NMR 
experiment, the bpy and 5mazpy signals are assigned. The protons on pyridine ring of 
5mazpy was assigned using the cross peak at the 1H-1H COSY NMR spectrum 
(Figure 3.123). The proton H4 (8.16 ppm, doublet, J = 8 Hz) of 5mazpy displays 
intense cross peak with proton H3 (8.80 ppm, doublet, J = 8 Hz) and weak cross peak 
 with proton H6 (7.86 ppm, singlet)  in COSY NMR spectrum. The proton H3 on 
pyridine ring C of bpy occurs at the lowest field (8.82 ppm) due to trans to nitrogen 
atom of azo group. The assignment is performed by comparison with [Ru(bpy)3] 
(BF4)2 (Tempiam, S., 2002). In pyridine ring of bpy, proton H3 appears at lowest 
field, this is similar to the [Ru(bpy)3](BF4)2 complex. The phenyl protons occur at the 
highfield region (7.33 to 7.16 ppm). The triplet peak at 7.33 ppm corresponding to 
proton H10 are observed. The protons methyl signal are assigned at 2.34 ppm as 
singlet peak. 
   The 13C NMR spectrum (Figure 3.124) consists with the DEPT 135 
NMR spcetrum (Figure 3.125). Twenty-two methine carbons, seven quaternary 
carbons, and one methyl carbon are observed. The 1H-13C HMQC NMR spectrum 
(Figure 3.126) shows cross peak which supports the 1H, 13C, DEPT 135, and 1H-1H 




















 f) Nuclear Magnetic Resonance spectroscopy of the [Ru(phen)25mazpy]Cl2.9H2O 
complex 
 














δ (ppm) J (Hz) Number of H
13C NMR 
δ (ppm) 
7A(phen) 8.90 (d) 8 1 141.98 
4B(phen), 
3(5mazpy) 
8.85 (d) 8, 5 2 140.19, 129.50 
4A(phen) 8.79 (d) 8 1 139.86 
2B(phen) 8.76 (d) 5 1 155.73 
7B(phen) 8.50 (d) 8.5 1 138.89 
5,6A(phen) 8.40 (m) - 2 129.31 
5B(phen) 8.20 (d) 8 1 129.01 
4(5mazpy) 8.16 (d) 7.5 1 142.31 
















































8.04 (m) - 4 
154.52, 127.97,  
152.87, 127.97 
9B(phen) 7.89 (d) 6.5 1 150.82 
6(5mazpy) 7.83 (s) - 1 153.49 
3A(phen) 7.76 (dd) 8, 8 1 127.64 
8B(phen) 7.58 (dd) 8, 8 1 127.40 
10(5mazpy) 7.09 (m) - 1 131.63 
8,8′(5mazpy), 
9,9′(5mazpy) 6.92 (m) - 4 
125.55,  
129.72 









d = doublet, dd = doublet of doublet, m = multiplet, s = singlet, and t = triplet 
 
  The 1H NMR spectrum of [Ru(phen)25mazpy]Cl2 is shown in Figure 
3.127. As this complex has C1 symmetry, all ligands are inequivalent. Twenty-two 
proton signals are observed at aromatic region, and one proton signals is found at 
aliphatic region. The 1H-1H COSY NMR spectrum is shown in Figure 3.128. Using 
COSY connectivities the other resonances are assigned. Assignments of proton 
resonances are made by spin-spin splitting, comparative integration and chemical 
 shift. The proton H7 of phen (A) is assigned the resonance at 8.90 ppm (doublet, J = 8 
Hz) which occurs at the lowest field due to trans to the azo nitrogen. The 5mazpy 
signals are clearly present in the 1H NMR spectrum, the proton H6 at 7.83 ppm 
(singlet), the proton H4 at 8.16 ppm (doublet, J = 7.5 Hz), and the proton H3 at 8.85 
ppm (doublet, J = 8 Hz), and the methyl at 2.24 ppm, respectively. The phenyl 
protons occur at highfield region (7.09 ppm (H10), 6.92 ppm (H8,8′, H9,9′)) which 
are similarly to [Ru(phen)25mazpy)](PF6)2.  
  The 13C NMR spectrum of this complex (Figure 3.129) correlates with 
the DEPT 135 NMR spectrum (Figure 3.130). There are twenty-two methine carbons, 
eleven quaternary carbons, and only one methyl carbon in this molecule. Besides, the 
assignments of all signals were made from 1H-13C HMQC NMR spectroscopy 





















 3.7  DNA binding 
  
  The numerous biological experiments performed so far suggest that 
DNA is the main cellular target of antitumor drugs because the interaction between 
small molecules and DNA can cause DNA damage in cancer cells, blocking the 
division of cancer cells  and resulting in cell date (Quiroga et al., 1998). In this 
experiment, we interested to study interaction of ruthenium complexes with calf 
thymus DNA (CT DNA). The DNA binding of ruthenium(II) complexes, 
[Ru(5mazpy)2L](NO3)2,    [Ru(5mazpy)2L′]Cl2,  and [Ru(L′)25mazpy]Cl2 (L = azpy, 
5mazpy; L′ = bpy, phen), with CT DNA had been monitored by absorption titration, 
competitive binding and viscosity measurements. 
 
3.7.1  Absorption titration 
 
Absorption spectral titration of the complexes with CT DNA was 
followed by monitoring the MLCT bands. The absorption spectra of the 
[Ru(5mazpy)3](NO3)2.5H2O, [Ru(5mazpy)2azpy](NO3)2.4H2O, [Ru(5mazpy)2bpy]Cl2. 
6H2O, [Ru(5mazpy)2phen]Cl2.7H2O, [Ru(bpy)25mazpy]Cl2.6H2O, and [Ru(phen)2 
5mazpy]Cl2.9H2O complexes in the absence and presence of increasing amounts of 
CT DNA are shown in Figure  3.132 to Figure 3.137. As the DNA concentration is 
increased, the MLCT transition bands of [Ru(5mazpy)3](NO3)2.5H2O, [Ru(5mazpy)2 
azpy](NO3)2.4H2O, [Ru(bpy)25mazpy]Cl2.6H2O, and [Ru(phen)25mazpy]Cl2.9H2O at 
494 nm and Ru(5mazpy)2bpy]Cl2.6H2O, [Ru(5mazpy)2phen]Cl2.7H2O at 515 nm 
exhibited hypochromism. The binding constant (Kb) for binding of the ruthenium(II) 
complexes to CT DNA are summarizes in Table 3.46. In the all complexes, although 
no red shift is found, notable hypochromicities are observed. To compare 
quantitatively the binding strength of the six complexes, the intrinsic binding, Kb, was 
determined according to following equation (29) (Wolfe et al., 1987). 
 
 [DNA]/(εa-εf) = [DNA]/(εb-εf) + 1/(Kb(εb-εf))                                 (29) 
    The εa, εf and εb correspond to Aobs/[Ru], the extinction coefficient for 
the free ruthenium complex and the extinction coefficient for the ruthenium complex 
in fully bound form, respectively. The slope and y intercept of the linear fit of 
[DNA]/(εa-εf) versus [DNA] are 1/(εb-εf) and 1/Kb(εb-εf), respectively.  The binding 
constant (Kb) can be obtained from the slope to the y intercept. 
 
Table 3.46  Absorption spectral data and binding constant (Kb) for binding of the 
[Ru(5mazpy)2L](NO3)2, [Ru(5mazpy)2L′]Cl2  and [Ru(L′)25mazpy]Cl2 








[Ru(5mazpy)3](NO3)2.5H2O 494 6.08 1.5(±0.1)x105 
[Ru(5mazpy)2azpy](NO3)2.4H2O 494 7.73 1.2(±0.2)x105 
[Ru(5mazpy)2bpy]Cl2.6H2O 515 10.82 8.5(±0.2)x104 
[Ru(5mazpy)2phen]Cl2.7H2O 515 7.04 9.0(±0.3)x104 
[Ru(bpy)25mazpy]Cl2.6H2O 494 9.17 6.5(±0.2)x104 
[Ru(phen)25mazpy]Cl2.9H2O 494 9.01 1.5(±0.2)x105 
 
aIn MLCT band; Hypochromism, [(Afree-Abound)/Afree]x100% 
 
The complexes of [Ru(5mazpy)3](NO3)2.5H2O and [Ru(5mazpy)2 
azpy](NO3)2.4H2O exhibit MLCT transition at 494 nm which show a decrease in 
intensity that a maximum value of 6.08% and 7.73%, respectively as the amount of 
DNA is increase. Intrinsic  binding constants, Kb, of the [Ru(5mazpy)3](NO3)2 .5H2O 
and [Ru(5mazpy)2azpy](NO3)2.4H2O complexes are obtained as ca. 1.5(±0.1)x105, 
and  1.2(±0.2)x105 M-1, respectively. Then the binding constants of 
[Ru(5mazpy)2bpy] Cl2.6H2O and [Ru(5mazpy)2phen]Cl2.7H2O are calculated by the 
ration of slope to intercept as 8.5(±0.2)x104 M-1 and 9.0(±0.3)x104 M-1, respectively. 
 In addition, the percentage hypochromicities of MLCT band upon binding to DNA 
are found to be 10.82% and 7.04% for [Ru(5mazpy)2bpy]Cl2.6H2O and 
[Ru(5mazpy)2phen]Cl2.7H2O, respectively. The binding constants of 
[Ru(bpy)25mazpy]Cl2.6H2O and [Ru(phen)2 5mazpy]Cl2.9H2O, with calf thymus 
DNA were determined from the decay of the absorbance monitor at 494 nm of both 
complexes. The determined binding constants are about 6.5(±0.2)x104 M-1 (%H = 
9.17) and 1.5(±0.2)x105 M-1 (%H = 9.01)  for [Ru(bpy)25mazpy]Cl2.6H2O and 
[Ru(phen)25mazpy]Cl2.9H2O, respectively.  
These values are comparable to that observed for [Ru(phen)2phi]2+ (phi 
= 9,10-phenanthrenequinonediimine) (4.7x104 M-1) (Pyle et al., 1989), but smaller 
than those observed for [Ru(bpy)2(dppz)]2+ (>106 M-1) (Friedman et al., 1990) and 
[Ru(ip)2(dppz)]2+ (ip = imidazo[4,5-f][1,10]phenanthroline) (2.1x107 M-1) (Jenkins et 
al., 1992). The strength of the interaction of complexes with DNA increases in order 
[Ru(5mazpy)3](NO3)2.5H2O, [Ru(phen)2(5mazpy)]Cl2.9H2O, [Ru(5mazpy)2azpy] 
(NO3)2.4H2O, [Ru(5mazpy)2phen]Cl2.7H2O, [Ru(5mazpy)2bpy]Cl2.6H2O, and [Ru 
(bpy)25mazpy]Cl2.6H2O. The moderate binding for these complexes was comparable 
to those observed for many ruthenium complexes (Zou et al., 2001), but smaller than 
the classical interactions and metallointercalators whose binding constants are in the 
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Figure 3.132  (a) Absorption spectra of the  [Ru(5mazpy)3](NO3)2.5H2O complex in  
tris base buffer pH 7.4 upon addition of CT DNA in the absence (top 
line) and presence of CT DNA; [Ru] = 40 µM. The arrow showing the 
intensity change upon increasing DNA concentration. Plot [DNA]/(εa-
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Kb =  1x105 M-1 


























Figure 3.133  (a) Absorption spectra of the  [Ru(5mazpy)2azpy](NO3)2.4H2O  
complex in  tris base buffer  pH 7.4 upon addition of CT DNA in the 
absence (top line) and presence  of CT DNA; [Ru] = 40 µM. The arrow 
showing the intensity change upon increasing DNA concentration. Plot 
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Figure 3.134 (a) Absorption spectra of the  [Ru(5mazpy)2bpy]Cl2.6H2O complex in 
tris base buffer pH 7.4 upon addition of CT DNA in the absence (top 
line) and presence  of CT DNA; [Ru] = 40 µM. The arrow showing the 
intensity change upon increasing DNA concentration. Plot [DNA]/(εa-
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Figure 3.135  (a) Absorption spectra of the  [Ru(5mazpy)2phen]Cl2.7H2O complex in 
tris base buffer pH 7.4 upon addition of CT DNA in the absence (top 
line) and presence of CT DNA; [Ru] = 40 µM. The arrow showing the 
intensity change upon increasing DNA concentration. Plot [DNA]/(εa-
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Figure 3.136 (a) Absorption spectra of the [Ru(bpy)25mazpy]Cl2.6H2O complex in 
tris base buffer pH 7.4 upon addition of CT DNA in the absence (top 
line) and presence of CT DNA; [Ru] = 40 µM. The arrow showing the 
intensity change upon increasing DNA concentration. Plot [DNA]/(εa-
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Figure 3.137  (a) Absorption spectra of the [Ru(phen)25mazpy]Cl2.9H2O complex in 
tris base buffer pH 7.4 upon addition of CT DNA in the absence (top 
line) and presence  of CT DNA; [Ru] = 40 µM. The arrow showing the 
intensity change upon increasing DNA concentration. Plot [DNA]/(εa-
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 3.7.2  Competitive binding 
 
No luminescence is observed for all of complexes, [Ru(5mazpy)3] 
(NO3)2.5H2O, [Ru(5mazpy)2azpy](NO3)2.4H2O, [Ru(5mazpy)2bpy]Cl2.6H2O, [Ru 
(5mazpy)2phen]Cl2.7H2O, [Ru(bpy)25mazpy]Cl2.6H2O, and [Ru(phen)25mazpy]Cl2.9 
H2O at room temperature in aqueous solution. Hence competitive binding studies 
using ethidium bromide (EB) bound to DNA were carried out for these complexes. 
The quenching extent of fluorescence of EB bound to DNA was used to determine the 
binding of complexes and DNA. Binding of complex results in the displacement of 
bound EB molecule with a reduction of emission intensity. The addition of the 
complexes to DNA pretreated with EB caused appreciable reduction in the emission 
intensity, indicating that the displacement of EB fluorophore by the complexes results 
in a decrease of the binding of EB to DNA. The data form this experiment were fited 
into the classical Stern-Volmer equation (30) (Lakowicz and Webber, 1973). 
 
                                           I0/I = 1+Kr                                                                    (30) 
 
  The I0 and I are the luminescence intensities in the absence and 
presence of complex, respectively; K is a linear Stern-Volmer quenching constant; r is 
the ration of total concentration of complex to that of DNA.                                
The emission spectra of EB bound to DNA in the absence and presence 
of complex and the fluorescence quenching curves of EB bound to DNA by the 
ruthenium (II) complexes and are shown in Figure 3.138-3.143. The Emission spectral 
data and linear Stern-Volmer quenching constant (K) on binding to CT DNA are 
summarized in Table 3.47.  
In the plot of I0/I versus [Ru]/[DNA], K was given by the ratio of the 
slope to the intercept. The K values for [Ru(5mazpy)3](NO3)2.5H2O, [Ru(5mazpy)2 
azpy](NO3)2.4H2O were estimated using equation (2) which are 4.92 (R = 0.997) and 
4.47 (R = 0.992) respectively, and suggest that the interaction of the complex [Ru 
(5mazpy)3](NO3)2.5H2O with DNA is strong as compared to that with [Ru(5mazpy)2 
azpy](NO3)2.4H2O which is consistent with the above absorption spectral results. 
   In comparison of the [Ru(5mazpy)2bpy]Cl2.6H2O and  [Ru(5mazpy)2 
phen]Cl2.7H2O complexes, the K of [Ru(5mazpy)2bpy]Cl2.6H2O and  [Ru(5mazpy)2 
phen]Cl2.7H2O are 4.04 and 4.68, respectively; the R values of their linear fit plot of 
I0/I versus [Complex]/[DNA] are 0.994 and 0.995, respectively. The data suggest that 
the interaction of  [Ru(5mazpy)2phen]Cl2.7H2O with CT DNA is stronger than [Ru 
(5mazpy)2bpy]Cl2.6H2O which correspond to the data absorption titration.   
The K values for the complexes [Ru(bpy)25mazpy]Cl2.6H2O and 
[Ru(phen)25mazpy]Cl2.9H2O were 4.37 and 4.46, respectively. According to these 
data, the magnitude of binding affinity of both complexes with DNA is 
[Ru(bpy)25mazpy]Cl2.6H2O < [Ru(phen)25mazpy]Cl2.9H2O. All of these results  are 
consistent with the above absorption spectral results.                                              
 
Table 3.47  Emission spectral data and linear Stern-Volmer quenching constants (K) 
for  binding of the [Ru(5mazpy)2L](NO3)2, [Ru(5mazpy)2L]Cl2  and 
[Ru(L′)25mazpy]Cl2 complexes with CT  DNA 
 
Complexes I0 I I0/I K %H 
[Ru(5mazpy)3](NO3)2.5H2O 395 335 1.18 4.92 15.19 
[Ru(5mazpy)2azpy](NO3)2.4H2O 385 329 1.17 4.74 14.55 
[Ru(5mazpy)2bpy]Cl2.6H2O 378 330 1.15 4.04 12.70 
[Ru(5mazpy)2phen]Cl2.7H2O 386 332 1.17 4.68 13.99 
[Ru(bpy)25mazpy]Cl2.6H2O 401 348 1.15 4.37 13.22 
[Ru(phen)25mazpy]Cl2.9H2O 384 330 1.16 4.46 14.06 
 
 





























Figure 3.138  (a) Emission spectra (λex = 340 nm) of EB in Tris-base buffer in the 
absence (top line) and presence of increasing of concentrations of the  
[Ru(5mazpy)3](NO3)2.5H2O complex. Arrow shows that the  intensity 
changes upon increasing concentrations. (b) Fluorescence  quenching 
curves of EB bound to DNA by [Ru(5mazpy)3](NO3)2.5H2O ([EB] = 2  






















































Figure 3.139  (a) Emission spectra (λex = 340 nm) of EB in Tris-base buffer in the 
absence (top line) and presence of increasing of concentrations of the  
[Ru(5mazpy)2azpy](NO3)2.4H2O complex. Arrow shows that the  
intensity changes upon increasing concentrations. (b) Fluorescence  
quenching curves of EB bound to DNA by [Ru(5mazpy)2azpy](NO3)2 





























   











      












Figure 3.140  (a) Emission spectra (λex = 340 nm) of EB in Tris-base buffer in the 
absence (top line) and presence of increasing of concentrations of the  
[Ru(5mazpy)2bpy]Cl2.6H2O complex. Arrow shows that the  intensity 
changes upon increasing concentrations. (b) Fluorescence quenching 
curves of EB bound to DNA by [Ru(5mazpy)2bpy]Cl2.6H2O ([EB] = 2  








































        
 












Figure 3.141  (a) Emission spectra (λex = 340 nm) of EB in Tris-base buffer in the 
absence (top line) and presence of increasing of concentrations of the  
[Ru(5mazpy)2phen]Cl2.7H2O complex. Arrow shows that the  
intensity changes upon increasing concentrations. (b) Fluorescence  
quenching curves of EB bound to DNA by [Ru(5mazpy)2phen]Cl2. 






















































Figure 3.142  (a) Emission spectra (λex = 340 nm) of EB in Tris-base buffer in the 
absence (top line) and presence of increasing of concentrations of the  
[Ru(bpy)25mazpy]Cl2.6H2O complex. Arrow shows that the  intensity 
changes upon increasing concentrations. (b) Fluorescence  quenching 
curves of EB bound to DNA by [Ru(bpy)25mazpy]Cl2.6H2O ([EB] = 2  






















































Figure 3.143  (a) Emission spectra (λex = 340 nm) of EB in Tris-base buffer in the 
absence (top line) and presence of increasing of concentrations of the  
[Ru(phen)25mazpy]Cl2.9H2O complex. Arrow shows that the  intensity 
changes upon increasing concentrations. (b) Fluorescence  quenching 
curves of EB bound to DNA by [Ru(phen)25mazpy]Cl2.9H2O ([EB] = 




























 3.7.3  Viscosity measurements 
 
Further clarification of the interaction between the ruthenium 
complexes and DNA was carried out by viscosity measurements. Hydrodynamic 
measurements that are sensitive to length change (i.e., viscosity, sedimentation)  and 
are regarded as the least ambiguous and the most critical tests of binding in solution in 
the absence of crystallographic structural data. A classical intercalation model results 
in lengthening the DNA helix, as base pairs are separated to accommodate  the 
binding ligand, leading to the increase of DNA viscosity. In contrast, a partial and/or 
non-classical intercalation of ligand could bind (or kink) the DNA helix, reducing its 
effective length and, concomitantly, its viscosity (Satyanarayana et al., 1992). Effects 
of the complexes together with [Ru(bpy)3]Cl2.7H2O and Eithidium Bromide EB on 
the viscosity are shown in Figure 3.144-3.146. Ethidium bromide (EB) is a known 
DNA classical intercalator and increase the relative specific viscosity for the 
lengthening of the DNA double helix through the intercalation mode; while for 
complex  [Ru(bpy)3]2+  which has been well known to bind with DNA only through 
the electrostatic mode, it exerts essentially no effect on DNA viscosity.  
The effects of [Ru(5mazpy)3](NO3)2.5H2O, [Ru(5mazpy)2azpy](NO3)2 
.4H2O on the viscosity of CT DNA is shown in Figure 3.144. The viscosity of CT 
DNA bound with the both complexes and EB increase dramatically, indicating that 
both complexes intercalate the base pairs of DNA but is still smaller than those bound 
with EB. The experimental results suggest that the relative viscosity of CT DNA 
increase, which follows the order EB > [Ru(5mazpy)3](NO3)2.5H2O > [Ru(5mazpy)2 
azpy](NO3)2.4H2O. 
The effects of the [Ru(5mazpy)2bpy]Cl2.6H2O, together with   [Ru 
(5mazpy)2phen]Cl2.7H2O, on the viscosity of rod-like DNA are shown in Figure 
3.145. Upon increasing concentration of [Ru(5mazpy)2bpy]Cl2.6H2O and [Ru 
(5mazpy)2phen]Cl2.7 H2O, the viscosity of the DNA also increase but is smaller than 
those bound with EB. The results indicat that [Ru(5mazpy)2phen]Cl2.7H2O can 
intercalate into DNA base pairs slightly stronger than [Ru(5mazpy)2bpy]Cl2.6H2O. 
Figure 3.146 shows the effects of [Ru(bpy)25mazpy]Cl2.6H2O and 
[Ru(phen)25mazpy]Cl2.9H2O  on the viscosity of CT DNA. On increasing the 
 amounts of [Ru(bpy)25mazpy]Cl2.6H2O and [Ru(phen)25mazpy]Cl2.9H2O, the 
relative viscosity of DNA increase steadily, this is similar to the behavior of EB. The 
increase degree of viscosity, which may depend on its affinity to DNA, follows the 
order of EB >  [Ru(phen)25mazpy]Cl2.9H2O > [Ru(bpy)25mazpy]Cl2.6H2O. The 














Figure 3.144  Effects of increasing amount of the complexes of [Ru(5mazpy)3](NO3)2 
.5H2O  (z),  [Ru(5mazpy)2azpy](NO3)2.4H2O (), [Ru(bpy)3]Cl2. 
6H2O () and Ethidium Bromide () on relative viscosities of CT 




































Figure 3.145  Effects of increasing amount of the complexes of [Ru(5mazpy)2bpy] 
Cl2.6H2O (), [Ru(5mazpy)2phen]Cl2.7H2O (z), [Ru(bpy)3]Cl2.6H2O 
() ,and Ethidium Bromide ()on relative viscosities of CT DNA at 













Figure 3.146  Effects of increasing amount of the [Ru(bpy)25mazpy]Cl2.6H2O  (),  
[Ru(phen)25mazpy]Cl2.9H2O  (z), [Ru(bpy)3]Cl2.6H2O  (), 
                       [Ru (phen)3]Cl2.7H2O (c) complexes and Ethidium Bromide ()on 
relative viscosities of CT DNA at 25°C. ([DNA] = 300 µM, 
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 3.7.4  Cyclic voltammetry 
 
The application of electrochemical methods to study of 
metallointercalation and coordination of metal ions and chelates to DNA provides a 
useful complement to the previously used methods of investigation, such as UV-
Visible spectroscopy. A summary of the voltammetric results is given in Table 3.48 
and typical CV responses of ruthenium complexes in Tris-base buffer in the presence 
and absence of CT DNA are shown in Figure 3.147 to Figure 3.152.  
On the addition of DNA (R = 5) to all the complexes, the peak 
potential seperation ∆Ep decrease or increase depending on the ligand.  The E1/2 values 
of the DNA-bound complexes  follow the same order as that for free complexes. 
Analogous to the treatment of the association of small molecules with micelles 
(Kaifer and Bard 1985). In addition, the positive shifts of peak potentials indicate that 
this interaction mode may be intercalation between ruthenium complex and DNA 
(Carter and Bard, 1987). The formal potentials, (E1/2) were taken as the average of the 
anodic (Epa) and cathodic peak potentials (Epc) obtained from cyclic voltammetry. The 
net shift in E1/2 can be used to estimate the ratio of equilibrium constants for the 
binding of Ru(II) and Ru(III) complexes to DNA using the equation (31) (Maheswari 
and Palaniandavar, 2004). 
 
                         E0′b- E0′f = 0.059 log(K2+/K3+)                                (31) 
 
The E0′b and E0′f are the formal potentials of the 3+/2+ couple in the 
free and bound forms, respectively, and K2+ and K3+ are the binding constants for the 
respective binding of 2+ and 3+ species to DNA.  
All of complexes, the cyclic voltammetric data of complexes in the 
absence and presence of DNA showed only reduction peak. In this work, the first  
reduction peak was used to estimated the K2+/K3+ value. In the absence of DNA, the 
ligand based reduction is observed at -0.53 V and -0.54 V for [Ru(5mazpy)3](NO3)2 
.5H2O (Figure 3.147) and [Ru(5mazpy)2azpy](NO3)2.4H2O (Figure 3.148), 
respectively. In the absence of DNA this peak shifts to -0.50 V and -0.52 V for the 
former and latter complexes, respectively . 
 The cyclic voltammograms of [Ru(5mazpy)2bpy]Cl2.6H2O and [Ru 
(5mazpy)2phen]Cl2.7H2O in the absenc and presence of DNA are displayed in Figure 
3.149 and 3.150, respectively. In the absence of DNA, the Epc of -0.71 V for 
[Ru(5mazpy)2bpy]Cl2.6H2O, -0.67 V [Ru(5mazpy)2phen]Cl2.7H2O  and the Epa of 
both complexes occurs at -0.64 V and -0.61 V, respectively. The formal potential E1/2, 
take as the average of Epc, are -0.64, and -0.63 V, respectively. In the presence of 
DNA, the formal potential E1/2 of [Ru(5mazpy)2bpy]Cl2.6H2O and [Ru(5mazpy)2 
phen]Cl2.7H2O are -0.57, and -0.55 V, respectively. In the solution at the same 
concentration of both complexes caused a shift to positive potential.  
The [Ru(bpy)25mazpy]Cl2.6H2O (Figure 3.151) and [Ru(phen)2 
5mazpy]Cl2.9 H2O (Figure 3.152)  complexes shows the irreversible wave peak. The 
anodic peak potential in the absence of DNA of [Ru(bpy)25mazpy]Cl2.6H2O and 
[Ru(phen)25mazpy]Cl2.9H2O at -0.96 V, and -0.98 V, respectively. The anodic peak 
potential of the reduction of ligand has been found to shift to a more positive value of 
-0.92 V ([Ru(bpy)25mazpy]Cl2.6H2O) and -0.90 V ([Ru(phen)25mazpy]Cl2.9H2O) in 
the presence of DNA. 
 
Table 3.48  Cyclic voltammetric data behavioura of the [Ru(5mazpy)2L]Cl2, 
[Ru(5mazpy)2L′](NO3)2 and [Ru(L′)25mazpy]Cl2 complexes in the 
absence and presence of CT DNA  
 





























































































a Measured vs ferrocene methanol, scan rate 100 mVs-1; supporting electrolyte                      
(pH  7.1); complex concentration 5x10-4 M. 
b R = [DNA]/[Ruthenium] 
c Based on E1/2 values from cyclic voltammetry measurements. 
 
On the addition of DNA (R = 5) to all the complexes,  the reduction 
peak shifts to less negative potential and slightly drop of the voltammetric currents 
which can be attributed to diffusion of the metal complexes bound to the large, slowly 
























Figure 3.147 Cyclic voltammograms of the  [Ru(5mazpy)3](NO3)2.5H2O complex in   
absence (solid line) and presence (dash line) of CT DNA in 5 mM 















Figure 3.148  Cyclic voltammograms of the  [Ru(5mazpy)2azpy](NO3)2.4H2O 
complex in  absence  (solid line) and presence (dash line) of CT DNA in 5 mM Tris 













































Figure 3.149  Cyclic voltammograms of the  [Ru(5mazpy)2bpy]Cl2.6H2O complex in 
absence (solid line) and presence (dash line) of CT DNA in 5 mM Tris 















Figure 3.150  Cyclic voltammograms of the  [Ru(5mazpy)2phen]Cl2.7H2O complex 
in absence (solid line) and presence (dash line) of CT DNA in 5 mM 

















































Figure 3.151  Cyclic voltammograms of the  [Ru(bpy)25mazpy]Cl2.6H2O complex in  
absence (solid line) and presence (dash line) of CT DNA in 5 mM Tris 















Figure 3.152  Cyclic voltammograms of the  [Ru(phen)25mazpy]Cl2.9H2O complex 
in absence  (solid line) and presence (dash line) of CT DNA in 5 mM 

































 3.7.5  DNA cleavage study 
 
The potential of the present complexes to cleave DNA was studied by 
gel electrophoresis using pBIND DNA in TAE buffer. When circular plasmid DNA 
was subjected to electrophoresis, relatively. Fast migration will be observed for the 
intact supercoil form (Form I, ccc form). If scission occurs on one strand (nicking), 
the supercoiled will relax to generate  a slower-moving open circular form (Form II, 
OC form). If the both strands are cleaved, a linear form (Form III) will be generated 
(Selvakumar et al., 2006). 
Figure 3.153 reveals the conversion of Form I, II and III in the 
presence of varying concentrations of [Ru(5mazpy)3](NO3)2.5H2O and [Ru(5mazpy)2 
azpy](NO3)2.4H2O. No DNA cleavage is observed for controls in which the complex 
was absent (lane 0) with increasing concentration of [Ru(5mazpy)3](NO3)2.5H2O 
(lane 1-5) diminish gradually, whereas Form II increase. In addition, linear form, 
Form III, are observed.   
Figure 3.154 shows the gel electrophoretic seperation of pBIND DNA 
with different concentrations of [Ru(5mazpy)2bpy]Cl2.6H2O and [Ru(5mazpy)2phen] 
Cl2.7H2O. Control experiment (lane 0) suggests that untreated DNA does not show 
any cleavage, with increasing concentration of rutenium(II) complexes (lane 1-5 for 
[Ru(5mazpy)2bpy]Cl2.6H2O, lane 6-10 for [Ru(5mazpy)2phen]Cl2.7H2O). The amount 
of Form I of pBIND DNA decreases whereas that of Form II increase and slightly 
increase Form III. Under comparable experimental conditions, [Ru(5mazpy)2phen]Cl2 
.9H2O exhibits more effective DNA cleavage activity than [Ru(5mazpy)2bpy]Cl2.6 
H2O.  
Figure 3.155 exhibits gel electrophoresis separation of pBIND DNA 
after incubation with [Ru(bpy)25mazpy]Cl2.6H2O and [Ru(phen)25mazpy]Cl2.9H2O. 
For pBIND untreated with complex, no cleavage is observed (lane 0). On the other 
hand, formation of the open circular form, Form II, of DNA is found when DNA is 
treated with [Ru(bpy)25mazpy]Cl2.6H2O (lane 1-5) and [Ru(phen)25mazpy]Cl2.9H2O 
(lane 6-10). The different DNA cleavage efficiency of the six complexes is due to the 
different binding affinity of the complexes to DNA. 
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Figure 3.153  Electrophoresis behavior of the pBIND DNA in the presence of 
complexes on 1% agarose gel electrophoresis. Lane 0: plasmid DNA;   
                         lane 1-5: plasmid DNA was incubated with 20, 40, 60, 80, and 100 µM 
of [Ru(5mazpy)2azpy](NO3)2.4H2O, respectively;  lane 6-10: plasmid 
DNA was incubated with 20, 40, 60, 80, and 100 µM of [Ru(5mazpy)3] 
(NO3)2.5H2O respectively. Form I, II and III refer to supercoil form, 
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Figure 3.154  Electrophoresis behavior of the pBIND DNA in the presence of 
complexes on 1% agarose gel electrophoresis. Lane 0: plasmid DNA;   
                         lane 1-5: plasmid DNA was incubated with 20, 40, 60, 80, and 100 µM 
of [Ru(5mazpy)2phen]Cl2.7H2O, respectively;  lane 6-10: plasmid 
DNA was incubated with 20, 40, 60, 80, and 100 µM of [Ru(5mazpy)2 
bpy]Cl2.6H2O respectively. Form I, II and III refer to supercoil form, 
open circular form, and linear form, respectively. 
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Figure 3.155  Electrophoresis behavior of the pBIND DNA in the presence of 
complexes on 1% agarose gel electrophoresis. Lane 0: plasmid DNA;   
                         lane 1-5: plasmid DNA was incubated with 20, 40, 60, 80, and 100 µM 
of [Ru(phen)25mazpy]Cl2.9H2O, respectively;  lane 6-10: plasmid 
DNA was incubated with 20, 40, 60, 80, and 100 µM of  
                         [Ru(bpy)2 5mazpy]Cl2.6H2O respectively. Form I, II and III refer to 





















 3.8  Cytotoxicity assay 
 
The ruthenium(II) complexes exhibit a widely applied foreground in 
the search of new anticancer drugs (Velders et al, 2000; Hotze et al, 2004 ). Recently, 
some ruthenium(II) complexes, ctc-[Ru(azpy)2Cl2] (α), ccc-[Ru(azpy)2Cl2] (β), tcc-
[Ru(azpy)2 Cl2] (γ), have been reported. The α-[Ru(azpy)2Cl2] complex shows a very 
pronounced cytotoxicity, higher than that of cisplatin in all cell lines. The β-
[Ru(azpy)2Cl2] complex was approximately a factor of 10 less active than the α-
[Ru(azpy)2Cl2] and, in contrast to literature data (Velders et al, 2000), γ-
[Ru(azpy)2Cl2] showed an activity comparable to that of the α-[Ru(azpy)2Cl2]. To 
further investigate the cytotoxic activity, the rutenium(II) complexes with 5-methyl-2-
(phenylazo)pyridine ligand have been studied. The first part of cytotoxicity was 
studied at Cancer Drug Resistance Group, Centenary Institute of Cancer Medicine & 
Cell Biology,  University of Sydney, Australia. There were several human tumor cell 
lines (A549, CEM, IGROV, MCF-7, PC3, SK-MEL-28, and WIDR). The compounds 
in the second part were tested IC50 at National Center for Genetic Engineering and 
Biotechnology, Bangkok, Thailand, with three cell lines (Anti-NCI-H187, BC, and 
KB). 
The in vitro cytotoxicity effects of the parent complexes, α,β,γ-
[Ru(azpy)2Cl2], and the α,β,γ-[Ru(5mazpy)2Cl2] complexes were compared with 
cisplatin (positive control), in a series of human tumor cell lines are listed in Table 
3.49. A DMSO stock solution was used in the cytotoxicity tests of all complexes, as 
these complexes are poorly water soluble.  The IC50 values represent the 
concentration of a drug that is required for 50% reduction of cellular growth. The α-
[Ru(5mazpy)2Cl2] complex is more active in all cell lines, while γ-[Ru(5mazpy)2Cl2] 
is less active in all cell lines. In addition, the α-[Ru(5mazpy)2 Cl2] complex shows 
higher activity in the lung cancer (A549) and colon cancer cell lines (WIDR) cell lines 
than that of cisplatin. However, this isomer shows activity slightly below that of 
cisplatin in ovarian cencer (IGROV), breast cancer (MCF-7), and prostate cancer 
(PC3), melanoma cancer (SK-MEL-28), and leukemia (CEM) cell lines. In 
comparison to the parent complexes, α,β,γ-[Ru(azpy)2Cl2], the α,β,γ-[Ru(5mazpy)2 
 Cl2] complexes show a lower activity than the α,β,γ-[Ru(azpy)2Cl2] complexes in 
most cell lines. The IC50 curves of α,β,γ-[Ru(azpy)2Cl2], α,β,γ-[Ru(5mazpy)2Cl2], and 
cisplatin are illustrated in Figure 3.156-3.162, respectively. Results from these data 
showed that the α-isomer of [Ru(L)2Cl2] (L = azpy, 5mazpy) displayed a high 
cytotoxicity. 
 
Table 3.49  IC50 valuesa (µM) of a series of ruthenium(II) complexes and cisplatin 
against  a resies of tumor cell lines (A549, CEM, IGROV, MCF-7, PC3,  




A549 CEM IGROV MCF-7 PC3 SK-MEL-28 WIDR 
α-[Ru(azpy)2Cl2] 0.13 0.60 0.14 0.29 0.26 0.15 0.20 
β-[Ru(azpy)2Cl2] 2.05 10.39 1.97 3.39 8.84 4.50 4.66 
γ-[Ru(azpy)2Cl2] 0.01 0.15 0.016 0.053 0.039 0.028 0.045 
α-[Ru(5mazpy)2Cl2] 0.50 1.41 0.71 1.48 1.37 1.03 0.78 
β-[Ru(5mazpy)2Cl2] 17.25 13.07 16.61 19.23 18.55 8.87 8.38 
γ-[Ru(5mazpy)2Cl2] >26 >26 >26 >26 >26 >26 >26 
cisplatin 0.90 2.97 0.40 0.41 0.52 0.94 4.64 
 
amethod: cytotoxicity assay at Cancer Drug Resistance Group, Centenary Institute of 
Cancer Medicine & Cell Biology, University of Sydney, Australia. A549: lung cancer; 
CEM: leukemia; IGROV: ovarian cancer; MCF-7: breast cancer; PC3: prostate 
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Figure 3.156  IC50 curves of the α-[Ru(azpy)2Cl2] complex against a resies of tumor 
cell lines A549 (a), CEM (b), IGROV (c), MCF-7 (d), PC3 (e), SK-
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Figure 3.157  IC50 curves of the β-[Ru(azpy)2Cl2] complex against a resies of tumor 
cell lines A549 (a), CEM (b), IGROV (c), MCF-7 (d), PC3 (e), SK-
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Figure 3.158  IC50 curves of the γ-[Ru(azpy)2Cl2] complex against a resies of tumor 
cell lines A549 (a), CEM (b), IGROV (c), MCF-7 (d), PC3 (e), SK-
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Figure 3.159  IC50 curves of the α-[Ru(5mazpy)2Cl2] complex against a resies of 
tumor cell lines A549 (a), CEM (b), IGROV (c), MCF-7 (d), PC3 (e), 
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Figure 3.160  IC50 curves of the β-[Ru(5mazpy)2Cl2] complex against a resies of  
tumor cell lines A549 (a), CEM (b), IGROV (c), MCF-7 (d), PC3 (e), 
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Figure 3.161  IC50 curves of the γ-[Ru(5mazpy)2Cl2] complex against a resies of 
tumor cell lines A549 (a), CEM (b), IGROV (c), MCF-7 (d), PC3 (e), 
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Figure 3.162  IC50 curves of cisplatin against a resies of tumor cell lines A549 (a), 
















 Besides, the IC50 values of ruthenium(II) complexes, in small cell lung 
cancer (Anti-NCI-H187), breast cancer (BC), and oral human epidermal carcinoma 
(KB) cell lines were determined. The cytotoxicity of ruthenium(II) complexes in a 
series of human tumor cell lines are listed in Table 3.50. In comparison to the parent 
complexes, α,β,γ-[Ru(azpy)2Cl2], the γ-[Ru(5mazpy)2Cl2] complex is slightly active 
only in small cell lung cancer cell line. In addition, the γ isomer shows a higher 
activity than ellipticine which is positive control. The α,β,γ-[Ru(5mazpy)2Cl2] 
complexes are inactive in oral human epidermal carcinoma and breast cancer. The tris 
chelates complexes, [Ru(5mazpy)3](PF6)2, [Ru(5mazpy)2azpy](PF6)2, [Ru(5mazpy)3] 
(NO3)2.5H2O, and [Ru(5mazpy)2azpy](NO3)2.4H2O, are active in all cell lines (Anti-
NCI-H187, BC, KB). The [Ru(5mazpy)2bpy](PF6)2 and [Ru(phen)25mazpy](PF6)2 
complexes show weakly active in small cell lung cancer. The [Ru(5mazpy)2phen] 
(PF6)2 complex displays moderatly active (IC50 = 7.64 µg/mL) in oral human 
epidermal carcinoma. The complexes of [Ru(5mazpy)2bpy]Cl2.6H2O and [Ru 
(5mazpy)2phen]Cl2.9H2O show weakly active in oral human epidermal carcinoma 
with IC50 17.64 and 15.41 µg/mL, respectively. 
 
Table 3.50  IC50 valuesa (µg/mL) of a series of ruthenium(II) complexes and cisplatin  




Anti-NCI-H187 BC KB  
Vero 
cell 
5mazpy 5.34 (m) inactive inactive 12.90 
α-[Ru(5mazpy)2Cl2] 0.24 (s) inactive inactive >50 
β-[Ru(5mazpy)2Cl2] inactive inactive inactive - 
γ-[Ru(5mazpy)2Cl2] 0.49 (s) inactive inactive >50 
α-[Ru(azpy)2Cl2] inactive 1.27 (s) 4.28 (s) >50 
β-[Ru(azpy)2Cl2] inactive 0.98 (s) inactive >50 
γ-[Ru(azpy)2Cl2] 1.12 (s) 0.278 (s) 0.401 (s) >50 
 




Anti-NCI-H187 BC KB  
Vero  
cell 
[Ru(5mazpy)3](PF6)2 5.23 (m) 3.88 (s) 1.03 (s) >50 
[Ru(5mazpy)2azpy](PF6)2 5.03 (m) 8.71 (m) 2.09 (s) >50 
[Ru(5mazpy)2bpy](PF6)2 17.85 (w) Inactive Inactive >50 
[Ru(5mazpy)2phen](PF6)2 Inactive Inactive 7.64 (m) >50 
[Ru(bpy)25mazpy](PF6)2 Inactive Inactive Inactive - 
[Ru(phen)25mazpy](PF6)2 10.35 (w) Inactive Inactive >50 
[Ru(5mazpy)3](NO3)2.5H2O 4.23 (s) 4.93 (s) 1.20 (s) >50 
[Ru(5mazpy)2azpy](NO3)2.4H2O 4.38 (s) 8.90 (m) 2.01 (s) >50 
[Ru(5mazpy)2bpy]Cl2.6H2O Inactive Inactive 17.64 (w) >50 
[Ru(5mazpy)2phen]Cl2.7H2O Inactive Inactive 15.41 (w) >50 
[Ru(bpy)25mazpy]Cl2.6H2O 16.01 (w) Inactive Inactive >50 
[Ru(phen)25mazpy]Cl2.9H2O Inactive Inactive Inactive - 
Doxorubicin 0.029 0.140 0.103 - 
Ellipticine 0.618 0.134 0.413 0.5 
 
a method: sulforhodamine B (SRB) assay at National Center for Genetic Engineering 
and Biotechnology, Bangkok, Thailand. Anti-NCI-H187: small cell lung cancer; BC: 
Breast cancer; KB: Oral human epidermal carcinoma  
IC50 (µg/mL) Activity 
> 20  Inactive 
> 10-20 Weakly active  
5 – 10  Moderately active 
< 5   Strongly active 
 
 




  The new a symmetric bidentate ligand, 5-methyl-2-(phenylazo) 
pyridine (5mazpy), was synthesized and it reacted with RuCl3.3H2O in ethanol under 
refluxing condition. Three isomers of [Ru(5mazpy)2Cl2] were isolated by column 
chromatography. There are cis-trans-cis (ctc, α), cis-cis-cis (ccc, β), and trans-cis-cis 
(tcc, γ) by the order of coordinating pairs of Cl, N(py), and N(azo), respectively. In 
addition, the [Ru(5mazpy)2L](PF6)2, [Ru(5mazpy)2L′](PF6)2, and [Ru(L′)25mazpy] 
(PF6)2 complexes (L = 2-(phenylazo)pyridne (azpy), 5-methly-2-(phenylazo)pyridne 
(5mazpy); L′ = 2, 2′-bipyridine  (bpy), and 1,10-phenanthroline (phen)) were also 
synthesized. They have been characterized by elemantal analysis, mass spectrometry, 
UV-Visible absorption spectroscopy, infrared spectroscopy, 1H, 13C, DEPT 135, 1H-
1H COSY, and 1H-13C HMQC NMR spectroscopy and their electrochemical 
properties were also studied by cyclic voltammetry. The structures of 5mazpy, ctc-, 
ccc-, tcc-[Ru(5mazpy)2Cl2], and [Ru(5mazpy)2bpy](PF6)2 have been confirmed by X-
ray crystallography.  
  Results from X-ray crystallography show that the N-N distances in ctc-
, ccc-, tcc-[Ru(5mazpy)2Cl2], and [Ru(azpy)2bpy](PF6)2 are longer than those in the 
free 5mazpy ligand. In addition, the average Ru-N(azo) distances are shorter than 
average Ru-N(py) distances. The 5mazpy ligand exhibits a sharp band at 1389 cm-1, 
corresponding to N=N stretching mode. In the  ctc-, ccc-, and tcc-[Ru(5mazpy)2Cl2] 
complexes the υ(N=N) is red shifted by 1299-1334 cm-1, which is a good indication of 
N-coordination. The υ(N=N) in [Ru(5mazpy)2L](PF6)2, [Ru(5mazpy)2L′](PF6)2, and 
[Ru(L′)25mazpy](PF6)2 is also shifted to lower energy than that of the free ligand. In 
addition, in [Ru(5mazpy)2L′](PF6)2 (L′ = bpy, phen), N=N stretching mode occurs at 
lower energy than [Ru(5mazpy)2L](PF6)2 (L = azpy , 5mazpy). As the [Ru(5mazpy)2 
L](PF6)2 complexes contain more azoimine group than the [Ru(5mazpy)2L′](PF6)2 
complexes. Besides the υ(N=N) in [Ru(L′)25mazpy](PF6)2 (L′ = bpy ,phen) appears at 
lower frequencies than that [Ru(5mazpy)2L′](PF6)2 because the former complexes 
 contain one azo imine ligand and the latter complexes contain  two azoimine ligands. 
Solution electronic spectra of the complexes revealed that the ctc-, and ccc-
[Ru(5mazpy)2Cl2] complexes exhibit highly intense MLCT transitions at higher 
energy than the tcc-[Ru(5mazpy)2Cl2] complex. Only one intense band is observed in 
the visible region for [Ru(5mazpy)2L](PF6)2, [Ru(5mazpy)2L′](PF6)2, and [Ru(L′)2 
5mazpy](PF6)2. The 1H, 13C, DEPT 135, 1H-1H COSY, and 1H-13C HMQC NMR 
spectroscopy are used to supported the structure of compounds. All the three isomers 
of [Ru(5mazpy)2Cl2] exhibit one reversible peak and one irriversible peak. 
Furthermore, The reduction potential in negative region shifts from the free ligand 
value. In [Ru(5mazpy)2L](PF6)2, [Ru(5mazpy)2L′](PF6)2, and [Ru(L′)25mazpy](PF6)2, 
the [Ru(5mazpy)2azpy](PF6)2 complex can accept electron better than those of 
[Ru(5mazpy)3](PF6)2 and [Ru(5mazpy)2bpy](PF6)2 ≈ [Ru(5mazpy)2phen](PF6)2.  
The water soluble complexes, [Ru(5mazpy)2L](NO3)2, [Ru(5mazpy)2 
L′]Cl2, and [Ru(L′)25mazpy]Cl2 (L = azpy, 5mazpy; L′ = bpy, phen) were also 
synthesized for study DNA binding properties. The interaction of a series of mixed 
ligand complexes with Calf thymus DNA has been monitored by absorption titration, 
competitive binding, viscosity measurements and cyclic voltammetry. Furthermore, 
the cleavage experiment was also investigated by argarose gel electrophoresis.  
  The ctc, ccc, tcc-[Ru(5mazpy)2Cl2], [Ru(5mazpy)2L](PF6)2, [Ru(L′)2 
5mazpy](PF6)2, [Ru(5mazpy)2L′](PF6)2, [Ru(5mazpy)2L](NO3)2, [Ru(5mazpy)2L′]Cl2, 
and [Ru(L′)25mazpy]Cl2 complexes were investigated the activity against a series of 
tumor cell lines (A549, CEM, IGROV, MCF-7, PC3, SK-MEL-28, WIDR, Anti-NCI-
H187, BC, and KB). The results show that the ctc-[Ru(5mazpy)2Cl2] complex is high 
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Figure A.1  Cyclic voltammograms of the 5mazpy ligand in the reduction range with  












































 Figure A.2  Cyclic voltammograms of the ctc-[Ru(5mazpy)2Cl2] complex – couple      
(a), couple II (b) in the reduction range and couple Ru(II/III) (c) in 


















































































 Figure A.3  Cyclic voltammograms of the ccc-[Ru(5mazpy)2Cl2] complex - couple I 
(a), couple II (b) in the reduction range and couple Ru(II/III) (c) in 



















































































 Figure A.4  Cyclic voltammograms of the tcc-[Ru(5mazpy)2Cl2] complex - couple I 
(a), couple II (b) in the reduction range and couple Ru(II/III) (c) in 


















































































Figure A.5  Cyclic voltammograms of the [Ru(5mazpy)3](PF6)2 complex - couple I 
(a), couple II (b), and couple III (c) in the reduction range with various 












































































 Figure A.6  Cyclic voltammograms of the [Ru(5mazpy)3](PF6)2 complex - couple IV 


































































Figure A.7  Cyclic voltammograms of the [Ru(5mazpy)2azpy](PF6)2 complex - 
couple I (a), couple II (b), and couple III (c) in the reduction range with 
































































  Figure A.8 Cyclic voltammograms of the [Ru(5mazpy)2azpy](PF6)2 complex - 
couple IV (a), and couple V (b) in the reduction range with various scan 


























































Figure A.9  Cyclic voltammograms of the [Ru(5mazpy)2bpy](PF6)2 complex - couple  
I (a), couple II (b), and couple (III) (c) in the reduction range with various 

































































Figure A.10  Cyclic voltammograms of the [Ru(5mazpy)2bpy](PF6)2 complex -  
couple IV (a), and couple V (b) in the reduction range with various scan  





























































Figure A.11  Cyclic voltammograms of the [Ru(5mazpy)2phen](PF6)2 complex -  
couple I (a), couple II (b), and couple (III) (c) in the reduction range 


































































  Figure A.12  Cyclic voltammograms of the [Ru(5mazpy)2phen](PF6)2 complex - 
couple IV (a), and couple V (b) in the reduction range with various scan 






























































Figure A.13  Cyclic voltammograms of the [Ru(bpy)25mazpy](PF6)2 complex - 
couple I (a), couple II (b), and couple (III) (c) in the reduction range 




































































Figure A.14  Cyclic voltammograms of the [Ru(bpy)25mazpy](PF6)2 complex - 
couple IV (a), in the reduction range and couple Ru(II/III) (b) in 

































































Figure A.15  Cyclic voltammograms of the [Ru(phen)25mazpy](PF6)2 complex - 
couple I (a), couple II (b), and couple (III) (c) in the reduction range 







































































Figure A.16  Cyclic voltammograms of the [Ru(phen)25mazpy](PF6)2 complex - 
couple IV (a), in the reduction range and couple Ru(II/III) (b) in 












































 Table A.2   Bond lengths (Å) and angles (o) of the 5mazpy ligand 
 
Bond lengths (Å) 
 
Atoms Distances (Å) 
                    N(1)-C(5) 
                    N(1)-C(1) 
                    N(2)-N(3) 
                    N(2)-C(5) 
                    N(3)-C(6) 
                    C(1)-C(2) 
                    C(2)-C(3) 
                    C(2)-C(12) 
                    C(3)-C(4) 
                    C(4)-C(5) 
C(6)-C(7) 
                    C(6)-C(11) 
                    C(7)-C(8) 
                    C(8)-C(9) 
C(9)-C(10) 
                    C(10)-C(11) 
                     1.329(2) 
                     1.330(3) 
                     1.228(2) 
                     1.442(3) 
                     1.445(3) 
                     1.381(3) 
                     1.382(3) 
                     1.500(3) 
                     1.373(3) 
                     1.385(3) 
                     1.379(3) 
                     1.381(3) 
                     1.379(3) 
                     1.378(4) 
                     1.376(4) 
                     1.371(3) 
 
Bond angles (o) 
Atoms Angles (o) 
                  C(5)-N(1)-C(1)  
                  N(3)-N(2)-C(5)  
                  N(2)-N(3)-C(6)  
                  N(1)-C(1)-C(2)  
                  C(1)-C(2)-C(3)  
C(11)-C(6)-N(3) 
                   116.45(18) 
                   112.75(17) 
                   113.70(18) 
                   125.8(2)  
115.75(19)    
 124.90(19) 




















Table A.3   Bond lengths (Å) and angles (o) of the ctc-[Ru(5mazpy)2Cl2] complex 
 
Bond lengths (Å) 
               
Atoms Distances (Å) 
                   Ru(1)-Cl(1)   
                   Ru(1)-N(1)  
                   Ru(1)-N(3)   
                   Ru(1)-Cl(1)    
                   Ru(1)-N(1)   
                   Ru(1)-N(3)   
                   2.4102(7)  
                   2.043(2)   
                   1.972(2)  
                   2.4102(7)  
2.043(2) 
                   1.972(2)   















                   120.0(2) 
                   119.9(2)  
                   119.8(2)  
                   120.6(3)  
                   119.6(2)  
                   121.8(2) 
                   122.5(2)  
                   120.44(19)  
                   118.38(19) 
                   123.13(19) 
                   111.88(17)  
                   125.00(18) 
                   120.0(2)  
                   115.1(2) 
   Table A.3  (continued) 
 
Atoms Distances (Å) 
                   N(1)-C(1)   
                   N(1)-C(6)   
                   N(2)-N(3)   
                   N(2)-C(6)   
                   N(3)-C(7)   
                   C(1)-C(2)   
                   C(2)-C(3)  
                   C(2)-C(4)   
                   C(4)-C(5)   
                   C(5)-C(6)   
                   C(7)-C(8)   
                   C(7)-C(12)   
                   C(8)-C(9)   
                   1.344(3)   
                   1.356(3)   
                   1.284(3)  
                   1.391(3)  
                   1.439(3)  
                   1.387(4)  
                   1.500(5)   
                   1.385(4)  
                   1.369(4)   
                   1.389(4)  
                   1.375(4)   
                   1.378(4)   
                   1.411(5)        
 
 Bond angles (o) 
 











                   88.70(6)   
                   171.64(6)   
                   91.24(2)   
                   95.53(6) 
                   85.17(6)   
                   99.14(8)   
                   95.53(6)   




 Table  A.3 (continued) 
 






















































                    120.7(4)   
                    120.6(3)   
                    120.7(4)   
 Table A.3  (continued) 
 




Table A.4  Bond lengths (Å) and angles (o) of the ccc-[Ru(5mazpy)2Cl2] complex 
 
Bond lengths (Å) 
               







































   Table A.4  (continued) 
 








































Bond angles (o) 
 
Atoms Angles (o) 
                  N(1)-Ru(1)-N(3)          
                  N(1)-Ru(1)-N(4)          
                  N(1)-Ru(1)-N(6)          
                  N(1)-Ru(1)-Cl(1)         
                    76.8(1) 
                    96.6(1) 
                    89.5(1) 
                    88.59(9) 
 
 Table A.4  (continued) 
 
Atoms Angles (o) 
                  N(1)-Ru(1)-Cl(2)        
                  N(3)-Ru(1)-N(4)         
                  N(3)-Ru(1)-N(6)          
                  N(3)-Ru(1)-Cl(1)         
                  N(3)-Ru(1)-Cl(2)        
                  N(4)-Ru(1)-N(6)          
                  N(4)-Ru(1)-Cl(1)         
                  N(4)-Ru(1)-Cl(2)         
                  N(6)-Ru(1)-Cl(1) 
                   N(6)-Ru(1)-Cl(2)         
                   Cl(1)-Ru(1)-Cl(2)        
                   Ru(1)-N(1)-C(1)         
                   Ru(1)-N(1)-C(6)         
                   C(1)-N(1)-C(6)          
                   N(3)-N(2)-C(6)          
                   Ru(1)-N(3)-N(2)         
                   Ru(1)-N(3)-C(7)         
N(2)-N(3)-C(7) 
                   Ru(1)-N(4)-C(13)        
                   Ru(1)-N(4)-C(18)        








                    177.58(8) 
                    171.9(1) 
                    98.6(1) 
                    90.98(9) 
                    100.83(8) 
                    76.6(1) 
                    93.46(9) 
                    85.79(8) 




















 Table A.4  (continued) 
 





















               C(16)-C(17)-C(18)       
































 Table A.5  Bond lengths (Å) and angles (o) of the tcc-[Ru(5mazpy)2Cl2] complex 
 
Bond lengths (Å) 
 



















































 Table A.5  (Continued)  
 
Bond angles (o) 
 





















































 Table A.5  (continued) 
 

































Table A.6  Bond lengths (Å) and angles (o) of the [Ru(5mazpy)2bpy](PF6)2 complex 
 
Bond lengths (Å) 
 













 Table A.6  (continued) 
 

























































 Table A.6  (continued) 
 
Bond angles (o) 
 





















































 Table A.6  (continued) 
 
Bond angles (o) 
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